No definition available.
Malignant neoplasm of eye, brain and central nervous system, including Hilmo
C3_EYE_BRAIN_NEURO_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3099 |
6. Filter based on genotype QC (FinnGen only) |
2986 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF14
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye, brain and central nervous system, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2986 | 1391 | 1595 |
| Unadjusted period prevalence (%) | 0.62 | 0.49 | 0.73 |
| Median age at first event (years) | 60.39 | 57.48 | 62.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3099
- Matched controls
- 30983
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
495.6
319.9
314
7
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
673.7
313.5
305
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
439.0
307.7
418
11
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
143.3
307.7
226
17
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
20.5
307.7
419
234
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
307.7
419
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
307.7
316
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
22.4
307.7
624
345
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
523.5
307.7
1066
31
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
22.3
307.7
428
221
A04AA02
ATC
granisetron; systemic, transdermal
1005.9
307.7
703
9
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
307.7
413
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
35.6
307.7
658
233
WF003
NOMESCO Finland
Adjuvant radiotherapy
2498.6
307.7
453
*
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
1253
*
H02AB02
ATC
dexamethasone; systemic
213.8
307.7
1635
161
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1855.8
307.7
322
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
169.5
307.7
176
11
L01AX03
ATC
temozolomide; systemic
+∞
307.7
866
*
N03AF02
ATC
oxcarbazepine; oral
11.1
307.7
415
426
ZXC40
NOMESCO Finland
Use of ultrasound
60.0
307.7
181
32
WF002
NOMESCO Finland
Radical radiotherapy
441.8
307.7
688
20
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
20.8
307.7
1362
1126
A03FA01
ATC
metoclopramide; systemic, rectal
10.5
307.7
1298
1984
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
35.9
307.7
346
108
N03AX18
ATC
lacosamide; systemic
41.7
307.7
250
65
Z51.5
ICD-10 Finland
Palliative care
17.8
307.7
762
557
ZXC95
NOMESCO Finland
Use of surgical navigator
42.1
307.7
439
121
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
385.5
307.7
343
10
N03AX14
ATC
levetiracetam; systemic
38.2
307.7
870
313
A04AA01
ATC
ondansetron; systemic, rectal
20.3
307.7
606
366
XX3DW
NOMESCO Finland
Time consuming IT work
14.4
307.7
693
609
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
17.8
307.7
956
759
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
351.2
307.7
573
20
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
305.3
288
*
JN4BD
NOMESCO Finland
Extensive body CT
7.9
288.8
428
616
AA1BD
NOMESCO Finland
Extensive CT of head and brain
15.7
281.8
249
171
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
13.9
278.8
265
207
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
276.2
261
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
273.0
258
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
30.0
272.0
181
64
XCD10
NOMESCO Finland
Electrophysiological examination of eye
11.3
269.4
294
285
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
268.7
254
*
AA1AD
NOMESCO Finland
CT of head and brain
3.6
265.4
1467
6176
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
253.7
240
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
248.3
235
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
245.1
232
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
240.8
228
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
236.5
224
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
418.3
236.1
234
6
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
20.0
226.2
176
93
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.2
226.1
420
761
N02AA05
ATC
oxycodone; systemic
4.0
225.1
803
2490
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
563.3
214.8
211
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
214.1
203
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.2
210.4
245
259
JN4AD
NOMESCO Finland
Body CT examination
5.7
208.7
430
857
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
207.7
197
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1067.0
206.6
200
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
537.4
205.3
202
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.2
203.6
321
490
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
20.0
203.4
158
83
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
422.0
200.5
199
5
XA800
NOMESCO Finland
Neuropsychological investigation
6.4
198.4
354
614
G40.10
ICD-10 Finland
Simple partial seizures
27.6
197.9
135
51
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
197.2
824
2819
WF004
NOMESCO Finland
Palliative radiotherapy
2089.9
192.6
185
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
189.5
180
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.3
189.1
570
1550
WX882
NOMESCO Finland
High dependency care
8.1
184.6
259
346
WZC00
NOMESCO Finland
Treatment plan or consultation
3.0
182.6
1284
5942
ZX050
NOMESCO Finland
Stereotactic radiotherapy
320.7
179.0
180
6
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
177.8
169
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
175.7
167
*
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
172.5
164
*
N03AB02
ATC
phenytoin; systemic
13.3
171.8
165
130
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
170.4
162
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
19.0
167.6
133
73
C61
ICD-10 Finland
Malignant neoplasm of prostate
349.4
166.8
167
5
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
165.1
157
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
421.4
162.0
161
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
248.8
162.0
165
7
ZXE20
NOMESCO Finland
More than three and less than five hours
3.7
161.4
620
1985
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
25.0
157.2
111
46
ZX070
NOMESCO Finland
Intensity modified radiotherapy
522.8
152.0
150
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
28.0
152.0
103
38
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
151.3
144
*
L03AA02
ATC
filgrastim; parenteral
179.9
148.0
154
9
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
257.0
144.5
147
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
173.8
142.8
149
9
115
Kela drug reimbursment
Breast cancer
+∞
142.8
136
*
L03AA13
ATC
pegfilgrastim; parenteral
720.0
141.0
138
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
21.7
138.0
103
49
N05BA09
ATC
clobazam; oral
19.4
136.5
107
57
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
136.5
130
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
209.3
135.9
140
7
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
135.8
928
4117
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
132.2
126
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
131.2
125
*
WZC30
NOMESCO Finland
Teaching
3.3
131.1
602
2136
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
10.5
130.5
146
145
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
11.6
126.7
132
118
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
122.7
117
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
122.7
117
*
WX402
NOMESCO Finland
General anaesthesia
2.8
122.7
793
3395
N74
ICPC
Malignant neoplasm nervous system
616.5
121.0
119
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
120.6
115
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
12.6
120.3
119
98
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.6
119.5
307
728
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
118.5
113
*
N05CD08
ATC
midazolam; nasal, systemic
7.0
118.2
186
281
WW500
NOMESCO Finland
Blood transfusion
7.8
117.6
167
225
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
116.4
111
*
WX140
NOMESCO Finland
Parabulbar anesthesy
4.6
111.6
286
676
H02AB09
ATC
hydrocortisone; systemic
7.2
110.2
168
245
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
15.4
106.9
94
63
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
106.9
102
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
17.4
106.8
88
52
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.7
106.3
137
164
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
105.8
680
2879
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
105.8
101
*
PJA12
NOMESCO Finland
Sentinel node biopsy
1053.0
104.9
102
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
359.1
104.9
105
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
103.7
99
*
H53.4
ICD-10 Finland
Visual field defects
6.7
103.1
168
263
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
102.7
98
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
21.3
102.6
77
37
L02AE02
ATC
leuprorelin; implant, parenteral
16.7
102.2
86
53
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
101.6
97
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
101.6
97
*
A79
ICPC
Malignancy NOS
215.1
101.1
104
5
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
99.9
1199
6730
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.9
98.8
228
494
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
97.2
1275
7401
JN4CD
NOMESCO Finland
Very extensive body CT
9.5
97.0
116
126
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
133.1
96.6
103
8
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
50.9
95.2
55
11
A02BC02
ATC
pantoprazole; systemic
2.3
94.6
2216
16122
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
+∞
94.2
90
*
L02BA01
ATC
tamoxifen; oral
43.8
93.9
56
13
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.2
92.2
163
277
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
91.1
87
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
25.1
91.0
64
26
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
904.0
90.2
88
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
90.0
86
*
116
Kela drug reimbursment
Prostate cancer
+∞
87.9
84
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
872.2
87.1
85
*
8000/3-C71.9
ICD-O-3
Neoplasm, malignant of brain, NOS
+∞
84.8
81
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
83.7
80
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
83.7
80
*
XX2RW, ,
NOMESCO Finland
14.1
82.8
76
55
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
81.6
78
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
81.6
78
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
81.6
78
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
11.3
81.6
86
78
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
13.4
81.2
77
59
183
Kela drug reimbursment
Lamotrigin and topiramate
10.4
80.5
90
89
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
402.5
79.2
79
*
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
+∞
78.5
75
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
78.5
75
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
78.5
75
*
XW000
NOMESCO Finland
Bone marrow biopsy
5.6
78.0
152
283
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
77.4
74
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
33.2
76.3
49
15
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
6.6
75.1
123
193
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
24.5
74.6
53
22
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
135.0
74.3
79
6
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
74.3
71
*
R4110
NOMESCO Finland
Physiotherapy
2.1
74.2
908
5019
JN6AD
NOMESCO Finland
CT of torso and neck
12.9
73.5
71
56
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.4
72.7
76
68
N76
ICPC
Neoplasm nervous system unspecified
101.3
72.2
79
8
ZXM40
NOMESCO Finland
Use of fluorescent substance
114.3
72.2
78
7
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
72.2
69
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.4
71.9
61
38
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
71.1
68
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
71.1
68
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
71.1
68
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
26.2
70.7
49
19
N03AF01
ATC
carbamazepine; oral, rectal
3.5
70.0
256
776
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
68.0
65
*
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
68.0
65
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
67.2
340
1250
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
66.9
64
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.7
66.7
410
1670
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.8
65.9
92
121
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
651.5
65.1
64
*
HAC20
NOMESCO Finland
Total mastectomy
103.8
65.1
71
7
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
6.8
64.6
102
154
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
63.8
61
*
N03AX23
ATC
brivaracetam; systemic
23.3
63.5
46
20
TAB00
NOMESCO Finland
Lumbar puncture
3.7
63.1
207
583
N03AG01
ATC
valproic acid; systemic, rectal
3.1
62.8
278
946
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.0
62.4
290
1015
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
17.3
61.8
51
30
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
61.7
59
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.6
61.5
43
17
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
60.6
58
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
60.6
58
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
59.9
113
204
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
15.0
59.7
53
36
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
59.6
57
*
L01BC06
ATC
capecitabine; oral
+∞
59.6
57
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
59.6
57
*
9450/3-C71.1
ICD-O-3
Oligodendroglioma, NOS, of frontal lobe
+∞
59.6
57
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
25.0
59.6
42
17
L02BG04
ATC
letrozole; oral
6.8
59.0
93
140
R4120
NOMESCO Finland
Occupational therapy
3.0
59.0
285
1019
Z51.0
ICD-10 Finland
Radiotherapy session
302.8
58.5
59
*
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
75.0
58.3
66
9
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
578.6
57.8
57
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
57.5
55
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
57.4
180
491
WX872
NOMESCO Finland
Intensive care
3.2
57.3
239
784
WX002
NOMESCO Finland
Sedation and analgesia
2.1
56.1
635
3360
ZXA05
NOMESCO Finland
Left side
2.0
56.1
779
4443
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
557.8
55.8
55
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
16.4
55.6
47
29
B01AB10
ATC
tinzaparin; parenteral
2.7
55.5
317
1239
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
55.4
53
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
54.5
337
1370
G40.89
ICD-10 Finland
Other epilepsy
13.6
54.5
51
38
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.6
53.9
77
104
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.5
53.7
389
1706
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
537.0
53.7
53
*
ZXA00
NOMESCO Finland
Right side
1.9
53.4
837
4965
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
+∞
53.3
51
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
53.3
51
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
52.2
50
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
51.3
672
3739
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
51.2
49
*
Z2446
NOMESCO Finland
Social worker
2.9
51.2
255
926
G41.9
ICD-10 Finland
Status epilepticus, unspecified
10.7
50.6
55
52
C50.99
ICD-10 Finland
Breast, unspecified
505.9
50.6
50
*
ZX120
NOMESCO Finland
Intravenous
2.8
50.3
273
1037
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
50.1
48
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
6.3
49.4
84
137
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
48.0
46
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
48.0
46
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
105.8
47.9
52
5
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
12.5
47.8
47
38
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
47.5
675
3852
N05CF01
ATC
zopiclone; oral
1.8
47.4
1023
6665
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.8
47.1
74
111
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
47.0
45
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
46.8
1422
10205
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
45.9
44
*
C72.1
ICD-10 Finland
Malignant neoplasm: Cauda equina
+∞
45.9
44
*
B01AB05
ATC
enoxaparin; parenteral
1.8
45.5
858
5355
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
45.5
629
3550
WW300
NOMESCO Finland
Transfer of autologic stem cells
233.3
45.1
46
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
44.9
575
3159
Z3231
NOMESCO Finland
Registered nurse
1.8
44.5
817
5051
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
443.8
44.3
44
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
155.6
43.9
46
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
43.8
42
*
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
43.8
42
*
ZX112
NOMESCO Finland
Subcutaneous
7.8
43.8
61
80
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
43.0
168
529
Z2445
NOMESCO Finland
Psychologist
3.3
42.9
166
519
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
12.5
42.7
42
34
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
42.6
351
1622
HA1AA
NOMESCO Finland
X-ray mammography
3.8
42.5
135
371
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.3
42.4
62
86
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
11.8
42.1
43
37
A28
ICPC
Limited function/disability NOS
1.9
42.0
622
3582
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
41.8
391
1904
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
41.8
40
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
+∞
41.8
40
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
41.8
40
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.8
41.6
65
97
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
41.4
205
740
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.2
40.7
43
39
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.4
39.8
58
80
A06AH03
ATC
naloxegol; oral
11.2
39.8
42
38
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
10.6
39.3
43
41
A04AD12
ATC
aprepitant; systemic
202.5
38.9
40
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
38.6
37
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
38.4
344
1644
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
38.2
2056
16762
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.9
38.2
116
309
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
37.6
36
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
37.6
36
*
CAA30
NOMESCO Finland
Biopsy of orbit
101.3
36.8
40
*
Y77
ICPC
Malignant neoplasm prostate
131.6
36.8
39
*
L02BB03
ATC
bicalutamide; oral
+∞
36.5
35
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
36.5
35
*
A98
ICPC
Health maint/preventive medicine
0.6
34.8
2433
26856
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
7.3
34.8
51
71
E23.00
ICD-10 Finland
Panhypopituitarism
10.1
34.5
39
39
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
34.4
33
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
34.4
33
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
34.4
33
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
34.4
33
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
39.6
34.3
43
11
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
8.7
34.0
43
50
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
33.4
32
*
9450/3-C71.9
ICD-O-3
Oligodendroglioma, NOS, of brain, NOS
+∞
33.4
32
*
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
33.4
32
*
G40
ICD-10 Finland
Epilepsy
6.0
33.4
59
100
WX704
NOMESCO Finland
Intubation
2.4
33.1
253
1128
WZC15, ,
NOMESCO Finland
64.1
33.0
38
6
101
Kela drug reimbursment
Anterior pituitary hypofunction
6.7
32.7
52
79
C71.70
ICD-10 Finland
Malignant tumor of the brainstem without histology
+∞
32.3
31
*
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
32.3
31
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
32.3
31
*
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
13.0
32.3
31
24
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
32.0
91
231
ZXD05
NOMESCO Finland
Urgent procedure
1.7
32.0
879
5993
C70.9
ICD-10 Finland
Malignant neoplasm: Meninges, unspecified
+∞
31.3
30
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
31.3
30
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
+∞
31.3
30
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
31.3
30
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
31.3
30
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
31.3
30
*
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
9.8
31.2
36
37
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
30.8
185
738
WX892
NOMESCO Finland
Monitored bed care
2.3
30.3
251
1158
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
30.2
29
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
30.2
29
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
30.2
29
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
30.2
29
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
30.2
29
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.1
29.9
63
126
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
305.3
29.8
30
*
2151
FHL
Resection, big brain
156.5
29.7
31
*
ZZR00
NOMESCO Finland
Flap of skin
8.5
29.6
38
45
R47.0
ICD-10 Finland
Dysphasia and aphasia
4.9
29.2
65
136
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
29.2
28
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
29.2
28
*
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
29.2
28
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
29.2
28
*
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
29.2
28
*
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
29.2
28
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
29.2
270
1303
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.5
28.8
34
36
CF2S4
NOMESCO Finland
Photography of conjunctiva
34.0
28.7
37
11
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.0
28.7
61
123
Z2221
NOMESCO Finland
Medical doctor
1.7
28.5
738
4933
ZXE00
NOMESCO Finland
One hour or less
1.6
28.5
1044
7586
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
28.2
27
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
28.2
27
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
28.2
27
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
28.2
27
*
9401/3-C71.1
ICD-O-3
Astrocytoma, anaplastic, NOS, of frontal lobe
+∞
28.2
27
*
180
Kela drug reimbursment
Interferon alfa
+∞
28.2
27
*
R50.9
ICD-10 Finland
Fever, unspecified
1.9
28.1
433
2500
H47.2
ICD-10 Finland
Optic atrophy
9.5
28.0
33
35
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
284.0
27.8
28
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
42.9
27.7
34
8
WF099
NOMESCO Finland
Other radiotherapy
42.9
27.7
34
8
XX1AD
NOMESCO Finland
Other CT-examination
101.0
27.7
30
*
WW200, ,
SPAT
0.5
27.3
400
6589
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
27.1
26
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
27.1
26
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
27.1
26
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
27.1
26
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
27.1
26
*
N18
ICPC
Paralysis/weakness
3.4
27.1
100
304
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
273.3
26.8
27
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
7.1
26.7
40
57
XCK00
NOMESCO Finland
Perimetry
2.3
26.7
219
1006
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
141.2
26.6
28
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
141.2
26.6
28
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
141.2
26.6
28
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
5.4
26.6
52
97
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
23.4
26.1
37
16
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
26.1
25
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
28.6
25.4
34
12
H01AC01
ATC
somatropin; parenteral
8.9
25.1
31
35
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
25.0
24
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
25.0
24
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
25.0
24
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
25.0
24
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
25.0
24
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
39.1
24.9
31
8
N03AX22
ATC
perampanel; oral
26.4
24.8
34
13
YX9AW, ,
NOMESCO Finland
252.1
24.7
25
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
32.3
24.6
32
10
H53.2
ICD-10 Finland
Diplopia
2.8
24.5
129
481
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
24.0
23
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
24.0
23
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
24.0
23
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
24.0
23
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
24.0
23
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
24.0
23
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
23.9
497
3122
C82.1
ICD-10 Finland
Follicular lymphoma grade II
241.7
23.7
24
*
L02BG06
ATC
exemestane; oral
241.7
23.7
24
*
N88
ICPC
Epilepsy
6.2
23.6
40
65
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
23.5
828
5912
R4130
NOMESCO Finland
Speech therapy
3.0
23.3
103
349
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
28.4
23.1
31
11
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.4
23.1
38
60
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
22.9
22
*
9451/3-C71.1
ICD-O-3
Oligodendroglioma, anaplastic, NOS, of frontal lobe
+∞
22.9
22
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
22.9
22
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
22.9
22
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
22.9
22
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
22.9
22
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
22.9
22
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
7.4
22.9
33
45
CH2S4
NOMESCO Finland
Photography of iris
65.5
22.8
26
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
231.6
22.6
23
*
X76
ICPC
Malignant neoplasm breast female
120.9
22.6
24
*
CD2S4
NOMESCO Finland
Photography of eye
6.8
22.5
35
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
22.3
346
1996
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.5
22.2
78
230
H47.1
ICD-10 Finland
Papilloedema, unspecified
7.1
22.0
33
47
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
21.9
21
*
9382/3-C71.1
ICD-O-3
Oligoastrocytoma, NOS, of frontal lobe
+∞
21.9
21
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
21.9
21
*
C69.21
ICD-10 Finland
Retina
+∞
21.9
21
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
21.9
21
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
21.9
21
*
C71.7
ICD-10 Finland
Malignant neoplasm: Brain stem
+∞
21.9
21
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
21.9
21
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
25.2
21.7
30
12
WPB10
NOMESCO Finland
Making a convalescent care decision
25.2
21.7
30
12
N75
ICPC
Benign neoplasm nervous system
80.7
21.7
24
*
C90.0
ICD-10 Finland
Multiple myeloma
221.5
21.6
22
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
115.8
21.6
23
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
115.8
21.6
23
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
8.8
21.5
27
31
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
5.2
21.4
44
86
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
43.6
21.4
26
6
CBA10
NOMESCO Finland
Biopsy of eyelid
6.4
21.4
35
55
102
Kela drug reimbursment
Diabetes insipidus
26.6
21.3
29
11
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
21.3
322
1842
D69.5
ICD-10 Finland
Secondary thrombocytopenia
23.3
21.2
30
13
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
9.0
21.2
26
29
SPAT1153
SPAT
Removal of sutures
1.5
21.0
802
5801
C10AA07
ATC
rosuvastatin; oral
0.6
21.0
517
7549
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
21.0
235
1216
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
20.9
20
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
20.9
20
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
20.9
20
*
L01CB01
ATC
etoposide; systemic
+∞
20.9
20
*
C71.49
ICD-10 Finland
Malignant tumor in occipital lobe other or unspecified histology
+∞
20.9
20
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
20.9
20
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
20.9
20
*
WW409
NOMESCO Finland
Other aferesis
77.3
20.7
23
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
110.8
20.6
22
*
AA1AA
NOMESCO Finland
Head X-ray examination
5.5
20.5
39
71
R51.80
ICD-10 Finland
Headache
1.7
20.5
438
2762
2152
FHL
Extraction, big brain
22.5
20.4
29
13
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
20.3
402
6196
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
48.3
20.1
24
5
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
48.3
20.1
24
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
20.1
85
281
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
16.2
20.1
32
20
XA400
NOMESCO Finland
EEG
6.0
19.9
35
59
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
23.5
19.9
28
12
N05BA04
ATC
oxazepam; oral
1.5
19.9
731
5238
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
19.8
19
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
19.8
19
*
C71.65
ICD-10 Finland
Malignant tumor of the cerebellum primary neuroectodermal tumor
+∞
19.8
19
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
19.8
19
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
19.8
19
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
19.8
19
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
19.8
19
*
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
19.8
19
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
19.8
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
19.7
125
512
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.6
19.7
65
184
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
19.3
458
2966
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.3
19.3
32
51
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
46.3
19.2
23
5
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
16.8
19.1
30
18
1XC02, ,
NOMESCO Finland
7.2
19.1
28
39
Z31.5
ICD-10 Finland
Genetic counselling
2.5
19.0
121
497
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
18.9
161
750
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
55.3
18.9
22
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
18.8
18
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.8
18
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
18.8
18
*
C69.20
ICD-10 Finland
Retina
+∞
18.8
18
*
9401/3-C71.2
ICD-O-3
Astrocytoma, anaplastic, NOS, of temporal lobe
+∞
18.8
18
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
18.8
18
*
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
18.8
18
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
18.8
18
*
1CD02, ,
NOMESCO Finland
+∞
18.8
18
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
18.7
138
605
WX730
NOMESCO Finland
Conventional respirator
3.6
18.7
62
176
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.3
18.6
69
211
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
100.6
18.6
20
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
100.6
18.6
20
*
OAA41
NOMESCO Finland
Health check based on individual needs
191.1
18.5
19
*
R4190
NOMESCO Finland
Nutritional therapy
2.7
18.5
101
384
A06AD11
ATC
lactulose; oral
1.6
18.5
424
2721
KAC10
NOMESCO Finland
Total nephrectomy with capsule
44.3
18.2
22
5
E23.2
ICD-10 Finland
Diabetes insipidus
21.8
18.2
26
12
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.9
18.0
52
134
C10AX09
ATC
ezetimibe; oral
0.5
18.0
192
3534
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
18.0
155
726
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
52.8
17.9
21
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
17.9
401
6029
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.2
17.8
69
217
G41.2
ICD-10 Finland
Complex partial status epilepticus
18.1
17.8
27
15
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
17.7
17
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
17.7
17
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
17.7
17
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
17.7
17
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
17.7
17
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
17.7
17
*
9401/3-C71.9
ICD-O-3
Astrocytoma, anaplastic, NOS, of brain, NOS
+∞
17.7
17
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
17.7
17
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
17.7
17
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
17.7
17
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
17.7
17
*
1911X
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]
+∞
17.7
17
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
17.7
17
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
17.7
17
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
67.0
17.7
20
*
AAF00
NOMESCO Finland
Ventriculostomy
5.2
17.7
36
70
RS221, ,
NOMESCO Finland
3.7
17.6
55
150
C50
ICD-10 Finland
Malignant neoplasm of breast
95.6
17.6
19
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.0
17.5
50
128
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.6
17.5
28
43
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
17.5
55
151
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
6.8
17.4
27
40
H02AB04
ATC
methylprednisolone; systemic
1.6
17.4
402
2582
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
21.0
17.3
25
12
A07AA02
ATC
nystatin; oral
2.1
17.0
160
776
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
7.5
17.0
24
32
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
7.2
16.9
25
35
L28
ICPC
Limited function/disability (L)
1.5
16.9
561
3917
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.5
16.9
58
169
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
22.0
16.8
24
11
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.4
16.8
60
179
CDC00
NOMESCO Finland
Enucleation of eye
63.7
16.7
19
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
63.7
16.7
19
*
2159
FHL
Other measure in this category
63.7
16.7
19
*
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
63.7
16.7
19
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
16.7
16
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
16.7
16
*
C71.74
ICD-10 Finland
Malignant tumor of the brainstem ependyoma
+∞
16.7
16
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
16.7
16
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
16.7
16
*
19109
ICD-8 Finland
Malignant neoplasm of brain, Unspecified
+∞
16.7
16
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
16.7
16
*
L02BG03
ATC
anastrozole; oral
35.2
16.7
21
6
GD1AA, ,
SPAT
0.5
16.7
144
2846
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
16.6
197
1039
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
16.6
332
5138
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
90.5
16.6
18
*
FM1FN
NOMESCO Finland
Heart function isotope examination
170.8
16.5
17
*
XX9XW, ,
NOMESCO Finland
6.0
16.5
29
49
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
6.3
16.3
27
43
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.4
16.3
59
178
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
16.2
149
716
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.3
16.2
41
96
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
12.8
16.1
28
22
ZX108
NOMESCO Finland
Inhalation
6.0
16.0
28
47
ZXY02
NOMESCO Finland
Neuropsychologist
6.0
16.0
28
47
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
47.7
16.0
19
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
5.6
16.0
30
54
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.9
16.0
47
123
L03
ICPC
Low back symptom/complaint
0.6
16.0
415
6055
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
21.0
16.0
23
11
OAB43, ,
SPAT
0.6
15.9
352
5325
N28
ICPC
Limited function/disability (N)
2.9
15.8
72
249
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.6
15.7
25
38
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
15.7
61
192
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
33.5
15.7
20
6
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
15.7
292
1771
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
15.6
15
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
15.6
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.6
15
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
15.6
15
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
15.6
15
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
15.6
15
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
4.6
15.6
37
82
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
85.5
15.6
17
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
85.5
15.6
17
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
11.8
15.5
28
24
D33.12
ICD-10 Finland
Cerebellum
160.8
15.5
16
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
160.8
15.5
16
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
160.8
15.5
16
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
15.5
449
3040
ZXC96
NOMESCO Finland
Robot assisted procedure
6.2
15.5
26
42
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
3.9
15.5
45
117
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
15.3
242
1399
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
12.4
15.3
27
22
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.0
15.3
23
33
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
7.0
15.3
23
33
CS494
NOMESCO Finland
Other visual field testing
2.6
15.2
88
345
S18
ICPC
Laceration/cut
1.4
15.1
1228
10060
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
45.2
15.1
18
*
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
45.2
15.1
18
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
4.2
15.0
39
93
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
15.0
149
739
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.7
14.9
46
125
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
15.1
14.9
24
16
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
56.9
14.8
17
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.0
14.8
31
62
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
14.7
188
1017
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
21.1
14.6
21
10
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
14.6
14
*
C72.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous system
+∞
14.6
14
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
14.6
14
*
9450/3-C71.2
ICD-O-3
Oligodendroglioma, NOS, of temporal lobe
+∞
14.6
14
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
14.6
14
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
14.6
14
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
14.6
14
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
14.6
14
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
14.6
14
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
14.6
14
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
14.6
14
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
14.6
14
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
14.6
14
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
14.6
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
14.6
14
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
14.6
14
*
C71.61
ICD-10 Finland
Malignant tumor of cerebellum grade II glioma
+∞
14.6
14
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
14.6
14
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.5
14.6
16
*
3779
FHL
Other operations in this group include disc removal
80.5
14.6
16
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
14.5
112
502
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
150.7
14.5
15
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
150.7
14.5
15
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
150.7
14.5
15
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
12.6
14.4
25
20
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
14.2
372
5433
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.6
14.0
82
324
TPX15
NOMESCO Finland
Removal of vascular injection port
15.8
13.9
22
14
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
13.9
129
623
R03AC02
ATC
salbutamol; inhalant
0.7
13.9
1053
12738
L13
ICPC
Hip symptom/complaint
0.6
13.6
238
3827
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.1
13.6
131
642
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
75.5
13.6
15
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
13.5
13
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
13.5
13
*
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
13.5
13
*
197
Kela drug reimbursment
Sunitinib
+∞
13.5
13
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
13.5
13
*
C71.92
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade III glioma
+∞
13.5
13
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
13.5
13
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
13.5
13
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
13.5
13
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
13.5
13
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
13.5
13
*
C69.0
ICD-10 Finland
Malignant neoplasm: Conjunctiva
+∞
13.5
13
*
C71.42
ICD-10 Finland
Malignant tumor of the occipital lobe grade III glioma
+∞
13.5
13
*
AA5JS
NOMESCO Finland
Extensive PET-MRI of brain metabolism
+∞
13.5
13
*
9450/3-C71.3
ICD-O-3
Oligodendroglioma, NOS, of parietal lobe
+∞
13.5
13
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
13.5
13
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
13.5
13
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.5
13.5
82
330
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
13.5
175
952
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
13.5
129
631
CAW99
NOMESCO Finland
Other operation on orbit
140.6
13.5
14
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
140.6
13.5
14
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
140.6
13.5
14
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
140.6
13.5
14
*
N02BE01
ATC
paracetamol; systemic, rectal
1.4
13.4
2522
23317
SPAT1229
SPAT
Assessment of need for aid
1.8
13.4
215
1249
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
25.8
13.4
18
7
Z97.0
ICD-10 Finland
Presence of artificial eye
25.8
13.4
18
7
AAK00
NOMESCO Finland
Cranioplasty
18.3
13.4
20
11
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.7
13.3
408
5779
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.4
13.3
47
140
OAB42, ,
SPAT
0.5
13.2
137
2558
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.8
13.2
64
230
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
40.2
13.1
16
*
N03AF04
ATC
eslicarbazepine; oral
40.2
13.1
16
*
F80.1
ICD-10 Finland
Expressive language disorder
3.8
13.1
39
103
ZXD35
NOMESCO Finland
Usual procedure
2.3
13.1
95
415
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
15.1
13.1
21
14
N02AA01
ATC
morphine; systemic, rectal
3.4
13.0
46
137
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
16.8
13.0
20
12
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
28.5
12.9
17
6
OAA67, ,
SPAT
0.5
12.9
157
2791
N19
ICPC
Speech disorder
3.0
12.9
55
184
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.1
12.7
21
15
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
9.7
12.7
25
26
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.1
12.7
122
598
N03AX11
ATC
topiramate; oral
2.6
12.7
71
275
ZX100
NOMESCO Finland
Oral
3.5
12.6
42
120
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
12.6
184
1040
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
12.5
12
*
C71.79
ICD-10 Finland
Malignant tumor of the brainstem other or unspecified histology
+∞
12.5
12
*
1922A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord
+∞
12.5
12
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
12.5
12
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
12.5
12
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
12.5
12
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
12.5
12
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
12.5
12
*
ZX131
NOMESCO Finland
Intrathecal
+∞
12.5
12
*
L02BX03
ATC
abiraterone; oral
+∞
12.5
12
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
12.5
12
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
12.5
12
*
19107
ICD-8 Finland
Malignant neoplasm of brain, Cerebelli
+∞
12.5
12
*
9470/3-C71.6
ICD-O-3
Medulloblastoma, NOS, of cerebellum, NOS
+∞
12.5
12
*
L02AE04
ATC
triptorelin; parenteral
+∞
12.5
12
*
9382/3-C71.9
ICD-O-3
Oligoastrocytoma, NOS, of brain, NOS
+∞
12.5
12
*
19100
ICD-8 Finland
Malignant neoplasm of brain, Lobi frontalis
+∞
12.5
12
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
12.5
12
*
L01CA04
ATC
vinorelbine; systemic
+∞
12.5
12
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
24.4
12.5
17
7
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
130.5
12.4
13
*
PA2AD
NOMESCO Finland
CT angiography of brain
3.8
12.4
37
98
ZX121
NOMESCO Finland
Central venous catheter
13.2
12.4
21
16
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
13.2
12.4
21
16
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
12.3
102
472
AAA00
NOMESCO Finland
Exploratory craniotomy
37.7
12.2
15
*
J01MA12
ATC
levofloxacin; systemic
1.5
12.1
443
3141
N03AX09
ATC
lamotrigine; oral
2.0
12.1
127
643
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.8
12.1
59
213
H26.2
ICD-10 Finland
Complicated cataract
3.2
12.0
46
144
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
18.1
12.0
18
10
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
12.0
109
523
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
5.7
11.9
22
39
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
11.9
394
5516
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
13.4
11.9
20
15
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.4
11.9
42
125
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
11.9
327
4750
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
46.8
11.9
14
*
D33.43
ICD-10 Finland
Spinal cord
46.8
11.9
14
*
SPAT1290
SPAT
Preparation of deceased person
46.8
11.9
14
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
46.8
11.9
14
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
11.7
11.8
21
18
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.7
11.8
19
13
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.8
11.6
57
206
D33.30
ICD-10 Finland
Acoustic neuroma
4.6
11.6
27
59
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
30.1
11.6
15
5
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
30.1
11.6
15
5
M25.5
ICD-10 Finland
Pain in joint
0.7
11.6
517
6859
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.2
11.6
100
470
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
11.6
862
10553
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
65.2
11.6
13
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
11.6
134
702
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.1
11.6
31
76
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
11.5
96
445
G82.2
ICD-10 Finland
Paraplegia, unspecified
5.3
11.5
23
44
N03AX15
ATC
zonisamide; oral
11.1
11.5
21
19
C10AA05
ATC
atorvastatin; oral
0.7
11.5
809
9988
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
11.5
11
*
C69.29
ICD-10 Finland
Retina
+∞
11.5
11
*
C69.69
ICD-10 Finland
Malignant tumor in orbital other or unspecified histology
+∞
11.5
11
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
11.5
11
*
JJ1AQ
NOMESCO Finland
Liver SPECT with low dose CT
+∞
11.5
11
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
11.5
11
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
11.5
11
*
9380/3-C71.1
ICD-O-3
Glioma, malignant of frontal lobe
+∞
11.5
11
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
11.5
11
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
11.5
11
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
11.5
11
*
AA003
NOMESCO Finland
Adjuvant radiotherapy of brain
+∞
11.5
11
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
11.5
11
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
11.5
11
*
C70.1
ICD-10 Finland
Malignant neoplasm: Spinal meninges
+∞
11.5
11
*
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
11.5
11
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
11.5
11
*
3AA13, ,
NOMESCO Finland
+∞
11.5
11
*
C72.0
ICD-10 Finland
Malignant neoplasm: Spinal cord
+∞
11.5
11
*
D43
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of brain and central nervous system
+∞
11.5
11
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
11.5
11
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.5
11
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
11.4
91
414
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
120.4
11.4
12
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
120.4
11.4
12
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
120.4
11.4
12
*
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
120.4
11.4
12
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
4.7
11.4
26
56
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.8
11.3
57
209
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.9
11.3
146
794
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
11.3
384
5349
AAF15
NOMESCO Finland
Ventriculoatrial shunt
10.6
11.2
21
20
ZXA10
NOMESCO Finland
Bilateral
1.4
11.2
465
3373
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.0
11.2
128
668
N29
ICPC
Neurological sympt/complt other
2.5
11.2
66
263
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.9
11.1
32
83
RS222, ,
NOMESCO Finland
3.4
11.1
39
116
M79.6
ICD-10 Finland
Pain in limb
0.7
11.0
790
9737
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
4.0
10.9
30
75
WX142
NOMESCO Finland
Sub-tenon anesthesy
3.8
10.9
32
84
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
43.5
10.9
13
*
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
5.4
10.9
21
39
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
17.9
10.7
16
9
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
4.7
10.7
24
51
R83
ICPC
Respiratory infection other
0.7
10.6
334
4734
NG1AA, ,
SPAT
0.4
10.6
53
1296
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
60.2
10.6
12
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
5.3
10.6
21
40
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.1
10.5
20
20
OAB48, ,
SPAT
0.6
10.5
155
2612
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
110.4
10.4
11
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
110.4
10.4
11
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
10.4
10
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
10.4
10
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
10.4
10
*
AA5FK
NOMESCO Finland
Functional assessment (fMRI) of brain
+∞
10.4
10
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
10.4
10
*
159
Kela drug reimbursment
Pazopanib
+∞
10.4
10
*
1916A
ICD-9 Finland
Malignant neoplasm of brain, Cerebellum[PIKKUAIVOJEN SYÖPÄ, ASTROCYTOMA (GR I-II)]
+∞
10.4
10
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
10.4
10
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
10.4
10
*
C71.63
ICD-10 Finland
Malignant tumor of cerebellum grade IV glioma
+∞
10.4
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
10.4
10
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
10.4
10
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
10.4
10
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
10.4
10
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
10.4
10
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
10.4
10
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
32.6
10.3
13
*
TQW20
NOMESCO Finland
Tatoe
32.6
10.3
13
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
10.3
114
589
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
10.3
1537
17275
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
18.8
10.3
15
8
R11
ICD-10 Finland
Nausea and vomiting
1.6
10.2
213
1332
N06DX01
ATC
memantine; oral
0.5
10.2
79
1625
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
13.1
10.1
17
13
EB1VA, ,
NOMESCO Finland
0.6
10.1
224
3417
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
10.1
204
1264
M54.5
ICD-10 Finland
Low back pain
0.7
9.9
619
7818
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.9
9.9
113
590
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
16.7
9.9
15
9
R1260
NOMESCO Finland
Evaluation of communicative skills
2.6
9.9
57
225
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.6
9.9
209
3222
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
26.1
9.8
13
5
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
10.6
9.8
18
17
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
9.5
9.7
19
20
L15
ICPC
Knee symptom/complaint
0.7
9.7
386
5247
D31.2
ICD-10 Finland
Benign neoplasm: Retina
13.4
9.7
16
12
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
13.4
9.7
16
12
F74
ICPC
Neoplasm of eye/adnexa
55.2
9.6
11
*
M01AH05
ATC
etoricoxib; oral
0.8
9.6
1260
14447
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
5.0
9.6
20
40
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.4
9.6
64
271
G41.0
ICD-10 Finland
Grand mal status epilepticus
11.4
9.5
17
15
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
9.5
122
663
D32.05
ICD-10 Finland
Cerebral meninges
10.0
9.5
18
18
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
15.1
9.5
15
10
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
100.3
9.4
10
*
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
100.3
9.4
10
*
CCA10
NOMESCO Finland
Biopsy of lacrimal gland
100.3
9.4
10
*
R05
ICPC
Cough
0.7
9.4
371
5050
S77
ICPC
Malignant neoplasm of skin
17.6
9.4
14
8
9380/3-C71.2
ICD-O-3
Glioma, malignant of temporal lobe
+∞
9.4
9
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
9.4
9
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
C71.71
ICD-10 Finland
Malignant tumor of the brainstem grade II glioma
+∞
9.4
9
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
9.4
9
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
9.4
9
*
19101
ICD-8 Finland
Malignant neoplasm of brain, Lobi temporalis
+∞
9.4
9
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
9.4
9
*
WW402
NOMESCO Finland
Leucoferesis
+∞
9.4
9
*
9391/3-C71.7
ICD-O-3
Ependymoma, NOS, of brain stem
+∞
9.4
9
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
9.4
9
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
9.4
9
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
9.4
9
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
9.4
9
*
8000/3-C71.1
ICD-O-3
Neoplasm, malignant of frontal lobe
+∞
9.4
9
*
C69.9
ICD-10 Finland
Malignant neoplasm: Eye, unspecified
+∞
9.4
9
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
9.4
9
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
9.4
9
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
9.4
9
*
XX2XW
NOMESCO Finland
Other teleradiological consultation
8.0
9.3
20
25
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
9.3
217
1393
A86
ICD-10 Finland
Unspecified viral encephalitis
4.5
9.3
22
49
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
8.7
9.3
19
22
WZC00, ,
SPAT
0.6
9.3
182
2857
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.7
9.2
174
1059
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
9.2
40
136
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
4.2
9.2
24
58
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
9.2
59
1300
C01DA14
ATC
isosorbide mononitrate; oral
0.7
9.1
249
3636
B01AB04
ATC
dalteparin; parenteral
1.9
9.1
109
580
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
11.5
9.1
16
14
WPA13
NOMESCO Finland
Palliative consultation
8.3
9.1
19
23
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
36.8
9.0
11
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
9.0
9.0
18
20
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
9.0
304
4260
N05AD01
ATC
haloperidol; systemic
2.1
8.9
87
430
AAF50
NOMESCO Finland
Third ventriculostomy
18.6
8.9
13
7
2132
FHL
Ventricular operators sunt
24.1
8.9
12
5
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
24.1
8.9
12
5
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
8.9
78
371
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.6
8.9
15
12
A10BK03
ATC
empagliflozin; oral
0.6
8.8
110
1941
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.4
8.7
31
93
R03DC03
ATC
montelukast; oral
0.6
8.7
199
3022
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
7.2
8.7
20
28
CA1ME
NOMESCO Finland
Ultrasound oculometry
3.7
8.7
27
74
N05BA01
ATC
diazepam; systemic, rectal
1.5
8.7
324
2300
EB4VA, ,
NOMESCO Finland
0.6
8.7
202
3053
207
Kela drug reimbursment
Chronic arrhythmias
0.6
8.7
217
3229
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
50.1
8.7
10
*
C43
ICD-10 Finland
Malignant melanoma of skin
50.1
8.7
10
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
50.1
8.7
10
*
2312
FHL
Extirpation or destruction
50.1
8.7
10
*
OAA80, ,
SPAT
0.5
8.6
84
1602
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.6
8.6
21
32
FM2CE, ,
NOMESCO Finland
4.6
8.6
20
44
DFF20
NOMESCO Finland
Audiometry for children
11.6
8.6
15
13
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
8.5
1364
15376
XX8XW, ,
NOMESCO Finland
16.3
8.5
13
8
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
3.1
8.5
35
115
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
10.0
8.5
16
16
CKA10
NOMESCO Finland
Biopsy of vitreous body
10.0
8.5
16
16
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
10.0
8.5
16
16
A04AA03
ATC
tropisetron; systemic
27.6
8.5
11
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
8.4
115
1982
CAB10
NOMESCO Finland
Lateral orbitotomy with excision of lesion
90.3
8.4
9
*
153
Kela drug reimbursment
Lenalidomid
90.3
8.4
9
*
2311
FHL
Resection
90.3
8.4
9
*
1XC03, ,
NOMESCO Finland
90.3
8.4
9
*
M05BA02
ATC
clodronic acid; systemic
90.3
8.4
9
*
L04AX04
ATC
lenalidomide; oral
90.3
8.4
9
*
XKD00
NOMESCO Finland
Uroflowmetry
1.4
8.4
338
2434
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
8.4
231
1542
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
8.4
312
2215
ZXC86
NOMESCO Finland
Use of endoscopic device
4.5
8.4
20
45
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
8.3
8
*
1BC01, ,
NOMESCO Finland
+∞
8.3
8
*
C71.41
ICD-10 Finland
Malignant tumor of occipital lobe grade II glioma
+∞
8.3
8
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
8.3
8
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
8.3
8
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
8.3
8
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
C71.73
ICD-10 Finland
Malignant tumor of the brain stem grade IV glioma
+∞
8.3
8
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
8.3
8
*
C69.50
ICD-10 Finland
Malignant tumor of lacrimal gland and lacrimal duct without histology
+∞
8.3
8
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
8.3
8
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
8.3
8
*
1919X
ICD-9 Finland
Malignant neoplasm of brain, Brain, unspecified[TARKEMMIN MÄÄRITTELEMÄTÖN AIVOSYÖPÄ,EI HIST VAHV]
+∞
8.3
8
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
C71.5
ICD-10 Finland
Malignant neoplasm: Cerebral ventricle
+∞
8.3
8
*
YA1WD, ,
NOMESCO Finland
+∞
8.3
8
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
8.3
8
*
C71.62
ICD-10 Finland
Malignant tumor of cerebellum grade III glioma
+∞
8.3
8
*
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
+∞
8.3
8
*
ZX004, ,
NOMESCO Finland
+∞
8.3
8
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
8.3
8
*
L01XE04
ATC
[U] sunitinib
+∞
8.3
8
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
8.3
8
*
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
8.3
8
*
8000/3-C71.2
ICD-O-3
Neoplasm, malignant of temporal lobe
+∞
8.3
8
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
8.3
8
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
8.3
8
*
1XC07, ,
NOMESCO Finland
+∞
8.3
8
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
8.3
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.3
8
*
1501
Kela drug reimbursment
Palbociclib
+∞
8.3
8
*
L02BX02
ATC
degarelix; parenteral
+∞
8.3
8
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
8.3
8
*
9445/3-C71.9
ICD-O-3
Glioblastoma, IDH-mutant of brain, NOS
+∞
8.3
8
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
8.3
8
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
8.3
8
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
AAA50
NOMESCO Finland
Intracranial endoscopy
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
8.3
8
*
1929X
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Nervous system, part unspecified
+∞
8.3
8
*
N03AX16
ATC
[U] pregabalin
1.3
8.3
539
4200
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
14.5
8.2
13
9
SPAT1109
SPAT
Analgesia with portable analgesic pump
7.5
8.1
18
24
M05BX04
ATC
denosumab; parenteral
1.8
8.1
118
668
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.5
8.1
19
42
PA6AD
NOMESCO Finland
CT of neck arteries
1.9
8.1
102
552
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
33.4
8.1
10
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
17.2
8.1
12
7
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
11.7
8.1
14
12
H02.4
ICD-10 Finland
Ptosis of eyelid
2.1
8.1
76
372
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
8.0
232
3353
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.6
8.0
192
1243
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.8
8.0
39
142
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.9
7.9
22
56
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
7.8
195
1273
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
3.3
7.8
28
85
R01AD12
ATC
fluticasone furoate; nasal
0.7
7.8
477
6072
A10BA02
ATC
metformin; oral
0.8
7.8
507
6397
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.0
7.8
33
111
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
45.1
7.7
9
*
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
45.1
7.7
9
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.1
7.7
30
96
JFB30
NOMESCO Finland
Right hemicolectomy
4.5
7.6
18
40
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.5
7.6
18
40
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
25.1
7.6
10
*
N80
ICPC
Head injury other
2.2
7.6
63
294
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.0
7.6
78
395
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.6
160
1005
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
10.0
7.5
14
14
M03BX01
ATC
baclofen; systemic
2.3
7.5
54
237
R74
ICPC
Upper respiratory infection acute
0.8
7.5
498
6274
ZXC50
NOMESCO Finland
Cryotherapy
2.3
7.5
52
225
Z50.5
ICD-10 Finland
Speech therapy
2.6
7.4
41
159
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
80.3
7.4
8
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
80.3
7.4
8
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
80.3
7.4
8
*
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
80.3
7.4
8
*
B72
ICPC
Hodgkin Lymphoma
80.3
7.4
8
*
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
80.3
7.4
8
*
D33.04
ICD-10 Finland
Temporal lobe
80.3
7.4
8
*
C72.4
ICD-10 Finland
Malignant neoplasm: Acoustic nerve
80.3
7.4
8
*
AA5GG
NOMESCO Finland
Extensive functional MRI examination of brain withhigh intensity magnet
80.3
7.4
8
*
XX4AW, ,
NOMESCO Finland
7.7
7.4
16
21
R07.4
ICD-10 Finland
Chest pain, unspecified
0.8
7.3
491
6181
NA3BG, ,
SPAT
0.3
7.3
18
617
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
7.3
206
2996
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.7
7.3
331
4416
L03AB04
ATC
interferon alfa-2a; parenteral
+∞
7.3
7
*
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
7.3
7
*
QX2AN
NOMESCO Finland
Other soft tissue tumour isotope imaging
+∞
7.3
7
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
7.3
7
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
7.3
7
*
C69.53
ICD-10 Finland
Malignant tumor of lacrimal gland and tear duct carcinoma
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
L01XE23
ATC
[U] dabrafenib
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
C69.89
ICD-10 Finland
Overall malignant tumor of the eye and adnexa other or unspecified histology
+∞
7.3
7
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
1920A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Cranial nerves
+∞
7.3
7
*
C71.04
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles ependyoma
+∞
7.3
7
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
7.3
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
7.3
7
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
7.3
7
*
C75.3
ICD-10 Finland
Malignant neoplasm: Pineal gland
+∞
7.3
7
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
7.3
7
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
7.3
7
*
19251
ICD-8 Finland
Malignant neoplasm of other part of nervous system, Sympathetic nervous system
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
C69.4
ICD-10 Finland
Malignant neoplasm: Ciliary body
+∞
7.3
7
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
1911A
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]
+∞
7.3
7
*
C79.40
ICD-10 Finland
Secondary malignant tumor of the spinal cord
+∞
7.3
7
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
7.3
7
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
7.3
7
*
394
Kela drug reimbursment
Palbociclib
+∞
7.3
7
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
7.3
7
*
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
+∞
7.3
7
*
343
Kela drug reimbursment
Pazopanib
+∞
7.3
7
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
7.3
7
*
C69.49
ICD-10 Finland
Malignant tumor of ciliary body other or unspecified histology
+∞
7.3
7
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
7.3
7
*
9382/3-C71.2
ICD-O-3
Oligoastrocytoma, NOS, of temporal lobe
+∞
7.3
7
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
1912X
ICD-9 Finland
Malignant neoplasm of brain, Temporal lobe[AIVOJEN OHIMOLOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUS]
+∞
7.3
7
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
7.3
68
332
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.2
7.3
60
279
L08
ICPC
Shoulder symptom/complaint
0.7
7.3
362
4760
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.3
7.2
26
79
WZC30, ,
SPAT
0.6
7.2
93
1626
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
30.1
7.1
9
*
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
30.1
7.1
9
*
C07AB07
ATC
bisoprolol; oral
0.8
7.1
1018
11704
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
0.5
7.1
73
1368
1CX01, ,
NOMESCO Finland
20.1
7.1
10
5
GDC00
NOMESCO Finland
Lobectomy of lung
20.1
7.1
10
5
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
20.1
7.1
10
5
S01ED51
ATC
timolol, combinations; ophthalmic
1.5
7.1
199
1334
N06DA02
ATC
donepezil; oral
0.5
7.1
65
1261
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
6.0
7.1
18
30
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
7.0
83
441
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.2
7.0
55
251
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.4
7.0
44
182
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
6.9
57
265
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.7
6.9
35
130
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
13.8
6.9
11
8
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.5
6.8
41
166
Z31.6
ICD-10 Finland
General counselling and advice on procreation
3.5
6.8
23
67
M54.4
ICD-10 Finland
Lumbago with sciatica
0.7
6.8
249
3448
S01EA03
ATC
apraclonidine; ophthalmic
3.0
6.8
29
98
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
6.8
102
1712
K22
ICPC
Risk factor cardiovascular disease
0.5
6.8
50
1043
H33.2
ICD-10 Finland
Serous retinal detachment
6.1
6.8
17
28
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
40.1
6.8
8
*
CKE40
NOMESCO Finland
Transpupillary photocoagulation of lesion of retina
40.1
6.8
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
40.1
6.8
8
*
DAB10
NOMESCO Finland
Partial excision of auricle
40.1
6.8
8
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
40.1
6.8
8
*
WPA43, ,
SPAT
16.7
6.7
10
6
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.7
6.7
193
2796
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
7.2
6.7
15
21
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
3.2
6.7
25
78
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
6.7
85
463
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
3.3
6.7
24
73
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
22.6
6.7
9
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
22.6
6.7
9
*
PH7FT
NOMESCO Finland
Inmplantation of filter to inferior vena cava with radiological guidance
22.6
6.7
9
*
L01AA02
ATC
chlorambucil; oral
22.6
6.7
9
*
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
3.7
6.6
20
54
H05.2
ICD-10 Finland
Exophthalmic conditions
7.8
6.6
14
18
XCD20
NOMESCO Finland
Photoangiography of eye
2.3
6.6
47
206
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.6
6.5
37
146
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
3.7
6.5
20
55
R5110, ,
SPAT
1.5
6.5
206
1420
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.4
63
314
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
6.4
40
165
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
70.0
6.4
7
*
AA5AK
NOMESCO Finland
Brain spectroscopy
70.0
6.4
7
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
70.0
6.4
7
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
70.0
6.4
7
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
7.4
6.4
14
19
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
14.3
6.4
10
7
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.7
6.4
224
3125
SDA03
NOMESCO Finland
Periodontal treatment
0.8
6.4
716
8473
H35.9
ICD-10 Finland
Retinal disorder, unspecified
3.7
6.4
19
51
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.2
6.3
13
16
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.1
6.3
25
81
RS121, ,
NOMESCO Finland
3.6
6.3
20
56
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
11.0
6.3
11
10
301
Kela drug reimbursment
Growth hormone
11.0
6.3
11
10
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
11.0
6.3
11
10
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
9.3
6.3
12
13
SAA02
NOMESCO Finland
Basic examination of mouth
0.8
6.3
1415
15615
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
18.0
6.3
9
5
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
6.2
6
*
AX099
NOMESCO Finland
Radiotherapy of whole central nervous system
+∞
6.2
6
*
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
6.2
6
*
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
6.2
6
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
6.2
6
*
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
6.2
6
*
9424/3-C71.9
ICD-O-3
Pleomorphic xanthoastrocytoma, NOS, of brain, NOS
+∞
6.2
6
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
6.2
6
*
C71.66
ICD-10 Finland
Malignant tumor of the cerebellum medullobastoma
+∞
6.2
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.2
6
*
19105
ICD-8 Finland
Malignant neoplasm of brain, Hypothalami
+∞
6.2
6
*
YX8CD
NOMESCO Finland
Stereotactic very extensive CT examination for dose design of radiotherapy
+∞
6.2
6
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
6.2
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.2
6
*
ZXC21, ,
NOMESCO Finland
+∞
6.2
6
*
1921A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Cerebral meninges
+∞
6.2
6
*
198
Kela drug reimbursment
Sorafenib
+∞
6.2
6
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
6.2
6
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
6.2
6
*
2141
FHL
Stereotactic biopsy of the brain
+∞
6.2
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.2
6
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
6.2
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.2
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.2
6
*
1911F
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,MUU]
+∞
6.2
6
*
8410/3-C44.1
ICD-O-3
Sebaceous carcinoma of eyelid
+∞
6.2
6
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
6.2
6
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
6.2
6
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
C71.05
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles primary neuroectodermal tumor
+∞
6.2
6
*
9401/3-C71.3
ICD-O-3
Astrocytoma, anaplastic, NOS, of parietal lobe
+∞
6.2
6
*
9445/3-C71.1
ICD-O-3
Glioblastoma, IDH-mutant of frontal lobe
+∞
6.2
6
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
6.2
6
*
9382/3-C71.3
ICD-O-3
Oligoastrocytoma, NOS, of parietal lobe
+∞
6.2
6
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
6.2
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.2
6
*
L02BA03
ATC
fulvestrant; parenteral
+∞
6.2
6
*
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
+∞
6.2
6
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
6.2
6
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
+∞
6.2
6
*
192
Kela drug reimbursment
Fulvestrant
+∞
6.2
6
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
6.2
6
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
6.2
6
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
6.2
6
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
6.2
6
*
1AC01, ,
NOMESCO Finland
+∞
6.2
6
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.6
6.2
127
1978
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
26.7
6.2
8
*
R84
ICPC
Malignant neoplasm bronchus/lung
26.7
6.2
8
*
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
26.7
6.2
8
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
26.7
6.2
8
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
26.7
6.2
8
*
L03AA04, ,
ATC
26.7
6.2
8
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
6.2
98
571
C03CA01
ATC
furosemide; systemic
1.2
6.2
804
6822
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
6.2
143
920
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
6.3
6.2
15
24
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
7.7
6.1
13
17
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
7.7
6.1
13
17
R1250
NOMESCO Finland
Evaluation of functional capability
1.9
6.1
67
348
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
6.1
681
5680
SDA04
NOMESCO Finland
Demanding periodontal treatment
0.8
6.1
466
5779
A10AB05
ATC
insulin aspart; parenteral
1.5
6.1
196
1354
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
653
5422
KEB00
NOMESCO Finland
Biopsy of prostate
3.8
6.1
18
48
R42
ICD-10 Finland
Dizziness and giddiness
1.3
6.1
579
4741
9101
FHL
Bone biopsy
8.6
6.0
12
14
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.6
6.0
33
128
G91.8
ICD-10 Finland
Other hydrocephalus
10.0
6.0
11
11
WPA44
NOMESCO Finland
Nursing home for palliative care
10.0
6.0
11
11
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
6.0
96
561
R053, ,
ICD-10 Finland
0.3
6.0
14
491
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.2
6.0
45
202
HAB99
NOMESCO Finland
Other partial excision of mammary gland
3.5
6.0
20
58
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Medical Oncology
90 [38004507]
90 [38004507]
5.0e+00
5.4e+00
—
1.0e+50
—
8.2e+00
6.0e+00
cases:7.24%
controls:0.05%
cases:6.41%
controls:0.03%
—
—
cases:2.89%
controls:0.00%
—
—
cases:54.23%
controls:0.03%
cases:38.27%
controls:0.15%
210
15
2690
28898
186
9
2717
28929
—
84
0
2819
28938
—
1289
9
1088
28322
625
38
1008
24872
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
1.0e+00
2.1e+00
5.1e+00
1.0e+50
6.7e+00
4.5e+00
2.2e+00
cases:3.86%
controls:1.39%
cases:3.72%
controls:0.46%
cases:10.13%
controls:0.07%
cases:1.34%
controls:0.00%
cases:30.22%
controls:0.06%
cases:35.34%
controls:0.58%
cases:15.74%
controls:2.03%
112
402
2788
28511
108
132
2795
28806
294
20
2609
28918
39
0
2864
28938
863
16
1993
28874
840
165
1537
28166
257
506
1376
24404
Neurology
13 [38004458]
13 [38004458]
2.6e-02
1.4e+00
3.7e+00
6.7e+00
3.8e+00
3.0e+00
2.1e+00
cases:10.21%
controls:9.97%
cases:14.81%
controls:4.18%
cases:24.04%
controls:0.77%
cases:25.84%
controls:0.04%
cases:25.46%
controls:0.79%
cases:45.81%
controls:4.23%
cases:49.72%
controls:10.42%
296
2884
2604
26029
430
1210
2473
27728
698
222
2205
28716
750
12
2153
28926
727
228
2129
28662
1089
1197
1288
27134
812
2595
821
22315
Neurosurgery
14 [38004459]
14 [38004459]
5.1e-01
1.9e+00
4.2e+00
—
6.1e+00
4.7e+00
3.0e+00
cases:3.90%
controls:2.37%
cases:5.99%
controls:0.94%
cases:10.95%
controls:0.19%
—
—
cases:38.73%
controls:0.14%
cases:48.51%
controls:0.83%
cases:31.05%
controls:2.12%
113
685
2787
28228
174
273
2729
28665
318
55
2585
28883
—
1106
40
1750
28850
1153
236
1224
28095
507
528
1126
24382
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
7.2e-01
2.0e+00
4.4e+00
—
5.5e+00
4.7e+00
3.9e+00
cases:0.59%
controls:0.29%
cases:1.86%
controls:0.25%
cases:5.37%
controls:0.07%
—
—
cases:13.34%
controls:0.07%
cases:21.41%
controls:0.25%
cases:16.66%
controls:0.42%
17
83
2883
28830
54
71
2849
28867
156
21
2747
28917
—
381
19
2475
28871
509
72
1868
28259
272
104
1361
24806
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
5.8e-01
2.1e+00
4.3e+00
1.0e+50
4.9e+00
4.2e+00
3.5e+00
cases:0.45%
controls:0.25%
cases:1.34%
controls:0.16%
cases:2.27%
controls:0.03%
cases:1.86%
controls:0.00%
cases:2.84%
controls:0.02%
cases:8.71%
controls:0.15%
cases:11.15%
controls:0.39%
13
73
2887
28840
39
46
2864
28892
66
9
2837
28929
54
0
2849
28938
81
6
2775
28884
207
42
2170
28289
182
97
1451
24813
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
G40.29 [2000502142]
-2.0e-02
2.0e+00
4.2e+00
1.0e+50
4.9e+00
4.0e+00
3.9e+00
cases:0.21%
controls:0.21%
cases:0.83%
controls:0.12%
cases:2.00%
controls:0.03%
cases:1.62%
controls:0.00%
cases:2.59%
controls:0.02%
cases:7.28%
controls:0.14%
cases:10.41%
controls:0.23%
6
61
2894
28852
24
34
2879
28904
58
9
2845
28929
47
0
2856
28938
74
6
2782
28884
173
39
2204
28292
170
57
1463
24853
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
1.9e+00
2.3e+00
—
1.0e+50
7.1e+00
4.4e+00
3.1e+00
cases:2.34%
controls:0.36%
cases:1.72%
controls:0.18%
—
—
cases:5.17%
controls:0.00%
cases:17.16%
controls:0.02%
cases:6.77%
controls:0.09%
cases:6.74%
controls:0.33%
68
105
2832
28808
50
52
2853
28886
—
150
0
2753
28938
490
5
2366
28885
161
25
2216
28306
110
83
1523
24827
lacosamide; oral, parenteral
N03AX18 [21604440]
N03AX18 [21604440]
—
1.8e+00
3.2e+00
—
4.0e+00
4.3e+00
3.9e+00
—
—
cases:0.34%
controls:0.06%
cases:0.69%
controls:0.03%
—
—
cases:1.12%
controls:0.02%
cases:4.54%
controls:0.07%
cases:4.65%
controls:0.10%
—
10
16
2893
28922
20
8
2883
28930
—
32
6
2824
28884
108
19
2269
28312
76
24
1557
24886
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
3.3e-01
2.3e+00
4.7e+00
—
4.7e+00
3.2e+00
1.6e+00
cases:0.45%
controls:0.32%
cases:1.34%
controls:0.13%
cases:1.86%
controls:0.02%
—
—
cases:2.66%
controls:0.02%
cases:2.02%
controls:0.08%
cases:1.59%
controls:0.33%
13
93
2887
28820
39
38
2864
28900
54
5
2849
28933
—
76
7
2780
28883
48
24
2329
28307
26
81
1607
24829
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
3.3e-01
2.3e+00
4.7e+00
—
4.7e+00
3.1e+00
1.6e+00
cases:0.45%
controls:0.32%
cases:1.38%
controls:0.13%
cases:1.89%
controls:0.02%
—
—
cases:2.66%
controls:0.02%
cases:2.02%
controls:0.09%
cases:1.65%
controls:0.33%
13
93
2887
28820
40
39
2863
28899
55
5
2848
28933
—
76
7
2780
28883
48
25
2329
28306
27
83
1606
24827
Outpatient Hospital
22 [8756]
22 [8756]
1.8e-01
6.8e-01
2.6e+00
6.1e+00
3.9e+00
2.1e+00
1.0e+00
cases:26.24%
controls:22.91%
cases:11.82%
controls:6.33%
cases:8.96%
controls:0.74%
cases:16.26%
controls:0.04%
cases:27.38%
controls:0.74%
cases:31.26%
controls:5.49%
cases:33.13%
controls:15.14%
761
6624
2139
22289
343
1832
2560
27106
260
215
2643
28723
472
13
2431
28925
782
215
2074
28675
743
1555
1634
26776
541
3772
1092
21138
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
9.9e-01
1.6e+00
3.2e+00
—
4.3e+00
4.2e+00
2.2e+00
cases:4.34%
controls:1.65%
cases:2.89%
controls:0.60%
cases:1.31%
controls:0.06%
—
—
cases:5.32%
controls:0.08%
cases:29.03%
controls:0.58%
cases:14.76%
controls:1.97%
126
478
2774
28435
84
174
2819
28764
38
16
2865
28922
—
152
23
2704
28867
690
165
1687
28166
241
490
1392
24420
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
-4.5e-02
6.7e-01
3.2e+00
6.2e+00
3.8e+00
1.9e+00
5.7e-01
cases:10.72%
controls:11.16%
cases:10.89%
controls:5.86%
cases:16.02%
controls:0.80%
cases:12.92%
controls:0.03%
cases:25.07%
controls:0.74%
cases:29.20%
controls:5.68%
cases:25.96%
controls:16.62%
311
3227
2589
25686
316
1697
2587
27241
465
231
2438
28707
375
9
2528
28929
716
215
2140
28675
694
1608
1683
26723
424
4139
1209
20771
Inpatient Hospital
21 [8717]
21 [8717]
1.5e-01
6.6e-01
2.6e+00
6.1e+00
3.9e+00
1.9e+00
8.1e-01
cases:32.97%
controls:29.66%
cases:17.43%
controls:9.86%
cases:15.57%
controls:1.39%
cases:27.49%
controls:0.08%
cases:37.89%
controls:1.27%
cases:40.77%
controls:9.07%
cases:38.46%
controls:21.80%
956
8577
1944
20336
506
2853
2397
26085
452
403
2451
28535
798
24
2105
28914
1082
367
1774
28523
969
2571
1408
25760
628
5430
1005
19480
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
3.5e+00
4.3e+00
—
1.0e+50
—
4.7e+00
3.1e+00
cases:9.55%
controls:0.31%
cases:5.65%
controls:0.08%
—
—
cases:33.45%
controls:0.00%
—
—
cases:7.15%
controls:0.07%
cases:7.72%
controls:0.37%
277
89
2623
28824
164
24
2739
28914
—
971
0
1932
28938
—
170
19
2207
28312
126
92
1507
24818
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
-1.6e-02
8.2e-01
3.5e+00
6.0e+00
3.1e+00
1.8e+00
4.3e-01
cases:3.41%
controls:3.47%
cases:5.27%
controls:2.39%
cases:9.96%
controls:0.32%
cases:8.89%
controls:0.02%
cases:7.18%
controls:0.36%
cases:13.50%
controls:2.56%
cases:14.08%
controls:9.65%
99
1002
2801
27911
153
691
2750
28247
289
92
2614
28846
258
7
2645
28931
205
103
2651
28787
321
726
2056
27605
230
2404
1403
22506
Benign neoplasm: Choroid
D31.3 [45566680]
D31.3 [45566680]
2.0e+00
3.1e+00
3.9e+00
1.0e+50
—
3.7e+00
2.6e+00
cases:0.97%
controls:0.13%
cases:1.24%
controls:0.06%
cases:0.86%
controls:0.02%
cases:0.69%
controls:0.00%
—
—
cases:2.10%
controls:0.05%
cases:2.33%
controls:0.18%
28
37
2872
28876
36
17
2867
28921
25
5
2878
28933
20
0
2883
28938
—
50
15
2327
28316
38
45
1595
24865
oxcarbazepine; oral
N03AF02 [21604418]
N03AF02 [21604418]
1.2e-01
1.8e+00
2.8e+00
—
3.9e+00
3.4e+00
3.2e+00
cases:0.59%
controls:0.52%
cases:2.38%
controls:0.41%
cases:2.62%
controls:0.16%
—
—
cases:5.46%
controls:0.12%
cases:10.14%
controls:0.38%
cases:11.82%
controls:0.54%
17
151
2883
28762
69
119
2834
28819
76
45
2827
28893
—
156
35
2700
28855
241
108
2136
28223
193
134
1440
24776
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
-3.5e-01
1.6e+00
3.6e+00
1.0e+50
3.7e+00
3.4e+00
2.6e+00
cases:0.31%
controls:0.44%
cases:1.03%
controls:0.20%
cases:0.90%
controls:0.02%
cases:0.86%
controls:0.00%
cases:1.68%
controls:0.04%
cases:5.22%
controls:0.18%
cases:5.94%
controls:0.48%
9
127
2891
28786
30
59
2873
28879
26
7
2877
28931
25
0
2878
28938
48
12
2808
28878
124
50
2253
28281
97
119
1536
24791
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
D32.00 [2000501307]
1.8e+00
2.1e+00
—
1.0e+50
4.3e+00
3.5e+00
3.2e+00
cases:0.72%
controls:0.12%
cases:0.59%
controls:0.07%
—
—
cases:0.65%
controls:0.00%
cases:1.58%
controls:0.02%
cases:2.69%
controls:0.08%
cases:3.80%
controls:0.16%
21
36
2879
28877
17
21
2886
28917
—
19
0
2884
28938
45
6
2811
28884
64
23
2313
28308
62
40
1571
24870
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.1e-02
7.6e-01
2.4e+00
5.3e+00
3.7e+00
1.9e+00
7.9e-01
cases:7.76%
controls:7.47%
cases:8.58%
controls:4.21%
cases:7.23%
controls:0.70%
cases:6.10%
controls:0.03%
cases:19.43%
controls:0.62%
cases:20.45%
controls:3.88%
cases:21.86%
controls:11.22%
225
2160
2675
26753
249
1218
2654
27720
210
202
2693
28736
177
9
2726
28929
555
179
2301
28711
486
1099
1891
27232
357
2795
1276
22115
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
1.7e-01
8.1e-01
3.1e+00
5.0e+00
3.0e+00
1.8e+00
8.6e-01
cases:2.90%
controls:2.45%
cases:1.83%
controls:0.82%
cases:1.93%
controls:0.09%
cases:2.55%
controls:0.02%
cases:2.17%
controls:0.11%
cases:4.80%
controls:0.85%
cases:6.18%
controls:2.71%
84
709
2816
28204
53
238
2850
28700
56
26
2847
28912
74
5
2829
28933
62
31
2794
28859
114
240
2263
28091
101
675
1532
24235
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
7.1e-01
1.6e+00
3.1e+00
1.0e+50
4.4e+00
2.6e+00
2.0e+00
cases:2.38%
controls:1.18%
cases:2.65%
controls:0.57%
cases:2.00%
controls:0.09%
cases:0.41%
controls:0.00%
cases:6.37%
controls:0.08%
cases:7.28%
controls:0.58%
cases:11.64%
controls:1.68%
69
342
2831
28571
77
164
2826
28774
58
27
2845
28911
12
0
2891
28938
182
24
2674
28866
173
165
2204
28166
190
418
1443
24492
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
7.5e-02
7.7e-01
2.4e+00
5.3e+00
3.5e+00
1.8e+00
6.8e-01
cases:8.83%
controls:8.24%
cases:9.68%
controls:4.72%
cases:8.03%
controls:0.81%
cases:6.20%
controls:0.03%
cases:20.03%
controls:0.72%
cases:21.83%
controls:4.57%
cases:23.58%
controls:13.47%
256
2383
2644
26530
281
1367
2622
27571
233
234
2670
28704
180
10
2723
28928
572
208
2284
28682
519
1295
1858
27036
385
3355
1248
21555
Emergency Room Visit
ER [9203]
ER [9203]
6.2e-02
7.5e-01
3.0e+00
5.6e+00
2.6e+00
1.6e+00
7.1e-01
cases:33.90%
controls:32.53%
cases:20.43%
controls:10.78%
cases:21.53%
controls:1.30%
cases:21.94%
controls:0.10%
cases:15.44%
controls:1.38%
cases:35.89%
controls:9.89%
cases:42.68%
controls:26.81%
983
9405
1917
19508
593
3120
2310
25818
625
375
2278
28563
637
29
2266
28909
441
400
2415
28490
853
2801
1524
25530
697
6679
936
18231
Ophthalmology
18 [38004463]
18 [38004463]
7.3e-02
6.6e-01
2.1e+00
5.8e+00
2.6e+00
1.9e+00
1.2e+00
cases:16.72%
controls:15.73%
cases:12.71%
controls:7.00%
cases:9.20%
controls:1.24%
cases:15.09%
controls:0.06%
cases:15.06%
controls:1.31%
cases:33.07%
controls:7.18%
cases:42.62%
controls:18.23%
485
4547
2415
24366
369
2025
2534
26913
267
358
2636
28580
438
16
2465
28922
430
379
2426
28511
786
2033
1591
26298
696
4541
937
20369
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
2.1e-01
7.1e-01
2.1e+00
3.8e+00
3.7e+00
2.5e+00
1.1e+00
cases:10.10%
controls:8.35%
cases:7.99%
controls:4.09%
cases:5.34%
controls:0.67%
cases:1.52%
controls:0.03%
cases:17.30%
controls:0.54%
cases:33.78%
controls:3.97%
cases:29.03%
controls:12.40%
293
2414
2607
26499
232
1184
2671
27754
155
195
2748
28743
44
10
2859
28928
494
156
2362
28734
803
1126
1574
27205
474
3088
1159
21822
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
3.0e-01
1.4e+00
3.0e+00
—
5.2e+00
2.8e+00
1.4e+00
cases:0.97%
controls:0.72%
cases:1.45%
controls:0.37%
cases:0.86%
controls:0.04%
—
—
cases:9.00%
controls:0.05%
cases:5.34%
controls:0.35%
cases:4.72%
controls:1.19%
28
207
2872
28706
42
107
2861
28831
25
13
2878
28925
—
257
15
2599
28875
127
100
2250
28231
77
296
1556
24614
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
1.1e+00
1.9e+00
3.0e+00
—
4.0e+00
2.1e+00
1.4e+00
cases:2.10%
controls:0.69%
cases:1.72%
controls:0.26%
cases:1.10%
controls:0.06%
—
—
cases:1.65%
controls:0.03%
cases:2.06%
controls:0.25%
cases:3.31%
controls:0.84%
61
199
2839
28714
50
74
2853
28864
32
16
2871
28922
—
47
9
2809
28881
49
71
2328
28260
54
208
1579
24702
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
1.5e-01
1.3e+00
2.2e+00
—
5.7e+00
2.9e+00
1.5e+00
cases:0.62%
controls:0.53%
cases:0.96%
controls:0.26%
cases:0.28%
controls:0.03%
—
—
cases:9.63%
controls:0.03%
cases:4.46%
controls:0.27%
cases:4.96%
controls:1.18%
18
154
2882
28759
28
75
2875
28863
8
9
2895
28929
—
275
10
2581
28880
106
76
2271
28255
81
293
1552
24617
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
9.5e-01
1.3e+00
1.5e+00
—
4.1e+00
4.7e+00
2.3e+00
cases:0.90%
controls:0.35%
cases:0.65%
controls:0.17%
cases:0.21%
controls:0.05%
—
—
cases:3.47%
controls:0.06%
cases:16.28%
controls:0.18%
cases:5.33%
controls:0.54%
26
101
2874
28812
19
50
2884
28888
6
14
2897
28924
—
99
17
2757
28873
387
50
1990
28281
87
134
1546
24776
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
-1.3e-02
9.1e-01
3.0e+00
4.5e+00
2.5e+00
1.8e+00
6.2e-01
cases:2.03%
controls:2.06%
cases:1.31%
controls:0.53%
cases:1.72%
controls:0.08%
cases:1.79%
controls:0.02%
cases:0.74%
controls:0.06%
cases:3.11%
controls:0.52%
cases:2.82%
controls:1.54%
59
596
2841
28317
38
153
2865
28785
50
24
2853
28914
52
6
2851
28932
21
17
2835
28873
74
148
2303
28183
46
384
1587
24526
Hematology
82 [38004501]
82 [38004501]
1.2e+00
1.9e+00
2.1e+00
—
3.1e+00
2.9e+00
2.1e+00
cases:1.55%
controls:0.47%
cases:1.41%
controls:0.22%
cases:0.62%
controls:0.08%
—
—
cases:1.96%
controls:0.09%
cases:4.21%
controls:0.24%
cases:4.16%
controls:0.52%
45
135
2855
28778
41
64
2862
28874
18
22
2885
28916
—
56
25
2800
28865
100
68
2277
28263
68
130
1565
24780
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
1.4e-01
7.1e-01
3.1e+00
—
5.2e+00
2.8e+00
1.4e+00
cases:2.48%
controls:2.16%
cases:1.21%
controls:0.60%
cases:1.62%
controls:0.07%
—
—
cases:9.52%
controls:0.06%
cases:7.32%
controls:0.46%
cases:6.37%
controls:1.67%
72
625
2828
28288
35
173
2868
28765
47
21
2856
28917
—
272
16
2584
28874
174
129
2203
28202
104
417
1529
24493
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-8.5e-01
-6.1e-01
6.5e-01
3.0e+00
4.8e+00
3.6e+00
2.7e+00
cases:13.21%
controls:26.28%
cases:5.03%
controls:8.86%
cases:1.69%
controls:0.89%
cases:0.55%
controls:0.03%
cases:5.36%
controls:0.05%
cases:14.05%
controls:0.46%
cases:14.51%
controls:1.14%
383
7599
2517
21314
146
2564
2757
26374
49
258
2854
28680
16
8
2887
28930
153
14
2703
28876
334
130
2043
28201
237
283
1396
24627
Electrophysiological examination of eye
XCD10 [2001300413]
XCD10 [2001300413]
1.3e+00
2.4e+00
—
1.0e+50
—
5.2e+00
4.2e+00
cases:0.83%
controls:0.23%
cases:0.69%
controls:0.06%
—
—
cases:2.58%
controls:0.00%
—
—
cases:7.45%
controls:0.05%
cases:9.49%
controls:0.16%
24
66
2876
28847
20
18
2883
28920
—
75
0
2828
28938
—
177
13
2200
28318
155
39
1478
24871
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
6.2e-02
1.3e+00
4.3e+00
—
4.1e+00
2.3e+00
1.1e+00
cases:2.52%
controls:2.37%
cases:3.20%
controls:0.91%
cases:7.20%
controls:0.11%
—
—
cases:4.55%
controls:0.08%
cases:7.66%
controls:0.82%
cases:7.84%
controls:2.87%
73
685
2827
28228
93
263
2810
28675
209
31
2694
28907
—
130
23
2726
28867
182
233
2195
28098
128
715
1505
24195
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.1e-01
8.0e-01
2.3e+00
4.8e+00
2.6e+00
1.7e+00
7.5e-01
cases:5.14%
controls:4.61%
cases:5.65%
controls:2.61%
cases:4.82%
controls:0.49%
cases:2.38%
controls:0.02%
cases:5.32%
controls:0.41%
cases:12.28%
controls:2.46%
cases:14.21%
controls:7.24%
149
1334
2751
27579
164
756
2739
28182
140
142
2763
28796
69
6
2834
28932
152
118
2704
28772
292
697
2085
27634
232
1803
1401
23107
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
4.3e-01
8.8e-01
2.6e+00
—
4.8e+00
2.5e+00
1.6e+00
cases:5.00%
controls:3.31%
cases:1.62%
controls:0.68%
cases:1.00%
controls:0.08%
—
—
cases:6.97%
controls:0.06%
cases:5.76%
controls:0.51%
cases:7.04%
controls:1.45%
145
956
2755
27957
47
196
2856
28742
29
22
2874
28916
—
199
17
2657
28873
137
145
2240
28186
115
361
1518
24549
phenytoin; oral, parenteral
N03AB02 [21604399]
N03AB02 [21604399]
—
1.5e+00
—
—
4.7e+00
3.8e+00
2.8e+00
—
—
cases:0.31%
controls:0.07%
—
—
—
—
cases:1.86%
controls:0.02%
cases:3.62%
controls:0.08%
cases:1.59%
controls:0.10%
—
9
20
2894
28918
—
—
53
5
2803
28885
86
24
2291
28307
26
24
1607
24886
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
1.2e+00
2.0e+00
—
—
3.7e+00
3.8e+00
2.1e+00
cases:0.45%
controls:0.14%
cases:0.28%
controls:0.04%
—
—
—
—
cases:0.67%
controls:0.02%
cases:2.52%
controls:0.06%
cases:1.29%
controls:0.16%
13
40
2887
28873
8
11
2895
28927
—
—
19
5
2837
28885
60
16
2317
28315
21
39
1612
24871
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
7.2e-01
3.0e+00
—
1.0e+50
—
5.0e+00
4.0e+00
cases:1.52%
controls:0.75%
cases:3.24%
controls:0.17%
—
—
cases:9.47%
controls:0.00%
—
—
cases:21.67%
controls:0.19%
cases:26.52%
controls:0.65%
44
216
2856
28697
94
48
2809
28890
—
275
0
2628
28938
—
515
55
1862
28276
433
161
1200
24749
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.7e-01
6.6e-01
3.4e+00
1.0e+50
5.1e+00
2.3e+00
1.8e+00
cases:2.97%
controls:2.27%
cases:1.03%
controls:0.54%
cases:1.17%
controls:0.04%
cases:2.45%
controls:0.00%
cases:4.52%
controls:0.03%
cases:3.41%
controls:0.34%
cases:5.33%
controls:0.88%
86
656
2814
28257
30
156
2873
28782
34
12
2869
28926
71
0
2832
28938
129
8
2727
28882
81
97
2296
28234
87
220
1546
24690
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
8.8e-02
1.5e-01
1.6e+00
6.0e+00
3.4e+00
1.1e+00
5.8e-01
cases:18.45%
controls:17.16%
cases:7.72%
controls:6.68%
cases:3.93%
controls:0.83%
cases:6.85%
controls:0.02%
cases:17.96%
controls:0.74%
cases:17.16%
controls:6.72%
cases:30.13%
controls:19.41%
535
4962
2365
23951
224
1934
2679
27004
114
241
2789
28697
199
5
2704
28933
513
215
2343
28675
408
1903
1969
26428
492
4836
1141
20074
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
4.1e-01
1.5e+00
3.8e+00
—
3.7e+00
2.4e+00
1.3e+00
cases:0.93%
controls:0.62%
cases:0.79%
controls:0.18%
cases:0.90%
controls:0.02%
—
—
cases:1.47%
controls:0.04%
cases:2.31%
controls:0.21%
cases:1.84%
controls:0.53%
27
180
2873
28733
23
52
2880
28886
26
6
2877
28932
—
42
11
2814
28879
55
60
2322
28271
30
131
1603
24779
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
6.6e-01
3.7e+00
—
1.0e+50
1.0e+50
4.6e+00
4.2e+00
cases:0.41%
controls:0.21%
cases:1.10%
controls:0.03%
—
—
cases:4.51%
controls:0.00%
cases:2.45%
controls:0.00%
cases:6.10%
controls:0.06%
cases:9.55%
controls:0.16%
12
62
2888
28851
32
8
2871
28930
—
131
0
2772
28938
70
0
2786
28890
145
18
2232
28313
156
40
1477
24870
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
3.9e-01
7.8e-01
2.7e+00
—
4.5e+00
2.6e+00
1.5e+00
cases:7.21%
controls:4.99%
cases:2.38%
controls:1.10%
cases:1.55%
controls:0.11%
—
—
cases:7.25%
controls:0.08%
cases:10.01%
controls:0.82%
cases:11.27%
controls:2.77%
209
1442
2691
27471
69
319
2834
28619
45
32
2858
28906
—
207
24
2649
28866
238
233
2139
28098
184
690
1449
24220
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
8.7e-01
3.5e+00
—
1.0e+50
—
5.1e+00
2.9e+00
cases:0.76%
controls:0.32%
cases:2.45%
controls:0.07%
—
—
cases:0.28%
controls:0.00%
—
—
cases:11.57%
controls:0.08%
cases:4.72%
controls:0.27%
22
92
2878
28821
71
21
2832
28917
—
8
0
2895
28938
—
275
22
2102
28309
77
67
1556
24843
Simple partial seizures
G40.10 [2000502135]
G40.10 [2000502135]
—
3.1e+00
—
—
1.0e+50
4.5e+00
4.6e+00
—
—
cases:0.38%
controls:0.02%
—
—
—
—
cases:0.81%
controls:0.00%
cases:2.44%
controls:0.03%
cases:3.18%
controls:0.03%
—
11
5
2892
28933
—
—
23
0
2833
28890
58
8
2319
28323
52
8
1581
24902
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
1.9e+00
3.2e+00
—
1.0e+50
—
4.0e+00
3.0e+00
cases:2.79%
controls:0.41%
cases:1.86%
controls:0.08%
—
—
cases:1.79%
controls:0.00%
—
—
cases:3.11%
controls:0.06%
cases:4.78%
controls:0.25%
81
119
2819
28794
54
22
2849
28916
—
52
0
2851
28938
—
74
16
2303
28315
78
63
1555
24847
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
4.6e-01
8.0e-01
2.0e+00
—
4.9e+00
2.6e+00
1.4e+00
cases:8.72%
controls:5.70%
cases:2.79%
controls:1.28%
cases:0.83%
controls:0.11%
—
—
cases:10.43%
controls:0.09%
cases:11.27%
controls:0.97%
cases:10.84%
controls:2.95%
253
1649
2647
27264
81
370
2822
28568
24
32
2879
28906
—
298
26
2558
28864
268
275
2109
28056
177
734
1456
24176
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
-1.2e-01
5.4e-01
2.9e+00
5.1e+00
2.4e+00
1.1e+00
1.5e-01
cases:6.34%
controls:7.08%
cases:5.65%
controls:3.37%
cases:7.68%
controls:0.45%
cases:4.51%
controls:0.03%
cases:4.80%
controls:0.45%
cases:9.84%
controls:3.59%
cases:12.74%
controls:11.18%
184
2047
2716
26866
164
974
2739
27964
223
131
2680
28807
131
8
2772
28930
137
130
2719
28760
234
1016
2143
27315
208
2785
1425
22125
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
182 [2001600181]
8.0e-01
3.1e+00
1.0e+50
—
1.0e+50
5.3e+00
3.6e+00
cases:0.34%
controls:0.16%
cases:1.10%
controls:0.05%
cases:1.76%
controls:0.00%
—
—
cases:5.22%
controls:0.00%
cases:7.82%
controls:0.04%
cases:4.84%
controls:0.14%
10
45
2890
28868
32
15
2871
28923
51
0
2852
28938
—
149
0
2707
28890
186
12
2191
28319
79
35
1554
24875
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
2.9e-01
9.6e-01
2.6e+00
1.0e+50
5.4e+00
2.1e+00
9.1e-01
cases:0.72%
controls:0.54%
cases:0.79%
controls:0.30%
cases:0.31%
controls:0.02%
cases:1.24%
controls:0.00%
cases:4.27%
controls:0.02%
cases:2.57%
controls:0.31%
cases:3.00%
controls:1.23%
21
157
2879
28756
23
88
2880
28850
9
7
2894
28931
36
0
2867
28938
122
6
2734
28884
61
87
2316
28244
49
307
1584
24603
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
3.4e-01
2.5e+00
—
1.0e+50
4.8e+00
3.1e+00
1.6e+00
cases:0.52%
controls:0.37%
cases:1.58%
controls:0.13%
—
—
cases:0.45%
controls:0.00%
cases:2.45%
controls:0.02%
cases:2.06%
controls:0.10%
cases:1.65%
controls:0.35%
15
107
2885
28806
46
39
2857
28899
—
13
0
2890
28938
70
6
2786
28884
49
27
2328
28304
27
88
1606
24822
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
4.6e-01
2.3e+00
—
—
4.9e+00
3.3e+00
1.5e+00
cases:0.48%
controls:0.30%
cases:1.03%
controls:0.11%
—
—
—
—
cases:2.66%
controls:0.02%
cases:1.98%
controls:0.08%
cases:1.29%
controls:0.29%
14
88
2886
28825
30
31
2873
28907
—
—
76
6
2780
28884
47
22
2330
28309
21
73
1612
24837
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
-4.0e-02
8.9e-01
2.0e+00
—
5.3e+00
2.5e+00
1.2e+00
cases:1.38%
controls:1.44%
cases:1.62%
controls:0.67%
cases:0.59%
controls:0.08%
—
—
cases:13.73%
controls:0.08%
cases:7.32%
controls:0.65%
cases:7.90%
controls:2.48%
40
415
2860
28498
47
194
2856
28744
17
24
2886
28914
—
392
23
2464
28867
174
184
2203
28147
129
618
1504
24292
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
-4.0e-02
9.0e-01
2.0e+00
—
5.2e+00
2.5e+00
1.2e+00
cases:1.38%
controls:1.44%
cases:1.62%
controls:0.67%
cases:0.59%
controls:0.08%
—
—
cases:13.80%
controls:0.09%
cases:7.28%
controls:0.65%
cases:7.90%
controls:2.46%
40
415
2860
28498
47
193
2856
28745
17
23
2886
28915
—
394
25
2462
28865
173
183
2204
28148
129
612
1504
24298
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
-3.8e-02
9.0e-01
2.0e+00
—
5.2e+00
2.5e+00
1.2e+00
cases:1.38%
controls:1.43%
cases:1.62%
controls:0.67%
cases:0.59%
controls:0.08%
—
—
cases:13.80%
controls:0.09%
cases:7.28%
controls:0.65%
cases:7.90%
controls:2.46%
40
414
2860
28499
47
193
2856
28745
17
23
2886
28915
—
394
25
2462
28865
173
183
2204
28148
129
614
1504
24296
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
-2.3e-02
8.6e-01
2.0e+00
—
5.3e+00
2.5e+00
1.2e+00
cases:1.38%
controls:1.41%
cases:1.58%
controls:0.68%
cases:0.59%
controls:0.08%
—
—
cases:13.80%
controls:0.08%
cases:7.32%
controls:0.66%
cases:7.84%
controls:2.49%
40
408
2860
28505
46
196
2857
28742
17
23
2886
28915
—
394
24
2462
28866
174
187
2203
28144
128
620
1505
24290
Emergency Medicine
93 [38004510]
93 [38004510]
-7.4e-02
5.6e-01
2.8e+00
5.0e+00
2.0e+00
1.2e+00
2.6e-01
cases:11.62%
controls:12.40%
cases:10.89%
controls:6.55%
cases:13.64%
controls:1.00%
cases:8.65%
controls:0.06%
cases:6.69%
controls:0.97%
cases:20.57%
controls:7.40%
cases:26.45%
controls:21.68%
337
3585
2563
25328
316
1895
2587
27043
396
289
2507
28649
251
18
2652
28920
191
280
2665
28610
489
2097
1888
26234
432
5401
1201
19509
Benign tumor of the meninges at the base of the brain
D32.02 [2000501309]
D32.02 [2000501309]
1.5e+00
2.0e+00
2.6e+00
1.0e+50
—
3.1e+00
2.6e+00
cases:0.41%
controls:0.09%
cases:0.45%
controls:0.06%
cases:0.31%
controls:0.02%
cases:0.28%
controls:0.00%
—
—
cases:1.30%
controls:0.06%
cases:1.47%
controls:0.11%
12
26
2888
28887
13
18
2890
28920
9
7
2894
28931
8
0
2895
28938
—
31
17
2346
28314
24
28
1609
24882
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.9e-01
6.8e-01
2.2e+00
3.5e+00
3.0e+00
1.7e+00
7.0e-01
cases:8.59%
controls:7.19%
cases:7.58%
controls:4.01%
cases:4.89%
controls:0.55%
cases:1.24%
controls:0.04%
cases:9.91%
controls:0.56%
cases:17.92%
controls:3.99%
cases:19.72%
controls:10.85%
249
2080
2651
26833
220
1159
2683
27779
142
158
2761
28780
36
11
2867
28927
283
163
2573
28727
426
1131
1951
27200
322
2702
1311
22208
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
4.4e-01
2.6e+00
—
1.0e+50
4.9e+00
2.8e+00
1.5e+00
cases:0.48%
controls:0.31%
cases:1.58%
controls:0.12%
—
—
cases:0.41%
controls:0.00%
cases:2.17%
controls:0.02%
cases:1.56%
controls:0.09%
cases:1.22%
controls:0.29%
14
90
2886
28823
46
36
2857
28902
—
12
0
2891
28938
62
5
2794
28885
37
26
2340
28305
20
72
1613
24838
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
1.4e+00
2.1e+00
—
—
—
5.1e+00
3.1e+00
cases:0.93%
controls:0.24%
cases:0.69%
controls:0.09%
—
—
—
—
—
—
cases:13.29%
controls:0.09%
cases:6.31%
controls:0.29%
27
70
2873
28843
20
25
2883
28913
—
—
—
316
26
2061
28305
103
73
1530
24837
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
3.1e-01
1.6e+00
4.7e+00
1.0e+50
—
3.3e+00
1.9e+00
cases:1.17%
controls:0.86%
cases:1.27%
controls:0.25%
cases:2.65%
controls:0.02%
cases:2.93%
controls:0.00%
—
—
cases:4.33%
controls:0.16%
cases:6.06%
controls:0.91%
34
250
2866
28663
37
72
2866
28866
77
7
2826
28931
85
0
2818
28938
—
103
45
2274
28286
99
227
1534
24683
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
5.3e-01
6.8e-01
3.2e+00
—
4.4e+00
1.9e+00
9.4e-01
cases:2.10%
controls:1.25%
cases:1.55%
controls:0.79%
cases:1.76%
controls:0.07%
—
—
cases:7.35%
controls:0.10%
cases:4.54%
controls:0.70%
cases:7.35%
controls:3.01%
61
362
2839
28551
45
230
2858
28708
51
21
2852
28917
—
210
29
2646
28861
108
198
2269
28133
120
749
1513
24161
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
5.0e-02
6.4e-01
2.0e+00
3.7e+00
2.6e+00
2.0e+00
5.3e-01
cases:3.97%
controls:3.78%
cases:3.31%
controls:1.77%
cases:2.10%
controls:0.28%
cases:0.86%
controls:0.02%
cases:3.89%
controls:0.29%
cases:12.66%
controls:1.90%
cases:10.59%
controls:6.52%
115
1093
2785
27820
96
511
2807
28427
61
81
2842
28857
25
6
2878
28932
111
84
2745
28806
301
538
2076
27793
173
1623
1460
23287
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
-2.7e-02
4.1e-01
2.3e+00
4.5e+00
2.9e+00
1.2e+00
2.5e-01
cases:26.45%
controls:26.98%
cases:23.67%
controls:17.03%
cases:25.28%
controls:3.16%
cases:17.29%
controls:0.22%
cases:36.80%
controls:3.22%
cases:41.52%
controls:17.85%
cases:44.83%
controls:38.74%
767
7802
2133
21111
687
4929
2216
24009
734
915
2169
28023
502
65
2401
28873
1051
929
1805
27961
987
5058
1390
23273
732
9649
901
15261
Photography of fundus of eye
XCK10 [2001301381]
XCK10 [2001301381]
3.7e-02
8.0e-01
2.7e+00
1.0e+50
3.6e+00
2.4e+00
2.0e+00
cases:2.24%
controls:2.16%
cases:1.31%
controls:0.59%
cases:0.69%
controls:0.04%
cases:2.41%
controls:0.00%
cases:2.17%
controls:0.06%
cases:5.64%
controls:0.55%
cases:9.06%
controls:1.39%
65
625
2835
28288
38
171
2865
28767
20
13
2883
28925
70
0
2833
28938
62
17
2794
28873
134
156
2243
28175
148
346
1485
24564
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
2.6e-01
6.8e-01
2.4e+00
1.0e+50
4.2e+00
2.8e+00
1.4e+00
cases:4.93%
controls:3.86%
cases:2.34%
controls:1.20%
cases:1.07%
controls:0.10%
cases:0.83%
controls:0.00%
cases:9.38%
controls:0.15%
cases:17.46%
controls:1.32%
cases:17.33%
controls:4.77%
143
1117
2757
27796
68
346
2835
28592
31
29
2872
28909
24
0
2879
28938
268
43
2588
28847
415
373
1962
27958
283
1188
1350
23722
General Practice
1 [38004446]
1 [38004446]
-1.1e-01
3.4e-01
1.7e+00
4.5e+00
2.9e+00
1.5e+00
4.3e-01
cases:12.17%
controls:13.36%
cases:7.34%
controls:5.36%
cases:4.89%
controls:0.91%
cases:2.76%
controls:0.03%
cases:13.24%
controls:0.81%
cases:20.70%
controls:5.39%
cases:22.78%
controls:16.11%
353
3863
2547
25050
213
1550
2690
27388
142
264
2761
28674
80
9
2823
28929
378
233
2478
28657
492
1527
1885
26804
372
4013
1261
20897
Headache
R51.80 [2000503603]
R51.80 [2000503603]
6.2e-02
1.1e+00
4.1e+00
1.0e+50
3.3e+00
1.8e+00
1.1e+00
cases:1.62%
controls:1.53%
cases:1.21%
controls:0.39%
cases:1.93%
controls:0.03%
cases:1.00%
controls:0.00%
cases:0.98%
controls:0.04%
cases:2.61%
controls:0.45%
cases:5.14%
controls:1.75%
47
441
2853
28472
35
112
2868
28826
56
9
2847
28929
29
0
2874
28938
28
11
2828
28879
62
127
2315
28204
84
436
1549
24474
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
1.9e-01
6.8e-01
2.5e+00
—
4.5e+00
2.5e+00
1.2e+00
cases:2.90%
controls:2.41%
cases:1.45%
controls:0.74%
cases:0.65%
controls:0.06%
—
—
cases:4.34%
controls:0.05%
cases:6.39%
controls:0.57%
cases:5.82%
controls:1.80%
84
698
2816
28215
42
213
2861
28725
19
16
2884
28922
—
124
14
2732
28876
152
161
2225
28170
95
448
1538
24462
Outpatient Visit
OP [9202]
OP [9202]
1.3e-01
3.8e-01
1.2e+00
4.4e+00
2.3e+00
1.8e+00
1.3e+00
cases:70.93%
controls:68.24%
cases:56.77%
controls:47.36%
cases:26.11%
controls:9.58%
cases:24.94%
controls:0.42%
cases:49.93%
controls:9.49%
cases:84.64%
controls:47.85%
cases:92.28%
controls:76.13%
2057
19730
843
9183
1648
13706
1255
15232
758
2771
2145
26167
724
122
2179
28816
1426
2743
1430
26147
2012
13555
365
14776
1507
18964
126
5946
letrozole; oral
L02BG04 [21603842]
L02BG04 [21603842]
2.4e+00
3.4e+00
1.0e+50
—
—
3.3e+00
2.2e+00
cases:1.03%
controls:0.10%
cases:0.72%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
—
—
cases:0.84%
controls:0.03%
cases:1.22%
controls:0.13%
30
28
2870
28885
21
7
2882
28931
5
0
2898
28938
—
—
20
9
2357
28322
20
33
1613
24877
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
2.2e-01
1.0e+00
3.3e+00
—
3.9e+00
2.1e+00
9.5e-01
cases:5.24%
controls:4.25%
cases:5.10%
controls:1.90%
cases:8.27%
controls:0.32%
—
—
cases:12.39%
controls:0.28%
cases:11.82%
controls:1.68%
cases:12.74%
controls:5.34%
152
1230
2748
27683
148
551
2755
28387
240
94
2663
28844
—
354
80
2502
28810
281
476
2096
27855
208
1330
1425
23580
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
2.8e-01
9.4e-01
2.6e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:2.76%
controls:2.09%
cases:1.17%
controls:0.46%
cases:0.76%
controls:0.06%
—
—
cases:2.59%
controls:0.04%
cases:3.20%
controls:0.39%
cases:4.72%
controls:1.18%
80
604
2820
28309
34
134
2869
28804
22
16
2881
28922
—
74
12
2782
28878
76
110
2301
28221
77
294
1556
24616
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
1.5e-01
6.7e-01
2.0e+00
4.1e+00
2.5e+00
1.6e+00
4.1e-01
cases:5.03%
controls:4.36%
cases:4.10%
controls:2.14%
cases:2.69%
controls:0.36%
cases:1.03%
controls:0.02%
cases:4.06%
controls:0.36%
cases:9.93%
controls:2.28%
cases:10.29%
controls:7.09%
146
1261
2754
27652
119
618
2784
28320
78
104
2825
28834
30
5
2873
28933
116
105
2740
28785
236
646
2141
27685
168
1766
1465
23144
Paediatric neurology
421 [44777781]
421 [44777781]
5.6e-01
1.3e+00
2.5e+00
1.0e+50
2.5e+00
2.4e+00
2.5e+00
cases:0.38%
controls:0.22%
cases:0.52%
controls:0.14%
cases:0.38%
controls:0.03%
cases:0.24%
controls:0.00%
cases:0.49%
controls:0.04%
cases:1.30%
controls:0.12%
cases:2.39%
controls:0.21%
11
63
2889
28850
15
40
2888
28898
11
9
2892
28929
7
0
2896
28938
14
12
2842
28878
31
34
2346
28297
39
52
1594
24858
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.9e-01
6.9e-01
3.1e+00
—
4.5e+00
2.0e+00
8.1e-01
cases:3.93%
controls:2.98%
cases:2.72%
controls:1.39%
cases:3.10%
controls:0.14%
—
—
cases:11.03%
controls:0.14%
cases:8.50%
controls:1.24%
cases:9.43%
controls:4.45%
114
862
2786
28051
79
401
2824
28537
90
40
2813
28898
—
315
40
2541
28850
202
350
2175
27981
154
1108
1479
23802
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
6.4e-02
5.1e-01
1.8e+00
3.3e+00
2.9e+00
1.8e+00
7.9e-01
cases:17.45%
controls:16.54%
cases:14.74%
controls:9.45%
cases:9.03%
controls:1.62%
cases:1.79%
controls:0.07%
cases:20.94%
controls:1.42%
cases:39.17%
controls:9.42%
cases:39.56%
controls:22.97%
506
4782
2394
24131
428
2734
2475
26204
262
470
2641
28468
52
20
2851
28918
598
411
2258
28479
931
2668
1446
25663
646
5723
987
19187
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
9.3e-01
1.4e+00
1.9e+00
—
2.6e+00
2.6e+00
1.6e+00
cases:1.76%
controls:0.70%
cases:1.10%
controls:0.27%
cases:0.48%
controls:0.07%
—
—
cases:0.63%
controls:0.05%
cases:2.57%
controls:0.19%
cases:2.88%
controls:0.59%
51
202
2849
28711
32
78
2871
28860
14
20
2889
28918
—
18
14
2838
28876
61
55
2316
28276
47
146
1586
24764
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
1.1e-01
5.3e-01
1.7e+00
3.2e+00
2.6e+00
2.0e+00
1.0e+00
cases:11.69%
controls:10.58%
cases:10.37%
controls:6.35%
cases:7.48%
controls:1.49%
cases:0.90%
controls:0.04%
cases:16.00%
controls:1.35%
cases:34.29%
controls:6.39%
cases:32.64%
controls:14.65%
339
3059
2561
25854
301
1837
2602
27101
217
431
2686
28507
26
11
2877
28927
457
389
2399
28501
815
1811
1562
26520
533
3650
1100
21260
Inpatient Visit
IP [9201]
IP [9201]
2.0e-01
6.8e-01
2.9e+00
—
4.5e+00
2.1e+00
8.8e-01
cases:7.38%
controls:6.14%
cases:5.03%
controls:2.61%
cases:4.65%
controls:0.28%
—
—
cases:19.43%
controls:0.27%
cases:17.71%
controls:2.53%
cases:17.58%
controls:8.13%
214
1776
2686
27137
146
754
2757
28184
135
80
2768
28858
—
555
78
2301
28812
421
716
1956
27615
287
2026
1346
22884
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
2.9e-01
7.6e-01
3.8e+00
1.0e+50
3.9e+00
2.2e+00
1.1e+00
cases:1.21%
controls:0.91%
cases:0.72%
controls:0.34%
cases:0.93%
controls:0.02%
cases:1.79%
controls:0.00%
cases:1.82%
controls:0.04%
cases:2.57%
controls:0.29%
cases:3.18%
controls:1.06%
35
263
2865
28650
21
98
2882
28840
27
6
2876
28932
52
0
2851
28938
52
11
2804
28879
61
82
2316
28249
52
264
1581
24646
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
1.2e-01
6.2e-01
2.0e+00
4.0e+00
2.5e+00
1.5e+00
4.4e-01
cases:4.72%
controls:4.22%
cases:3.75%
controls:2.06%
cases:2.48%
controls:0.36%
cases:0.96%
controls:0.02%
cases:3.92%
controls:0.35%
cases:9.13%
controls:2.18%
cases:9.86%
controls:6.57%
137
1219
2763
27694
109
596
2794
28342
72
103
2831
28835
28
5
2875
28933
112
101
2744
28789
217
617
2160
27714
161
1636
1472
23274
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
3.8e-01
7.2e-01
2.2e+00
1.0e+50
4.5e+00
2.1e+00
1.1e+00
cases:4.83%
controls:3.34%
cases:1.69%
controls:0.83%
cases:0.72%
controls:0.08%
cases:1.89%
controls:0.00%
cases:4.90%
controls:0.06%
cases:5.26%
controls:0.69%
cases:6.98%
controls:2.40%
140
965
2760
27948
49
239
2854
28699
21
23
2882
28915
55
0
2848
28938
140
17
2716
28873
125
195
2252
28136
114
598
1519
24312
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
4.8e-01
7.0e-01
1.7e+00
—
3.9e+00
3.0e+00
1.2e+00
cases:2.03%
controls:1.27%
cases:1.17%
controls:0.58%
cases:0.31%
controls:0.06%
—
—
cases:3.08%
controls:0.06%
cases:9.42%
controls:0.53%
cases:5.94%
controls:1.94%
59
366
2841
28547
34
169
2869
28769
9
16
2894
28922
—
88
18
2768
28872
224
149
2153
28182
97
484
1536
24426
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
1.9e-01
5.2e-01
1.6e+00
3.3e+00
2.7e+00
2.0e+00
9.7e-01
cases:5.41%
controls:4.53%
cases:3.79%
controls:2.29%
cases:2.27%
controls:0.48%
cases:0.45%
controls:0.02%
cases:6.02%
controls:0.45%
cases:13.71%
controls:2.15%
cases:14.76%
controls:6.17%
157
1311
2743
27602
110
662
2793
28276
66
139
2837
28799
13
5
2890
28933
172
130
2684
28760
326
609
2051
27722
241
1537
1392
23373
Subcutaneous
ZX112 [2001311492]
ZX112 [2001311492]
1.8e+00
2.5e+00
—
—
—
3.6e+00
3.0e+00
cases:0.34%
controls:0.06%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.76%
controls:0.02%
cases:0.92%
controls:0.04%
10
16
2890
28897
6
5
2897
28933
—
—
—
18
6
2359
28325
15
11
1618
24899
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
2.7e-01
6.0e-01
3.0e+00
—
4.5e+00
2.1e+00
7.5e-01
cases:5.86%
controls:4.52%
cases:3.51%
controls:1.97%
cases:4.13%
controls:0.21%
—
—
cases:15.02%
controls:0.20%
cases:11.65%
controls:1.66%
cases:11.94%
controls:6.01%
170
1307
2730
27606
102
569
2801
28369
120
62
2783
28876
—
429
57
2427
28833
277
470
2100
27861
195
1496
1438
23414
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
2.1e-01
6.4e-01
3.4e+00
1.0e+50
4.2e+00
2.0e+00
5.9e-01
cases:2.24%
controls:1.82%
cases:1.24%
controls:0.66%
cases:1.24%
controls:0.04%
cases:1.62%
controls:0.00%
cases:3.33%
controls:0.05%
cases:4.50%
controls:0.63%
cases:3.55%
controls:2.00%
65
525
2835
28388
36
190
2867
28748
36
12
2867
28926
47
0
2856
28938
95
15
2761
28875
107
178
2270
28153
58
498
1575
24412
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
1.7e-02
8.6e-01
1.8e+00
—
5.0e+00
2.2e+00
9.8e-01
cases:1.03%
controls:1.02%
cases:1.24%
controls:0.53%
cases:0.34%
controls:0.06%
—
—
cases:7.95%
controls:0.06%
cases:4.38%
controls:0.53%
cases:5.51%
controls:2.15%
30
294
2870
28619
36
153
2867
28785
10
17
2893
28921
—
227
16
2629
28874
104
149
2273
28182
90
535
1543
24375
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
7.6e-02
4.8e-01
1.7e+00
3.5e+00
2.4e+00
1.8e+00
8.8e-01
cases:9.90%
controls:9.24%
cases:8.58%
controls:5.48%
cases:5.72%
controls:1.09%
cases:0.55%
controls:0.02%
cases:10.96%
controls:1.06%
cases:26.46%
controls:5.40%
cases:25.47%
controls:12.47%
287
2672
2613
26241
249
1587
2654
27351
166
316
2737
28622
16
5
2887
28933
313
305
2543
28585
629
1529
1748
26802
416
3106
1217
21804
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
9.3e-02
4.8e-01
1.7e+00
3.3e+00
2.5e+00
1.9e+00
9.0e-01
cases:9.72%
controls:8.93%
cases:8.27%
controls:5.26%
cases:5.68%
controls:1.07%
cases:0.55%
controls:0.02%
cases:10.89%
controls:1.01%
cases:26.38%
controls:5.22%
cases:25.05%
controls:11.94%
282
2583
2618
26330
240
1523
2663
27415
165
311
2738
28627
16
6
2887
28932
311
293
2545
28597
627
1480
1750
26851
409
2975
1224
21935
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
9.1e-02
4.8e-01
1.7e+00
3.3e+00
2.5e+00
1.9e+00
9.0e-01
cases:9.72%
controls:8.95%
cases:8.27%
controls:5.27%
cases:5.65%
controls:1.08%
cases:0.55%
controls:0.02%
cases:10.92%
controls:1.02%
cases:26.42%
controls:5.22%
cases:25.17%
controls:12.00%
282
2589
2618
26324
240
1525
2663
27413
164
313
2739
28625
16
6
2887
28932
312
296
2544
28594
628
1479
1749
26852
411
2989
1222
21921
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
2.1e-01
1.4e+00
3.0e+00
—
3.1e+00
2.1e+00
1.1e+00
cases:0.55%
controls:0.45%
cases:0.59%
controls:0.14%
cases:0.48%
controls:0.02%
—
—
cases:0.74%
controls:0.03%
cases:0.97%
controls:0.12%
cases:0.92%
controls:0.31%
16
130
2884
28783
17
41
2886
28897
14
7
2889
28931
—
21
10
2835
28880
23
33
2354
28298
15
76
1618
24834
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
2.1e-01
1.4e+00
3.0e+00
—
3.1e+00
2.1e+00
1.1e+00
cases:0.55%
controls:0.45%
cases:0.59%
controls:0.14%
cases:0.48%
controls:0.02%
—
—
cases:0.74%
controls:0.03%
cases:0.97%
controls:0.12%
cases:0.92%
controls:0.31%
16
130
2884
28783
17
41
2886
28897
14
7
2889
28931
—
21
10
2835
28880
23
33
2354
28298
15
76
1618
24834
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
2.1e-01
1.4e+00
3.0e+00
—
3.1e+00
2.1e+00
1.1e+00
cases:0.55%
controls:0.45%
cases:0.59%
controls:0.14%
cases:0.48%
controls:0.02%
—
—
cases:0.74%
controls:0.03%
cases:0.97%
controls:0.12%
cases:0.92%
controls:0.31%
16
130
2884
28783
17
41
2886
28897
14
7
2889
28931
—
21
10
2835
28880
23
33
2354
28298
15
77
1618
24833
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
9.2e-02
4.8e-01
1.7e+00
3.3e+00
2.5e+00
1.9e+00
9.0e-01
cases:9.69%
controls:8.92%
cases:8.23%
controls:5.27%
cases:5.65%
controls:1.08%
cases:0.55%
controls:0.02%
cases:10.71%
controls:1.01%
cases:26.17%
controls:5.21%
cases:24.98%
controls:11.97%
281
2578
2619
26335
239
1524
2664
27414
164
313
2739
28625
16
6
2887
28932
306
293
2550
28597
622
1477
1755
26854
408
2981
1225
21929
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
-6.1e-02
2.5e-01
2.1e+00
4.8e+00
2.7e+00
8.3e-01
8.8e-02
cases:29.79%
controls:31.08%
cases:29.11%
controls:24.32%
cases:27.21%
controls:4.34%
cases:21.98%
controls:0.23%
cases:38.20%
controls:4.15%
cases:43.96%
controls:25.54%
cases:48.13%
controls:45.94%
864
8987
2036
19926
845
7037
2058
21901
790
1255
2113
27683
638
68
2265
28870
1091
1200
1765
27690
1045
7236
1332
21095
786
11443
847
13467
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
1.4e-01
6.1e-01
1.9e+00
3.9e+00
2.4e+00
1.4e+00
3.9e-01
cases:5.79%
controls:5.09%
cases:4.55%
controls:2.53%
cases:2.89%
controls:0.43%
cases:1.14%
controls:0.02%
cases:4.34%
controls:0.42%
cases:10.64%
controls:2.80%
cases:12.00%
controls:8.47%
168
1471
2732
27442
132
733
2771
28205
84
123
2819
28815
33
7
2870
28931
124
120
2732
28770
253
793
2124
27538
196
2111
1437
22799
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
-7.2e-02
6.2e-01
2.0e+00
4.3e+00
2.0e+00
1.2e+00
5.2e-01
cases:8.79%
controls:9.39%
cases:9.54%
controls:5.37%
cases:12.30%
controls:1.89%
cases:8.30%
controls:0.12%
cases:11.83%
controls:1.85%
cases:15.90%
controls:5.49%
cases:19.29%
controls:12.42%
255
2715
2645
26198
277
1554
2626
27384
357
548
2546
28390
241
35
2662
28903
338
534
2518
28356
378
1556
1999
26775
315
3095
1318
21815
Simple partial seizures with secondary generalization
G40.12 [2000502137]
G40.12 [2000502137]
—
1.1e+00
3.0e+00
1.0e+50
—
3.9e+00
3.7e+00
—
—
cases:0.21%
controls:0.07%
cases:0.41%
controls:0.02%
cases:0.69%
controls:0.00%
—
—
cases:2.90%
controls:0.06%
cases:4.10%
controls:0.11%
—
6
20
2897
28918
12
6
2891
28932
20
0
2883
28938
—
69
17
2308
28314
67
27
1566
24883
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
2.4e-01
7.4e-01
2.0e+00
—
4.2e+00
2.3e+00
1.3e+00
cases:4.10%
controls:3.27%
cases:1.58%
controls:0.76%
cases:0.55%
controls:0.07%
—
—
cases:3.68%
controls:0.06%
cases:6.02%
controls:0.61%
cases:7.59%
controls:2.22%
119
945
2781
27968
46
220
2857
28718
16
21
2887
28917
—
105
17
2751
28873
143
173
2234
28158
124
554
1509
24356
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
5.1e-01
7.2e-01
1.9e+00
—
4.8e+00
1.7e+00
9.3e-01
cases:9.21%
controls:5.74%
cases:4.13%
controls:2.05%
cases:1.45%
controls:0.22%
—
—
cases:19.61%
controls:0.20%
cases:9.21%
controls:1.84%
cases:14.39%
controls:6.23%
267
1661
2633
27252
120
593
2783
28345
42
64
2861
28874
—
560
57
2296
28833
219
521
2158
27810
235
1553
1398
23357
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
6.4e-02
4.6e-01
1.7e+00
3.3e+00
2.4e+00
1.8e+00
8.5e-01
cases:9.48%
controls:8.95%
cases:8.20%
controls:5.34%
cases:5.65%
controls:1.08%
cases:0.55%
controls:0.02%
cases:10.26%
controls:1.01%
cases:25.28%
controls:5.34%
cases:24.56%
controls:12.22%
275
2587
2625
26326
238
1546
2665
27392
164
313
2739
28625
16
6
2887
28932
293
293
2563
28597
601
1512
1776
26819
401
3044
1232
21866
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
2.8e-01
9.7e-01
2.1e+00
1.0e+50
3.0e+00
2.4e+00
2.0e+00
cases:1.45%
controls:1.10%
cases:0.72%
controls:0.28%
cases:0.24%
controls:0.03%
cases:0.83%
controls:0.00%
cases:1.02%
controls:0.05%
cases:3.37%
controls:0.30%
cases:5.39%
controls:0.73%
42
319
2858
28594
21
80
2882
28858
7
9
2896
28929
24
0
2879
28938
29
15
2827
28875
80
85
2297
28246
88
182
1545
24728
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
1.9e-01
7.5e-01
2.2e+00
—
2.9e+00
2.4e+00
2.3e+00
cases:0.90%
controls:0.74%
cases:0.96%
controls:0.46%
cases:1.31%
controls:0.15%
—
—
cases:2.17%
controls:0.12%
cases:4.84%
controls:0.47%
cases:6.12%
controls:0.65%
26
215
2874
28698
28
132
2875
28806
38
43
2865
28895
—
62
36
2794
28854
115
134
2262
28197
100
163
1533
24747
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
-5.9e-02
2.4e-01
2.1e+00
4.7e+00
2.6e+00
8.0e-01
4.6e-02
cases:30.00%
controls:31.26%
cases:29.38%
controls:24.65%
cases:27.21%
controls:4.41%
cases:21.29%
controls:0.24%
cases:37.92%
controls:4.24%
cases:43.88%
controls:25.92%
cases:47.46%
controls:46.31%
870
9039
2030
19874
853
7134
2050
21804
790
1276
2113
27662
618
70
2285
28868
1083
1224
1773
27666
1043
7342
1334
20989
775
11535
858
13375
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
1.8e+00
2.8e+00
—
—
—
3.8e+00
2.0e+00
cases:0.69%
controls:0.11%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:1.26%
controls:0.03%
cases:1.04%
controls:0.14%
20
33
2880
28880
10
6
2893
28932
—
—
—
30
8
2347
28323
17
35
1616
24875
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
4.5e-01
8.7e-01
3.3e+00
1.0e+50
3.4e+00
1.7e+00
1.2e+00
cases:1.17%
controls:0.75%
cases:0.65%
controls:0.28%
cases:0.83%
controls:0.03%
cases:0.83%
controls:0.00%
cases:0.60%
controls:0.02%
cases:1.14%
controls:0.20%
cases:2.20%
controls:0.69%
34
217
2866
28696
19
80
2884
28858
24
9
2879
28929
24
0
2879
28938
17
6
2839
28884
27
58
2350
28273
36
172
1597
24738
Epilepsy
G40 [45595935]
G40 [45595935]
5.0e-01
2.6e+00
—
—
—
4.6e+00
3.2e+00
cases:0.55%
controls:0.34%
cases:1.27%
controls:0.10%
—
—
—
—
—
—
cases:6.73%
controls:0.07%
cases:5.33%
controls:0.23%
16
97
2884
28816
37
28
2866
28910
—
—
—
160
21
2217
28310
87
57
1546
24853
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
3.4e-02
1.5e+00
3.6e+00
1.0e+50
2.1e+00
2.0e+00
1.2e+00
cases:0.86%
controls:0.83%
cases:1.17%
controls:0.26%
cases:0.76%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.46%
controls:0.06%
cases:1.68%
controls:0.24%
cases:2.39%
controls:0.76%
25
241
2875
28672
34
76
2869
28862
22
6
2881
28932
6
0
2897
28938
13
16
2843
28874
40
67
2337
28264
39
190
1594
24720
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
5.4e-02
4.2e-01
1.6e+00
3.2e+00
2.4e+00
1.8e+00
8.7e-01
cases:9.79%
controls:9.32%
cases:8.41%
controls:5.70%
cases:5.75%
controls:1.19%
cases:0.59%
controls:0.02%
cases:11.03%
controls:1.10%
cases:27.43%
controls:5.67%
cases:26.88%
controls:13.36%
284
2696
2616
26217
244
1649
2659
27289
167
344
2736
28594
17
7
2886
28931
315
317
2541
28573
652
1607
1725
26724
439
3329
1194
21581
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
-7.3e-02
8.2e-01
1.7e+00
—
4.9e+00
2.0e+00
9.8e-01
cases:1.10%
controls:1.19%
cases:1.34%
controls:0.60%
cases:0.38%
controls:0.07%
—
—
cases:7.88%
controls:0.07%
cases:4.38%
controls:0.60%
cases:5.88%
controls:2.29%
32
343
2868
28570
39
173
2864
28765
11
21
2892
28917
—
225
19
2631
28871
104
169
2273
28162
96
570
1537
24340
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2639-3 [3005895]
6.9e-02
1.1e+00
3.8e+00
1.0e+50
3.5e+00
2.1e+00
3.6e-01
cases:0.45%
controls:0.42%
cases:0.62%
controls:0.21%
cases:1.17%
controls:0.03%
cases:0.31%
controls:0.00%
cases:0.67%
controls:0.02%
cases:1.89%
controls:0.25%
cases:1.10%
controls:0.77%
13
121
2887
28792
18
62
2885
28876
34
8
2869
28930
9
0
2894
28938
19
6
2837
28884
45
70
2332
28261
18
192
1615
24718
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
1.5e+00
1.7e+00
—
1.0e+50
—
4.5e+00
2.7e+00
cases:0.55%
controls:0.12%
cases:0.41%
controls:0.08%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.32%
controls:0.04%
cases:3.00%
controls:0.20%
16
36
2884
28877
12
23
2891
28915
—
7
0
2896
28938
—
79
11
2298
28320
49
51
1584
24859
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
5.0e-02
4.2e-01
1.6e+00
3.2e+00
2.4e+00
1.8e+00
8.7e-01
cases:9.83%
controls:9.40%
cases:8.41%
controls:5.71%
cases:5.72%
controls:1.20%
cases:0.59%
controls:0.02%
cases:11.03%
controls:1.09%
cases:27.43%
controls:5.70%
cases:26.94%
controls:13.43%
285
2717
2615
26196
244
1652
2659
27286
166
346
2737
28592
17
7
2886
28931
315
316
2541
28574
652
1616
1725
26715
440
3346
1193
21564
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
G40.2 [45591172]
9.7e-01
2.7e+00
—
—
—
4.5e+00
3.1e+00
cases:0.34%
controls:0.13%
cases:0.79%
controls:0.05%
—
—
—
—
—
—
cases:4.25%
controls:0.05%
cases:4.04%
controls:0.19%
10
38
2890
28875
23
15
2880
28923
—
—
—
101
14
2276
28317
66
48
1567
24862
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
2.9e-02
4.1e-01
1.6e+00
3.2e+00
2.4e+00
1.8e+00
8.4e-01
cases:10.10%
controls:9.84%
cases:8.72%
controls:5.95%
cases:5.86%
controls:1.21%
cases:0.59%
controls:0.02%
cases:11.20%
controls:1.11%
cases:27.68%
controls:5.91%
cases:27.13%
controls:13.83%
293
2846
2607
26067
253
1721
2650
27217
170
350
2733
28588
17
7
2886
28931
320
320
2536
28570
658
1674
1719
26657
443
3445
1190
21465
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
9.5e-02
3.5e-01
1.7e+00
3.9e+00
2.3e+00
1.4e+00
6.1e-01
cases:8.00%
controls:7.33%
cases:8.30%
controls:6.01%
cases:7.20%
controls:1.46%
cases:3.31%
controls:0.07%
cases:12.18%
controls:1.31%
cases:22.59%
controls:6.46%
cases:22.47%
controls:13.60%
232
2118
2668
26795
241
1740
2662
27198
209
423
2694
28515
96
21
2807
28917
348
378
2508
28512
537
1830
1840
26501
367
3388
1266
21522
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.0e-01
2.9e-01
2.0e+00
4.5e+00
2.5e+00
8.7e-01
1.4e-01
cases:23.07%
controls:21.35%
cases:23.29%
controls:18.54%
cases:21.15%
controls:3.58%
cases:13.81%
controls:0.17%
cases:30.32%
controls:3.42%
cases:37.23%
controls:19.89%
cases:40.85%
controls:37.42%
669
6173
2231
22740
676
5366
2227
23572
614
1036
2289
27902
401
49
2502
28889
866
988
1990
27902
885
5635
1492
22696
667
9322
966
15588
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
2.8e-01
7.6e-01
2.7e+00
—
3.6e+00
2.1e+00
1.0e+00
cases:5.17%
controls:3.95%
cases:2.82%
controls:1.34%
cases:2.55%
controls:0.18%
—
—
cases:7.42%
controls:0.21%
cases:8.67%
controls:1.15%
cases:9.19%
controls:3.58%
150
1141
2750
27772
82
389
2821
28549
74
51
2829
28887
—
212
61
2644
28829
206
327
2171
28004
150
891
1483
24019
Plain photography of ocular fundus
CK2S4 [2001301455]
CK2S4 [2001301455]
5.1e-01
9.8e-01
3.2e+00
1.0e+50
2.6e+00
2.0e+00
1.3e+00
cases:1.14%
controls:0.69%
cases:0.93%
controls:0.35%
cases:0.59%
controls:0.02%
cases:0.96%
controls:0.00%
cases:0.81%
controls:0.06%
cases:2.48%
controls:0.34%
cases:3.74%
controls:1.00%
33
199
2867
28714
27
102
2876
28836
17
7
2886
28931
28
0
2875
28938
23
17
2833
28873
59
96
2318
28235
61
249
1572
24661
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
8.1e-02
5.0e-01
1.8e+00
3.8e+00
2.3e+00
1.4e+00
3.6e-01
cases:6.66%
controls:6.17%
cases:4.86%
controls:3.00%
cases:2.93%
controls:0.48%
cases:1.10%
controls:0.02%
cases:4.34%
controls:0.47%
cases:11.40%
controls:3.19%
cases:12.80%
controls:9.27%
193
1783
2707
27130
141
869
2762
28069
85
140
2818
28798
32
7
2871
28931
124
135
2732
28755
271
903
2106
27428
209
2308
1424
22602
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
3.1e-01
9.1e-01
2.5e+00
—
3.5e+00
2.2e+00
1.0e+00
cases:2.72%
controls:2.01%
cases:2.55%
controls:1.04%
cases:1.93%
controls:0.16%
—
—
cases:5.01%
controls:0.16%
cases:8.20%
controls:0.98%
cases:7.53%
controls:2.87%
79
581
2821
28332
74
302
2829
28636
56
47
2847
28891
—
143
45
2713
28845
195
277
2182
28054
123
715
1510
24195
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
48348-7 [3048469]
48348-7 [3048469]
—
2.1e+00
—
—
1.0e+50
4.7e+00
3.3e+00
—
—
cases:0.41%
controls:0.05%
—
—
—
—
cases:0.60%
controls:0.00%
cases:2.31%
controls:0.02%
cases:2.27%
controls:0.09%
—
12
14
2891
28924
—
—
17
0
2839
28890
55
6
2322
28325
37
22
1596
24888
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.7e-02
3.9e-01
1.6e+00
3.1e+00
2.4e+00
1.8e+00
8.3e-01
cases:10.10%
controls:9.86%
cases:8.54%
controls:5.97%
cases:5.86%
controls:1.23%
cases:0.59%
controls:0.03%
cases:11.52%
controls:1.15%
cases:27.81%
controls:5.86%
cases:27.19%
controls:13.97%
293
2850
2607
26063
248
1728
2655
27210
170
356
2733
28582
17
8
2886
28930
329
331
2527
28559
661
1660
1716
26671
444
3479
1189
21431
Intubation
WX704 [2001310820]
WX704 [2001310820]
2.3e-01
8.5e-01
3.1e+00
1.0e+50
4.2e+00
2.0e+00
7.7e-01
cases:0.93%
controls:0.74%
cases:0.48%
controls:0.21%
cases:0.93%
controls:0.04%
cases:1.69%
controls:0.00%
cases:1.58%
controls:0.02%
cases:2.06%
controls:0.28%
cases:1.90%
controls:0.89%
27
214
2873
28699
14
60
2889
28878
27
12
2876
28926
49
0
2854
28938
45
7
2811
28883
49
78
2328
28253
31
222
1602
24688
EKG study
11524-6 [3013512]
11524-6 [3013512]
7.1e-04
3.2e-01
2.4e+00
4.6e+00
2.2e+00
5.7e-01
-8.7e-02
cases:6.59%
controls:6.58%
cases:4.93%
controls:3.61%
cases:4.79%
controls:0.46%
cases:2.62%
controls:0.03%
cases:4.17%
controls:0.46%
cases:6.56%
controls:3.83%
cases:9.86%
controls:10.66%
191
1903
2709
27010
143
1046
2760
27892
139
133
2764
28805
76
8
2827
28930
119
134
2737
28756
156
1085
2221
27246
161
2655
1472
22255
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
1.6e-01
5.1e-01
1.9e+00
3.7e+00
2.3e+00
1.3e+00
3.2e-01
cases:6.48%
controls:5.58%
cases:4.93%
controls:3.02%
cases:3.10%
controls:0.47%
cases:1.14%
controls:0.03%
cases:4.52%
controls:0.46%
cases:11.15%
controls:3.36%
cases:13.29%
controls:10.03%
188
1612
2712
27301
143
873
2760
28065
90
136
2813
28802
33
8
2870
28930
129
133
2727
28757
265
953
2112
27378
217
2498
1416
22412
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
3.0e-01
1.4e+00
2.4e+00
—
3.4e+00
2.0e+00
9.1e-01
cases:0.52%
controls:0.38%
cases:0.72%
controls:0.18%
cases:0.38%
controls:0.03%
—
—
cases:0.63%
controls:0.02%
cases:0.97%
controls:0.14%
cases:1.35%
controls:0.55%
15
111
2885
28802
21
53
2882
28885
11
10
2892
28928
—
18
6
2838
28884
23
39
2354
28292
22
136
1611
24774
Palliative care
Z51.5 [45547323]
Z51.5 [45547323]
—
2.8e+00
—
1.0e+50
—
4.3e+00
2.9e+00
—
—
cases:0.45%
controls:0.03%
—
—
cases:0.59%
controls:0.00%
—
—
cases:7.19%
controls:0.11%
cases:6.31%
controls:0.35%
—
13
8
2890
28930
—
17
0
2886
28938
—
171
30
2206
28301
103
88
1530
24822
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
-3.2e-02
1.6e-01
2.1e+00
4.7e+00
2.7e+00
4.7e-01
-7.9e-02
cases:16.59%
controls:17.03%
cases:10.82%
controls:9.38%
cases:8.30%
controls:1.07%
cases:3.31%
controls:0.03%
cases:13.10%
controls:0.99%
cases:14.05%
controls:9.26%
cases:22.23%
controls:23.63%
481
4925
2419
23988
314
2714
2589
26224
241
309
2662
28629
96
9
2807
28929
374
286
2482
28604
334
2623
2043
25708
363
5887
1270
19023
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
-3.3e-02
2.1e-01
2.0e+00
4.6e+00
2.5e+00
7.5e-01
7.0e-03
cases:33.00%
controls:33.74%
cases:32.21%
controls:27.80%
cases:28.90%
controls:5.31%
cases:19.74%
controls:0.26%
cases:39.74%
controls:5.12%
cases:46.70%
controls:29.26%
cases:50.21%
controls:50.04%
957
9754
1943
19159
935
8046
1968
20892
839
1538
2064
27400
573
74
2330
28864
1135
1479
1721
27411
1110
8290
1267
20041
820
12465
813
12445
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
2.5e-01
5.3e-01
1.7e+00
3.3e+00
2.5e+00
1.6e+00
3.8e-01
cases:2.41%
controls:1.90%
cases:2.00%
controls:1.19%
cases:1.03%
controls:0.19%
cases:0.48%
controls:0.02%
cases:2.24%
controls:0.19%
cases:5.89%
controls:1.27%
cases:6.06%
controls:4.24%
70
549
2830
28364
58
344
2845
28594
30
54
2873
28884
14
5
2889
28933
64
56
2792
28834
140
360
2237
27971
99
1057
1534
23853
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
2.1e-02
2.5e-01
1.8e+00
4.4e+00
2.4e+00
8.8e-01
1.8e-01
cases:22.03%
controls:21.68%
cases:21.91%
controls:17.99%
cases:20.19%
controls:3.87%
cases:15.64%
controls:0.22%
cases:29.97%
controls:3.69%
cases:36.39%
controls:19.16%
cases:39.01%
controls:34.89%
639
6269
2261
22644
636
5207
2267
23731
586
1119
2317
27819
454
64
2449
28874
856
1067
2000
27823
865
5427
1512
22904
637
8691
996
16219
Internal Medicine
11 [38004456]
11 [38004456]
2.3e-02
4.1e-01
1.7e+00
4.3e+00
1.7e+00
1.3e+00
4.9e-01
cases:21.97%
controls:21.58%
cases:12.30%
controls:8.52%
cases:7.27%
controls:1.40%
cases:5.44%
controls:0.08%
cases:7.42%
controls:1.39%
cases:24.19%
controls:8.35%
cases:28.54%
controls:19.63%
637
6240
2263
22673
357
2465
2546
26473
211
406
2692
28532
158
22
2745
28916
212
403
2644
28487
575
2367
1802
25964
466
4891
1167
20019
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.3e-01
8.2e-01
2.0e+00
1.0e+50
3.2e+00
2.0e+00
1.6e+00
cases:6.00%
controls:4.39%
cases:2.48%
controls:1.11%
cases:1.10%
controls:0.15%
cases:2.17%
controls:0.00%
cases:2.87%
controls:0.12%
cases:6.52%
controls:0.94%
cases:10.66%
controls:2.33%
174
1268
2726
27645
72
321
2831
28617
32
44
2871
28894
63
0
2840
28938
82
36
2774
28854
155
266
2222
28065
174
580
1459
24330
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 [3033386]
41602-4 [3033386]
—
3.1e+00
—
—
—
3.6e+00
3.1e+00
—
—
cases:0.38%
controls:0.02%
—
—
—
—
—
—
cases:0.80%
controls:0.02%
cases:0.73%
controls:0.03%
—
11
5
2892
28933
—
—
—
19
6
2358
28325
12
8
1621
24902
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-1.8e-02
5.3e-01
4.0e+00
—
4.3e+00
1.0e+00
-1.4e-01
cases:3.83%
controls:3.89%
cases:2.51%
controls:1.50%
cases:4.99%
controls:0.10%
—
—
cases:8.37%
controls:0.12%
cases:3.41%
controls:1.23%
cases:4.29%
controls:4.92%
111
1126
2789
27787
73
434
2830
28504
145
29
2758
28909
—
239
35
2617
28855
81
348
2296
27983
70
1225
1563
23685
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
-2.4e-01
1.0e+00
2.4e+00
—
3.8e+00
1.9e+00
7.4e-01
cases:0.69%
controls:0.88%
cases:1.41%
controls:0.51%
cases:0.69%
controls:0.07%
—
—
cases:3.89%
controls:0.09%
cases:3.41%
controls:0.54%
cases:4.23%
controls:2.06%
20
254
2880
28659
41
149
2862
28789
20
19
2883
28919
—
111
26
2745
28864
81
152
2296
28179
69
512
1564
24398
Implantation of vascular injection port
TPX10 [2001309608]
TPX10 [2001309608]
1.3e+00
2.3e+00
—
—
1.0e+50
3.4e+00
2.7e+00
cases:0.38%
controls:0.10%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.63%
controls:0.00%
cases:1.09%
controls:0.04%
cases:0.98%
controls:0.06%
11
30
2889
28883
7
7
2896
28931
—
—
18
0
2838
28890
26
10
2351
28321
16
16
1617
24894
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
-2.0e-02
2.4e-01
2.0e+00
4.4e+00
2.4e+00
7.5e-01
4.0e-02
cases:13.45%
controls:13.68%
cases:8.41%
controls:6.71%
cases:6.03%
controls:0.87%
cases:1.62%
controls:0.02%
cases:7.60%
controls:0.74%
cases:12.87%
controls:6.55%
cases:20.21%
controls:19.57%
390
3956
2510
24957
244
1943
2659
26995
175
251
2728
28687
47
6
2856
28932
217
215
2639
28675
306
1856
2071
26475
330
4874
1303
20036
clobazam; oral
N05BA09 [21604574]
N05BA09 [21604574]
—
1.2e+00
—
—
2.8e+00
3.5e+00
3.4e+00
—
—
cases:0.17%
controls:0.05%
—
—
—
—
cases:0.35%
controls:0.02%
cases:1.72%
controls:0.05%
cases:2.27%
controls:0.08%
—
5
15
2898
28923
—
—
10
6
2846
28884
41
15
2336
28316
37
19
1596
24891
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.2e-01
4.8e-01
3.1e+00
—
3.9e+00
1.6e+00
5.8e-01
cases:7.72%
controls:6.89%
cases:4.93%
controls:3.12%
cases:7.54%
controls:0.35%
—
—
cases:15.76%
controls:0.37%
cases:12.92%
controls:2.85%
cases:15.31%
controls:9.18%
224
1991
2676
26922
143
902
2760
28036
219
101
2684
28837
—
450
108
2406
28782
307
808
2070
27523
250
2287
1383
22623
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
-2.6e-02
1.8e-01
1.9e+00
4.5e+00
2.4e+00
6.8e-01
-1.9e-03
cases:30.10%
controls:30.66%
cases:23.84%
controls:20.79%
cases:20.63%
controls:3.57%
cases:14.88%
controls:0.19%
cases:29.13%
controls:3.57%
cases:34.24%
controls:20.95%
cases:41.52%
controls:41.57%
873
8864
2027
20049
692
6016
2211
22922
599
1034
2304
27904
432
55
2471
28883
832
1032
2024
27858
814
5936
1563
22395
678
10354
955
14556
Diplopia
H53.2 [45576792]
H53.2 [45576792]
6.4e-01
2.4e+00
—
—
2.9e+00
2.5e+00
1.9e+00
cases:0.52%
controls:0.27%
cases:0.62%
controls:0.06%
—
—
—
—
cases:0.32%
controls:0.02%
cases:1.01%
controls:0.08%
cases:1.53%
controls:0.23%
15
79
2885
28834
18
16
2885
28922
—
—
9
5
2847
28885
24
24
2353
28307
25
58
1608
24852
Gas and Carbon monoxide and Electrolytes panel - Arterial blood
93685-6 [1001509]
93685-6 [1001509]
—
—
—
1.0e+50
—
5.3e+00
4.4e+00
—
—
—
—
—
—
cases:1.14%
controls:0.00%
—
—
cases:3.32%
controls:0.02%
cases:2.88%
controls:0.04%
—
—
—
33
0
2870
28938
—
79
5
2298
28326
47
9
1586
24901
General Surgery
2 [38004447]
2 [38004447]
3.4e-01
6.4e-01
1.4e+00
4.1e+00
1.7e+00
8.9e-01
5.1e-01
cases:20.59%
controls:15.57%
cases:8.44%
controls:4.63%
cases:2.45%
controls:0.59%
cases:2.00%
controls:0.03%
cases:3.54%
controls:0.63%
cases:10.10%
controls:4.42%
cases:20.33%
controls:13.28%
597
4502
2303
24411
245
1340
2658
27598
71
170
2832
28768
58
10
2845
28928
101
183
2755
28707
240
1253
2137
27078
332
3308
1301
21602
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
4.0e-01
1.4e+00
2.2e+00
—
3.5e+00
1.4e+00
1.2e+00
cases:1.55%
controls:1.04%
cases:1.86%
controls:0.49%
cases:0.93%
controls:0.10%
—
—
cases:1.86%
controls:0.06%
cases:2.15%
controls:0.53%
cases:3.74%
controls:1.19%
45
302
2855
28611
54
141
2849
28797
27
30
2876
28908
—
53
17
2803
28873
51
149
2326
28182
61
296
1572
24614
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
-2.4e-01
9.3e-01
3.6e+00
—
3.1e+00
1.6e+00
4.7e-01
cases:4.48%
controls:5.61%
cases:5.51%
controls:2.24%
cases:9.51%
controls:0.30%
—
—
cases:5.99%
controls:0.30%
cases:10.48%
controls:2.31%
cases:11.76%
controls:7.68%
130
1621
2770
27292
160
649
2743
28289
276
87
2627
28851
—
171
86
2685
28804
249
654
2128
27677
192
1913
1441
22997
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
1.8e-01
4.6e-01
1.5e+00
2.7e+00
2.5e+00
1.6e+00
6.0e-01
cases:18.66%
controls:16.04%
cases:13.71%
controls:9.13%
cases:8.78%
controls:2.04%
cases:0.79%
controls:0.06%
cases:21.01%
controls:2.08%
cases:34.24%
controls:9.50%
cases:29.70%
controls:18.83%
541
4638
2359
24275
398
2643
2505
26295
255
590
2648
28348
23
16
2880
28922
600
601
2256
28289
814
2692
1563
25639
485
4691
1148
20219
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.8e-01
6.7e-01
2.1e+00
—
3.4e+00
2.1e+00
1.2e+00
cases:9.10%
controls:7.73%
cases:4.20%
controls:2.20%
cases:1.89%
controls:0.23%
—
—
cases:7.35%
controls:0.28%
cases:14.64%
controls:1.98%
cases:15.98%
controls:5.25%
264
2235
2636
26678
122
637
2781
28301
55
66
2848
28872
—
210
80
2646
28810
348
561
2029
27770
261
1307
1372
23603
Very extensive body CT
JN4CD [2001310902]
JN4CD [2001310902]
1.5e+00
2.4e+00
—
1.0e+50
—
2.9e+00
2.6e+00
cases:0.31%
controls:0.07%
cases:0.28%
controls:0.02%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.46%
controls:0.02%
cases:1.16%
controls:0.08%
9
20
2891
28893
8
7
2895
28931
—
14
0
2889
28938
—
11
7
2366
28324
19
21
1614
24889
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
-4.2e-02
1.6e-01
1.8e+00
4.5e+00
2.4e+00
6.5e-01
-3.5e-02
cases:35.48%
controls:36.46%
cases:33.76%
controls:30.36%
cases:29.45%
controls:6.17%
cases:21.46%
controls:0.31%
cases:40.41%
controls:6.01%
cases:47.50%
controls:32.06%
cases:52.48%
controls:53.35%
1029
10542
1871
18371
980
8787
1923
20151
855
1785
2048
27153
623
90
2280
28848
1154
1735
1702
27155
1129
9083
1248
19248
857
13290
776
11620
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
-4.0e-02
1.6e-01
1.8e+00
4.5e+00
2.4e+00
6.5e-01
-3.8e-02
cases:35.62%
controls:36.55%
cases:33.86%
controls:30.41%
cases:29.49%
controls:6.17%
cases:21.46%
controls:0.31%
cases:40.41%
controls:6.04%
cases:47.50%
controls:32.13%
cases:52.48%
controls:53.42%
1033
10569
1867
18344
983
8801
1920
20137
856
1786
2047
27152
623
90
2280
28848
1154
1744
1702
27146
1129
9104
1248
19227
857
13308
776
11602
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
-4.1e-02
1.6e-01
1.9e+00
4.5e+00
2.4e+00
6.5e-01
-3.7e-02
cases:35.66%
controls:36.61%
cases:33.90%
controls:30.46%
cases:29.56%
controls:6.18%
cases:21.46%
controls:0.31%
cases:40.41%
controls:6.06%
cases:47.50%
controls:32.17%
cases:52.54%
controls:53.47%
1034
10584
1866
18329
984
8814
1919
20124
858
1789
2045
27149
623
90
2280
28848
1154
1751
1702
27139
1129
9114
1248
19217
858
13320
775
11590
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
-4.4e-02
1.6e-01
1.8e+00
4.5e+00
2.4e+00
6.5e-01
-3.8e-02
cases:35.52%
controls:36.53%
cases:33.79%
controls:30.39%
cases:29.45%
controls:6.17%
cases:21.46%
controls:0.31%
cases:40.37%
controls:6.04%
cases:47.45%
controls:32.09%
cases:52.48%
controls:53.42%
1030
10561
1870
18352
981
8795
1922
20143
855
1786
2048
27152
623
90
2280
28848
1153
1744
1703
27146
1128
9092
1249
19239
857
13307
776
11603
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
-4.1e-02
1.6e-01
1.8e+00
4.5e+00
2.4e+00
6.5e-01
-3.9e-02
cases:35.62%
controls:36.57%
cases:33.83%
controls:30.44%
cases:29.49%
controls:6.18%
cases:21.46%
controls:0.31%
cases:40.41%
controls:6.06%
cases:47.50%
controls:32.15%
cases:52.48%
controls:53.44%
1033
10573
1867
18340
982
8808
1921
20130
856
1788
2047
27150
623
90
2280
28848
1154
1750
1702
27140
1129
9109
1248
19222
857
13313
776
11597
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
-4.2e-02
1.6e-01
1.8e+00
4.5e+00
2.4e+00
6.4e-01
-3.9e-02
cases:35.59%
controls:36.55%
cases:33.83%
controls:30.44%
cases:29.49%
controls:6.18%
cases:21.46%
controls:0.31%
cases:40.37%
controls:6.04%
cases:47.45%
controls:32.17%
cases:52.48%
controls:53.46%
1032
10569
1868
18344
982
8810
1921
20128
856
1787
2047
27151
623
90
2280
28848
1153
1745
1703
27145
1128
9113
1249
19218
857
13317
776
11593
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
-4.1e-02
1.5e-01
1.9e+00
4.5e+00
2.4e+00
6.4e-01
-4.1e-02
cases:35.66%
controls:36.60%
cases:33.83%
controls:30.51%
cases:29.52%
controls:6.18%
cases:21.46%
controls:0.31%
cases:40.41%
controls:6.06%
cases:47.50%
controls:32.24%
cases:52.48%
controls:53.51%
1034
10582
1866
18331
982
8829
1921
20109
857
1788
2046
27150
623
90
2280
28848
1154
1752
1702
27138
1129
9133
1248
19198
857
13330
776
11580
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.5e-01
5.9e-01
1.9e+00
—
3.6e+00
2.0e+00
1.1e+00
cases:7.86%
controls:5.65%
cases:2.62%
controls:1.47%
cases:0.79%
controls:0.12%
—
—
cases:3.54%
controls:0.10%
cases:7.66%
controls:1.12%
cases:9.06%
controls:3.30%
228
1633
2672
27280
76
424
2827
28514
23
36
2880
28902
—
101
30
2755
28860
182
317
2195
28014
148
822
1485
24088
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
-2.5e-01
—
2.5e+00
—
3.2e+00
2.0e+00
1.7e+00
cases:0.59%
controls:0.75%
—
—
cases:0.48%
controls:0.04%
—
—
cases:0.77%
controls:0.03%
cases:1.14%
controls:0.16%
cases:1.35%
controls:0.26%
17
217
2883
28696
—
14
11
2889
28927
—
22
9
2834
28881
27
46
2350
28285
22
64
1611
24846
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
8.7e-01
9.2e-01
2.2e+00
—
3.3e+00
1.1e+00
9.3e-01
cases:2.41%
controls:1.02%
cases:1.03%
controls:0.41%
cases:0.34%
controls:0.04%
—
—
cases:0.77%
controls:0.03%
cases:1.09%
controls:0.36%
cases:3.31%
controls:1.34%
70
296
2830
28617
30
120
2873
28818
10
11
2893
28927
—
22
8
2834
28882
26
102
2351
28229
54
333
1579
24577
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
6.4e-03
3.1e-01
1.9e+00
3.6e+00
2.1e+00
1.2e+00
2.7e-01
cases:13.86%
controls:13.79%
cases:9.20%
controls:6.89%
cases:6.23%
controls:1.01%
cases:2.03%
controls:0.06%
cases:8.47%
controls:1.09%
cases:19.23%
controls:7.00%
cases:23.27%
controls:18.80%
402
3986
2498
24927
267
1994
2636
26944
181
291
2722
28647
59
16
2844
28922
242
315
2614
28575
457
1982
1920
26349
380
4682
1253
20228
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
4.8e-01
1.0e+00
1.7e+00
—
2.3e+00
2.7e+00
1.6e+00
cases:1.69%
controls:1.05%
cases:1.83%
controls:0.66%
cases:1.03%
controls:0.19%
—
—
cases:1.72%
controls:0.17%
cases:9.05%
controls:0.66%
cases:8.94%
controls:2.04%
49
305
2851
28608
53
191
2850
28747
30
54
2873
28884
—
49
50
2807
28840
215
186
2162
28145
146
507
1487
24403
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
3.8e-01
1.3e+00
3.1e+00
1.0e+50
3.2e+00
1.8e+00
6.3e-01
cases:0.48%
controls:0.33%
cases:0.48%
controls:0.13%
cases:0.45%
controls:0.02%
cases:0.41%
controls:0.00%
cases:0.74%
controls:0.03%
cases:0.84%
controls:0.14%
cases:0.92%
controls:0.49%
14
96
2886
28817
14
38
2889
28900
13
6
2890
28932
12
0
2891
28938
21
9
2835
28881
20
41
2357
28290
15
122
1618
24788
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
2.3e-01
5.6e-01
3.0e+00
—
3.7e+00
1.8e+00
7.6e-01
cases:1.97%
controls:1.57%
cases:1.41%
controls:0.82%
cases:1.96%
controls:0.10%
—
—
cases:3.71%
controls:0.09%
cases:4.25%
controls:0.72%
cases:3.98%
controls:1.90%
57
454
2843
28459
41
236
2862
28702
57
30
2846
28908
—
106
27
2750
28863
101
203
2276
28128
65
474
1568
24436
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
1.9e-01
1.4e+00
2.9e+00
—
3.1e+00
1.9e+00
7.6e-01
cases:0.59%
controls:0.48%
cases:0.72%
controls:0.18%
cases:0.52%
controls:0.03%
—
—
cases:0.74%
controls:0.03%
cases:1.05%
controls:0.16%
cases:1.22%
controls:0.57%
17
140
2883
28773
21
53
2882
28885
15
8
2888
28930
—
21
10
2835
28880
25
46
2352
28285
20
143
1613
24767
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
2.2e-01
9.3e-01
2.3e+00
—
2.8e+00
2.3e+00
9.4e-01
cases:6.03%
controls:4.92%
cases:5.37%
controls:2.18%
cases:2.17%
controls:0.22%
—
—
cases:4.13%
controls:0.26%
cases:17.84%
controls:2.22%
cases:16.11%
controls:6.98%
175
1423
2725
27490
156
632
2747
28306
63
65
2840
28873
—
118
75
2738
28815
424
629
1953
27702
263
1738
1370
23172
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
-1.1e-02
9.2e-01
1.9e+00
—
3.8e+00
1.9e+00
7.4e-01
cases:0.86%
controls:0.87%
cases:1.34%
controls:0.54%
cases:0.59%
controls:0.09%
—
—
cases:4.87%
controls:0.12%
cases:4.00%
controls:0.64%
cases:3.98%
controls:1.95%
25
252
2875
28661
39
156
2864
28782
17
25
2886
28913
—
139
34
2717
28856
95
182
2282
28149
65
485
1568
24425
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
3.1e-01
7.9e-01
2.2e+00
1.0e+50
3.0e+00
2.5e+00
1.4e+00
cases:0.93%
controls:0.68%
cases:0.59%
controls:0.27%
cases:0.45%
controls:0.05%
cases:0.17%
controls:0.00%
cases:1.30%
controls:0.06%
cases:3.03%
controls:0.25%
cases:3.12%
controls:0.81%
27
198
2873
28715
17
77
2886
28861
13
14
2890
28924
5
0
2898
28938
37
18
2819
28872
72
70
2305
28261
51
202
1582
24708
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
4.8e-01
1.2e+00
2.7e+00
—
—
3.2e+00
1.7e+00
cases:2.21%
controls:1.38%
cases:0.90%
controls:0.28%
cases:0.34%
controls:0.02%
—
—
—
—
cases:4.38%
controls:0.19%
cases:3.55%
controls:0.69%
64
398
2836
28515
26
80
2877
28858
10
7
2893
28931
—
—
104
55
2273
28276
58
171
1575
24739
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
-1.3e-01
9.3e-01
—
—
4.9e+00
2.3e+00
1.1e+00
cases:0.55%
controls:0.63%
cases:0.86%
controls:0.34%
—
—
—
—
cases:5.50%
controls:0.04%
cases:2.73%
controls:0.29%
cases:3.98%
controls:1.36%
16
182
2884
28731
25
99
2878
28839
—
—
157
13
2699
28877
65
83
2312
28248
65
339
1568
24571
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
-4.9e-02
9.1e-01
—
—
4.9e+00
2.2e+00
1.1e+00
cases:0.59%
controls:0.62%
cases:0.86%
controls:0.35%
—
—
—
—
cases:5.50%
controls:0.04%
cases:2.73%
controls:0.31%
cases:3.98%
controls:1.43%
17
178
2883
28735
25
101
2878
28837
—
—
157
12
2699
28878
65
87
2312
28244
65
356
1568
24554
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
-1.6e-01
4.0e-01
1.7e+00
—
4.6e+00
2.0e+00
7.8e-01
cases:0.76%
controls:0.89%
cases:0.62%
controls:0.42%
cases:0.31%
controls:0.06%
—
—
cases:4.24%
controls:0.04%
cases:2.82%
controls:0.40%
cases:3.25%
controls:1.51%
22
258
2878
28655
18
121
2885
28817
9
16
2894
28922
—
121
13
2735
28877
67
112
2310
28219
53
376
1580
24534
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
-5.5e-02
9.1e-01
—
—
4.8e+00
2.2e+00
1.1e+00
cases:0.59%
controls:0.62%
cases:0.83%
controls:0.34%
—
—
—
—
cases:5.43%
controls:0.04%
cases:2.69%
controls:0.30%
cases:3.80%
controls:1.36%
17
179
2883
28734
24
97
2879
28841
—
—
155
13
2701
28877
64
84
2313
28247
62
338
1571
24572
Other investigative procedure of eye
XCW99 [2001301491]
XCW99 [2001301491]
3.3e-01
6.8e-01
2.3e+00
—
2.5e+00
2.0e+00
1.5e+00
cases:2.31%
controls:1.67%
cases:1.14%
controls:0.58%
cases:0.65%
controls:0.07%
—
—
cases:1.02%
controls:0.08%
cases:4.00%
controls:0.54%
cases:6.55%
controls:1.56%
67
484
2833
28429
33
168
2870
28770
19
19
2884
28919
—
29
24
2827
28866
95
154
2282
28177
107
389
1526
24521
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
6.2e-02
9.1e-01
1.5e+00
—
2.5e+00
2.5e+00
1.6e+00
cases:1.55%
controls:1.46%
cases:1.24%
controls:0.50%
cases:0.41%
controls:0.09%
—
—
cases:1.05%
controls:0.09%
cases:5.81%
controls:0.49%
cases:7.65%
controls:1.73%
45
422
2855
28491
36
146
2867
28792
12
27
2891
28911
—
30
25
2826
28865
138
139
2239
28192
125
430
1508
24480
Perimetry
XCK00 [2001301380]
XCK00 [2001301380]
1.5e-01
8.8e-01
2.6e+00
1.0e+50
2.8e+00
2.2e+00
1.4e+00
cases:1.14%
controls:0.98%
cases:0.62%
controls:0.26%
cases:0.24%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.39%
controls:0.02%
cases:2.40%
controls:0.28%
cases:2.88%
controls:0.73%
33
284
2867
28629
18
75
2885
28863
7
5
2896
28933
5
0
2898
28938
11
7
2845
28883
57
78
2320
28253
47
183
1586
24727
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-1.2e-01
1.1e-01
1.7e+00
4.5e+00
2.2e+00
5.7e-01
-3.3e-02
cases:25.10%
controls:27.42%
cases:23.22%
controls:21.33%
cases:19.26%
controls:4.14%
cases:14.71%
controls:0.20%
cases:27.91%
controls:4.12%
cases:33.74%
controls:22.31%
cases:38.76%
controls:39.56%
728
7929
2172
20984
674
6173
2229
22765
559
1198
2344
27740
427
58
2476
28880
797
1189
2059
27701
802
6320
1575
22011
633
9854
1000
15056
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
1.2e+00
1.8e+00
—
—
3.3e+00
1.4e+00
1.2e+00
cases:0.72%
controls:0.23%
cases:0.65%
controls:0.11%
—
—
—
—
cases:0.49%
controls:0.02%
cases:0.42%
controls:0.10%
cases:0.86%
controls:0.26%
21
66
2879
28847
19
31
2884
28907
—
—
14
5
2842
28885
10
29
2367
28302
14
66
1619
24844
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
1.5e-01
9.6e-01
2.3e+00
—
2.8e+00
1.9e+00
8.5e-01
cases:2.90%
controls:2.50%
cases:3.07%
controls:1.19%
cases:1.07%
controls:0.11%
—
—
cases:2.21%
controls:0.13%
cases:7.82%
controls:1.23%
cases:9.49%
controls:4.28%
84
722
2816
28191
89
345
2814
28593
31
31
2872
28907
—
63
38
2793
28852
186
348
2191
27983
155
1065
1478
23845
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
-1.1e-01
7.5e-01
3.4e+00
—
3.0e+00
1.8e+00
3.9e-01
cases:1.48%
controls:1.65%
cases:1.55%
controls:0.74%
cases:2.24%
controls:0.08%
—
—
cases:1.82%
controls:0.10%
cases:4.54%
controls:0.78%
cases:4.41%
controls:3.02%
43
477
2857
28436
45
214
2858
28724
65
23
2838
28915
—
52
28
2804
28862
108
220
2269
28111
72
752
1561
24158
Otolaryngology
4 [38004449]
4 [38004449]
1.7e-01
4.3e-01
1.4e+00
4.1e+00
1.5e+00
8.5e-01
5.3e-01
cases:12.28%
controls:10.54%
cases:5.55%
controls:3.69%
cases:2.41%
controls:0.61%
cases:1.48%
controls:0.02%
cases:2.77%
controls:0.61%
cases:8.37%
controls:3.75%
cases:16.90%
controls:10.71%
356
3048
2544
25865
161
1069
2742
27869
70
177
2833
28761
43
7
2860
28931
79
176
2777
28714
199
1063
2178
27268
276
2668
1357
22242
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
ZXE06 [2001311400]
1.5e-01
—
2.1e+00
1.0e+50
3.1e+00
2.3e+00
1.4e+00
cases:0.72%
controls:0.63%
—
—
cases:0.24%
controls:0.03%
cases:0.31%
controls:0.00%
cases:0.74%
controls:0.03%
cases:1.30%
controls:0.13%
cases:0.73%
controls:0.18%
21
181
2879
28732
—
7
9
2896
28929
9
0
2894
28938
21
10
2835
28880
31
37
2346
28294
12
44
1621
24866
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
1.8e-01
1.0e+00
2.2e+00
—
3.2e+00
1.7e+00
7.3e-01
cases:1.34%
controls:1.12%
cases:1.62%
controls:0.59%
cases:1.21%
controls:0.13%
—
—
cases:1.93%
controls:0.08%
cases:3.03%
controls:0.59%
cases:3.61%
controls:1.77%
39
325
2861
28588
47
170
2856
28768
35
38
2868
28900
—
55
23
2801
28867
72
167
2305
28164
59
441
1574
24469
Nausea and vomiting
R11 [45539317]
R11 [45539317]
2.1e-01
1.7e+00
2.6e+00
—
2.2e+00
1.7e+00
6.8e-01
cases:0.86%
controls:0.70%
cases:1.14%
controls:0.21%
cases:0.65%
controls:0.05%
—
—
cases:0.25%
controls:0.03%
cases:1.26%
controls:0.24%
cases:1.71%
controls:0.88%
25
203
2875
28710
33
62
2870
28876
19
14
2884
28924
—
7
8
2849
28882
30
67
2347
28264
28
218
1605
24692
Neuropsychological rehabilitation
R4150 [2001310239]
R4150 [2001310239]
—
—
—
—
—
4.4e+00
4.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.02%
cases:1.96%
controls:0.02%
—
—
—
—
—
34
5
2343
28326
32
6
1601
24904
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
-2.1e-01
3.7e-01
1.8e+00
—
4.2e+00
1.9e+00
9.2e-01
cases:0.79%
controls:0.97%
cases:0.65%
controls:0.45%
cases:0.31%
controls:0.05%
—
—
cases:3.99%
controls:0.06%
cases:2.48%
controls:0.38%
cases:3.00%
controls:1.22%
23
281
2877
28632
19
131
2884
28807
9
15
2894
28923
—
114
18
2742
28872
59
107
2318
28224
49
303
1584
24607
Visual field defects
H53.4 [45557469]
H53.4 [45557469]
9.2e-01
1.7e+00
—
1.0e+50
—
4.1e+00
2.9e+00
cases:0.34%
controls:0.14%
cases:0.28%
controls:0.05%
—
—
cases:0.17%
controls:0.00%
—
—
cases:2.82%
controls:0.05%
cases:2.69%
controls:0.16%
10
40
2890
28873
8
14
2895
28924
—
5
0
2898
28938
—
67
13
2310
28318
44
39
1589
24871
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
D48.1 [45566694]
D48.1 [45566694]
1.8e+00
2.3e+00
—
—
—
2.7e+00
1.8e+00
cases:0.41%
controls:0.07%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.38%
controls:0.02%
cases:0.55%
controls:0.09%
12
20
2888
28893
6
6
2897
28932
—
—
—
9
7
2368
28324
9
22
1624
24888
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
29584-0 [3016018]
5.4e-01
3.0e+00
—
—
—
3.5e+00
2.2e+00
cases:0.21%
controls:0.12%
cases:0.86%
controls:0.04%
—
—
—
—
—
—
cases:1.39%
controls:0.04%
cases:1.16%
controls:0.13%
6
35
2894
28878
25
13
2878
28925
—
—
—
33
12
2344
28319
19
33
1614
24877
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
1.3e-01
7.6e-01
1.8e+00
—
3.8e+00
1.7e+00
5.6e-01
cases:1.66%
controls:1.46%
cases:1.62%
controls:0.76%
cases:0.72%
controls:0.12%
—
—
cases:4.45%
controls:0.10%
cases:4.04%
controls:0.79%
cases:5.63%
controls:3.31%
48
421
2852
28492
47
220
2856
28718
21
34
2882
28904
—
127
30
2729
28860
96
225
2281
28106
92
824
1541
24086
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
3.8e-01
9.2e-01
2.4e+00
1.0e+50
2.6e+00
1.6e+00
1.1e+00
cases:1.83%
controls:1.26%
cases:0.79%
controls:0.32%
cases:0.34%
controls:0.03%
cases:0.34%
controls:0.00%
cases:0.39%
controls:0.03%
cases:1.77%
controls:0.38%
cases:3.00%
controls:1.05%
53
365
2847
28548
23
92
2880
28846
10
9
2893
28929
10
0
2893
28938
11
8
2845
28882
42
107
2335
28224
49
262
1584
24648
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
N05CD08 [21604643]
—
—
—
—
2.5e+00
3.3e+00
2.8e+00
—
—
—
—
—
—
—
—
cases:0.28%
controls:0.02%
cases:2.15%
controls:0.08%
cases:2.39%
controls:0.15%
—
—
—
—
8
7
2848
28883
51
23
2326
28308
39
37
1594
24873
Examination of eyes and vision
Z01.0 [45566391]
Z01.0 [45566391]
-1.0e-04
4.2e-01
2.5e+00
1.0e+50
2.9e+00
2.0e+00
1.0e+00
cases:2.38%
controls:2.38%
cases:1.38%
controls:0.91%
cases:1.38%
controls:0.11%
cases:0.34%
controls:0.00%
cases:1.68%
controls:0.09%
cases:6.31%
controls:0.92%
cases:8.45%
controls:3.21%
69
688
2831
28225
40
264
2863
28674
40
32
2863
28906
10
0
2893
28938
48
26
2808
28864
150
261
2227
28070
138
799
1495
24111
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
1.9e-01
8.0e-01
2.7e+00
—
2.6e+00
1.7e+00
6.1e-01
cases:9.14%
controls:7.65%
cases:5.96%
controls:2.76%
cases:4.75%
controls:0.32%
—
—
cases:3.96%
controls:0.29%
cases:12.75%
controls:2.61%
cases:14.27%
controls:8.33%
265
2211
2635
26702
173
798
2730
28140
138
94
2765
28844
—
113
85
2743
28805
303
739
2074
27592
233
2074
1400
22836
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
4.3e-01
1.4e+00
—
—
—
4.0e+00
3.1e+00
cases:0.59%
controls:0.38%
cases:0.41%
controls:0.10%
—
—
—
—
—
—
cases:5.64%
controls:0.11%
cases:7.41%
controls:0.37%
17
111
2883
28802
12
30
2891
28908
—
—
—
134
31
2243
28300
121
92
1512
24818
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
-2.2e-02
4.0e-01
1.3e+00
4.1e+00
2.3e+00
7.7e-01
-3.4e-01
cases:3.10%
controls:3.17%
cases:2.14%
controls:1.45%
cases:0.93%
controls:0.25%
cases:1.24%
controls:0.02%
cases:2.24%
controls:0.24%
cases:3.95%
controls:1.87%
cases:4.29%
controls:5.91%
90
917
2810
27996
62
419
2841
28519
27
73
2876
28865
36
6
2867
28932
64
69
2792
28821
94
529
2283
27802
70
1471
1563
23439
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
-7.3e-02
7.4e-01
2.8e+00
—
3.3e+00
1.7e+00
6.2e-01
cases:0.38%
controls:0.41%
cases:0.69%
controls:0.33%
cases:0.62%
controls:0.04%
—
—
cases:0.91%
controls:0.03%
cases:1.89%
controls:0.35%
cases:2.27%
controls:1.23%
11
118
2889
28795
20
95
2883
28843
18
11
2885
28927
—
26
10
2830
28880
45
98
2332
28233
37
306
1596
24604
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
-1.2e-02
1.9e-01
1.6e+00
3.5e+00
2.2e+00
8.4e-01
7.6e-02
cases:31.48%
controls:31.74%
cases:27.66%
controls:23.97%
cases:16.12%
controls:3.83%
cases:3.93%
controls:0.12%
cases:26.26%
controls:3.62%
cases:43.67%
controls:25.04%
cases:49.30%
controls:47.40%
913
9177
1987
19736
803
6936
2100
22002
468
1107
2435
27831
114
35
2789
28903
750
1046
2106
27844
1038
7095
1339
21236
805
11807
828
13103
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
2.5e-01
1.2e+00
1.7e+00
—
3.3e+00
1.1e+00
1.1e+00
cases:1.00%
controls:0.78%
cases:1.00%
controls:0.30%
cases:0.31%
controls:0.06%
—
—
cases:1.23%
controls:0.04%
cases:0.97%
controls:0.34%
cases:2.57%
controls:0.87%
29
225
2871
28688
29
86
2874
28852
9
17
2894
28921
—
35
13
2821
28877
23
95
2354
28236
42
216
1591
24694
Catheterisation of bladder
TKC20 [2001306020]
TKC20 [2001306020]
3.9e-02
1.1e+00
2.9e+00
1.0e+50
2.4e+00
1.8e+00
3.0e-01
cases:0.59%
controls:0.56%
cases:0.52%
controls:0.17%
cases:0.45%
controls:0.02%
cases:0.38%
controls:0.00%
cases:0.32%
controls:0.03%
cases:1.22%
controls:0.19%
cases:0.86%
controls:0.64%
17
163
2883
28750
15
48
2888
28890
13
7
2890
28931
11
0
2892
28938
9
8
2847
28882
29
55
2348
28276
14
159
1619
24751
nystatin; oral
A07AA02 [21600604]
A07AA02 [21600604]
1.5e-01
8.7e-01
—
—
3.9e+00
3.3e+00
1.2e+00
cases:0.86%
controls:0.74%
cases:0.52%
controls:0.22%
—
—
—
—
cases:0.98%
controls:0.02%
cases:4.71%
controls:0.18%
cases:2.39%
controls:0.77%
25
214
2875
28699
15
63
2888
28875
—
—
28
6
2828
28884
112
51
2265
28280
39
191
1594
24719
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
CK2X4 [2001301456]
2.0e-01
5.7e-01
1.9e+00
1.0e+50
2.9e+00
2.0e+00
1.4e+00
cases:1.31%
controls:1.08%
cases:1.17%
controls:0.66%
cases:0.55%
controls:0.08%
cases:1.17%
controls:0.00%
cases:1.58%
controls:0.09%
cases:4.80%
controls:0.65%
cases:7.41%
controls:1.90%
38
311
2862
28602
34
192
2869
28746
16
23
2887
28915
34
0
2869
28938
45
25
2811
28865
114
183
2263
28148
121
473
1512
24437
Neurofibromatosis, type 1
Q85.00 [2000503516]
Q85.00 [2000503516]
2.8e+00
2.5e+00
—
—
—
—
3.1e+00
cases:0.28%
controls:0.02%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.02%
8
5
2892
28908
6
5
2897
28933
—
—
—
—
7
5
1626
24905
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
-1.3e-01
7.5e-01
2.6e+00
—
3.6e+00
2.1e+00
7.1e-01
cases:0.31%
controls:0.35%
cases:0.34%
controls:0.16%
cases:0.31%
controls:0.02%
—
—
cases:0.77%
controls:0.02%
cases:1.81%
controls:0.22%
cases:1.41%
controls:0.69%
9
102
2891
28811
10
47
2893
28891
9
7
2894
28931
—
22
6
2834
28884
43
61
2334
28270
23
173
1610
24737
Extensive CT of head and brain
AA1BD [2001300110]
AA1BD [2001300110]
1.4e+00
3.1e+00
1.0e+50
1.0e+50
1.0e+50
—
3.8e+00
cases:0.45%
controls:0.11%
cases:0.38%
controls:0.02%
cases:0.96%
controls:0.00%
cases:1.48%
controls:0.00%
cases:1.23%
controls:0.00%
—
—
cases:1.90%
controls:0.04%
13
31
2887
28882
11
5
2892
28933
28
0
2875
28938
43
0
2860
28938
35
0
2821
28890
—
31
11
1602
24899
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
3.1e-01
6.9e-01
1.7e+00
—
3.0e+00
2.0e+00
8.5e-01
cases:2.31%
controls:1.70%
cases:1.21%
controls:0.61%
cases:0.59%
controls:0.11%
—
—
cases:2.59%
controls:0.13%
cases:4.63%
controls:0.63%
cases:3.25%
controls:1.41%
67
492
2833
28421
35
176
2868
28762
17
32
2886
28906
—
74
38
2782
28852
110
179
2267
28152
53
351
1580
24559
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
5.1e-01
3.9e-01
1.5e+00
—
3.4e+00
1.8e+00
9.5e-01
cases:6.14%
controls:3.77%
cases:1.83%
controls:1.24%
cases:0.62%
controls:0.13%
—
—
cases:4.13%
controls:0.14%
cases:6.65%
controls:1.13%
cases:8.57%
controls:3.51%
178
1091
2722
27822
53
360
2850
28578
18
39
2885
28899
—
118
41
2738
28849
158
321
2219
28010
140
875
1493
24035
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
1.3e-01
5.1e-01
2.3e+00
—
3.6e+00
1.7e+00
5.3e-01
cases:4.52%
controls:3.97%
cases:1.52%
controls:0.92%
cases:1.07%
controls:0.11%
—
—
cases:3.71%
controls:0.10%
cases:4.42%
controls:0.80%
cases:4.65%
controls:2.81%
131
1148
2769
27765
44
266
2859
28672
31
31
2872
28907
—
106
29
2750
28861
105
228
2272
28103
76
699
1557
24211
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 [3035999]
2520-5 [3035999]
5.1e-01
3.0e+00
1.0e+50
1.0e+50
—
3.0e+00
2.3e+00
cases:0.17%
controls:0.10%
cases:0.72%
controls:0.04%
cases:0.83%
controls:0.00%
cases:0.17%
controls:0.00%
—
—
cases:0.67%
controls:0.04%
cases:0.80%
controls:0.08%
5
30
2895
28883
21
11
2882
28927
24
0
2879
28938
5
0
2898
28938
—
16
10
2361
28321
13
20
1620
24890
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.9e-02
2.6e-01
1.7e+00
3.4e+00
2.0e+00
8.4e-01
9.2e-02
cases:15.59%
controls:15.21%
cases:9.89%
controls:7.81%
cases:5.48%
controls:1.06%
cases:1.48%
controls:0.05%
cases:7.46%
controls:1.10%
cases:16.41%
controls:7.80%
cases:21.80%
controls:20.27%
452
4398
2448
24515
287
2260
2616
26678
159
306
2744
28632
43
14
2860
28924
213
318
2643
28572
390
2210
1987
26121
356
5050
1277
19860
X-ray mammography
HA1AA [2001303884]
HA1AA [2001303884]
1.9e+00
2.1e+00
—
1.0e+50
—
2.3e+00
1.9e+00
cases:1.17%
controls:0.17%
cases:0.41%
controls:0.05%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.46%
controls:0.05%
cases:1.29%
controls:0.20%
34
50
2866
28863
12
15
2891
28923
—
9
0
2894
28938
—
11
13
2366
28318
21
50
1612
24860
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
1.8e-01
7.0e-01
2.6e+00
1.0e+50
2.4e+00
2.0e+00
4.3e-01
cases:1.24%
controls:1.03%
cases:1.27%
controls:0.64%
cases:0.96%
controls:0.07%
cases:0.31%
controls:0.00%
cases:1.16%
controls:0.11%
cases:5.34%
controls:0.79%
cases:4.29%
controls:2.83%
36
299
2864
28614
37
185
2866
28753
28
20
2875
28918
9
0
2894
28938
33
31
2823
28859
127
224
2250
28107
70
704
1563
24206
Dysphasia and aphasia
R47.0 [45592421]
R47.0 [45592421]
—
2.5e+00
—
—
—
3.8e+00
1.9e+00
—
—
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.76%
controls:0.02%
cases:0.55%
controls:0.08%
—
7
6
2896
28932
—
—
—
18
5
2359
28326
9
21
1624
24889
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
606-4 [3016914]
—
2.7e+00
—
—
—
3.2e+00
2.2e+00
—
—
cases:0.86%
controls:0.06%
—
—
—
—
—
—
cases:1.30%
controls:0.05%
cases:1.10%
controls:0.12%
—
25
17
2878
28921
—
—
—
31
15
2346
28316
18
31
1615
24879
Appearance of Cerebral spinal fluid
10333-3 [3023410]
10333-3 [3023410]
3.1e-01
2.7e+00
—
—
—
3.7e+00
1.7e+00
cases:0.24%
controls:0.18%
cases:0.59%
controls:0.04%
—
—
—
—
—
—
cases:1.22%
controls:0.03%
cases:0.67%
controls:0.12%
7
51
2893
28862
17
11
2886
28927
—
—
—
29
9
2348
28322
11
31
1622
24879
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
2.0e-01
5.7e-01
1.9e+00
—
3.6e+00
2.5e+00
2.9e-01
cases:0.41%
controls:0.34%
cases:0.31%
controls:0.18%
cases:0.24%
controls:0.03%
—
—
cases:1.26%
controls:0.03%
cases:1.94%
controls:0.16%
cases:0.61%
controls:0.46%
12
98
2888
28815
9
51
2894
28887
7
10
2896
28928
—
36
10
2820
28880
46
46
2331
28285
10
114
1623
24796
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
-6.1e-02
3.8e-01
1.8e+00
1.0e+50
3.9e+00
1.9e+00
5.0e-01
cases:2.00%
controls:2.12%
cases:1.38%
controls:0.94%
cases:0.48%
controls:0.08%
cases:0.21%
controls:0.00%
cases:3.68%
controls:0.08%
cases:4.59%
controls:0.74%
cases:4.29%
controls:2.63%
58
614
2842
28299
40
273
2863
28665
14
23
2889
28915
6
0
2897
28938
105
23
2751
28867
109
210
2268
28121
70
656
1563
24254
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
3.7e-01
9.0e-01
2.5e+00
1.0e+50
2.5e+00
2.0e+00
1.5e-01
cases:0.38%
controls:0.26%
cases:0.62%
controls:0.25%
cases:0.48%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.53%
controls:0.04%
cases:2.52%
controls:0.35%
cases:1.84%
controls:1.59%
11
76
2889
28837
18
73
2885
28865
14
11
2889
28927
6
0
2897
28938
15
12
2841
28878
60
99
2317
28232
30
395
1603
24515
Sixth [abducent] nerve palsy
H49.2 [45557451]
H49.2 [45557451]
1.4e+00
2.7e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:0.24%
controls:0.06%
cases:0.31%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.50%
controls:0.03%
cases:0.73%
controls:0.07%
7
17
2893
28896
9
6
2894
28932
—
5
0
2898
28938
—
12
8
2365
28323
12
17
1621
24893
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
-1.8e-01
1.7e-01
1.2e+00
4.2e+00
2.0e+00
5.4e-01
-3.1e-01
cases:4.69%
controls:5.57%
cases:3.48%
controls:2.94%
cases:1.48%
controls:0.45%
cases:1.65%
controls:0.02%
cases:2.91%
controls:0.42%
cases:5.34%
controls:3.19%
cases:5.88%
controls:7.83%
136
1611
2764
27302
101
851
2802
28087
43
129
2860
28809
48
7
2855
28931
83
121
2773
28769
127
905
2250
27426
96
1951
1537
22959
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
-3.5e-02
7.0e-02
1.4e+00
4.2e+00
1.9e+00
4.1e-01
-9.2e-02
cases:39.93%
controls:40.77%
cases:39.61%
controls:37.96%
cases:34.34%
controls:11.36%
cases:29.87%
controls:0.61%
cases:44.78%
controls:11.04%
cases:50.40%
controls:40.31%
cases:55.54%
controls:57.81%
1158
11789
1742
17124
1150
10986
1753
17952
997
3288
1906
25650
867
176
2036
28762
1279
3190
1577
25700
1198
11419
1179
16912
907
14401
726
10509
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
1.6e+00
2.3e+00
—
1.0e+50
—
2.5e+00
1.5e+00
cases:1.03%
controls:0.20%
cases:1.55%
controls:0.16%
—
—
cases:1.79%
controls:0.00%
—
—
cases:2.10%
controls:0.17%
cases:3.18%
controls:0.74%
30
59
2870
28854
45
46
2858
28892
—
52
0
2851
28938
—
50
49
2327
28282
52
184
1581
24726
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
2.1e-01
3.0e+00
—
1.0e+50
—
3.4e+00
1.6e+00
cases:0.59%
controls:0.48%
cases:2.41%
controls:0.12%
—
—
cases:2.41%
controls:0.00%
—
—
cases:3.32%
controls:0.12%
cases:2.33%
controls:0.49%
17
138
2883
28775
70
36
2833
28902
—
70
0
2833
28938
—
79
34
2298
28297
38
122
1595
24788
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
2.1e-01
5.5e-01
2.0e+00
—
2.8e+00
2.1e+00
1.0e+00
cases:0.79%
controls:0.64%
cases:1.00%
controls:0.58%
cases:0.79%
controls:0.11%
—
—
cases:1.79%
controls:0.11%
cases:4.88%
controls:0.64%
cases:4.90%
controls:1.80%
23
186
2877
28727
29
168
2874
28770
23
31
2880
28907
—
51
32
2805
28858
116
181
2261
28150
80
448
1553
24462
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
2.8e-01
4.7e-01
1.9e+00
—
2.8e+00
2.1e+00
1.0e+00
cases:0.97%
controls:0.73%
cases:1.03%
controls:0.65%
cases:0.90%
controls:0.13%
—
—
cases:2.10%
controls:0.12%
cases:5.64%
controls:0.70%
cases:5.27%
controls:2.00%
28
211
2872
28702
30
188
2873
28750
26
38
2877
28900
—
60
36
2796
28854
134
198
2243
28133
86
499
1547
24411
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
1.8e-01
5.3e-01
1.8e+00
—
2.6e+00
2.0e+00
9.7e-01
cases:7.03%
controls:5.95%
cases:5.96%
controls:3.60%
cases:4.37%
controls:0.77%
—
—
cases:9.03%
controls:0.71%
cases:21.71%
controls:3.62%
cases:18.06%
controls:7.74%
204
1720
2696
27193
173
1042
2730
27896
127
224
2776
28714
—
258
205
2598
28685
516
1025
1861
27306
295
1929
1338
22981
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
1.4e-01
6.2e-01
2.5e+00
1.0e+50
2.4e+00
1.9e+00
5.0e-01
cases:1.72%
controls:1.51%
cases:1.69%
controls:0.92%
cases:1.24%
controls:0.10%
cases:0.52%
controls:0.00%
cases:1.58%
controls:0.15%
cases:6.98%
controls:1.09%
cases:6.43%
controls:4.01%
50
436
2850
28477
49
266
2854
28672
36
30
2867
28908
15
0
2888
28938
45
44
2811
28846
166
310
2211
28021
105
998
1528
23912
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
1.9e-01
3.7e-01
1.7e+00
—
3.9e+00
1.4e+00
8.2e-01
cases:5.97%
controls:4.96%
cases:1.89%
controls:1.32%
cases:0.59%
controls:0.10%
—
—
cases:5.67%
controls:0.12%
cases:4.50%
controls:1.16%
cases:7.90%
controls:3.65%
173
1435
2727
27478
55
382
2848
28556
17
30
2886
28908
—
162
34
2694
28856
107
330
2270
28001
129
910
1504
24000
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
7.4e-01
8.5e-01
1.5e+00
—
2.1e+00
1.6e+00
1.2e+00
cases:3.28%
controls:1.59%
cases:1.38%
controls:0.59%
cases:0.41%
controls:0.10%
—
—
cases:0.63%
controls:0.08%
cases:2.69%
controls:0.58%
cases:5.21%
controls:1.66%
95
461
2805
28452
40
171
2863
28767
12
28
2891
28910
—
18
23
2838
28867
64
165
2313
28166
85
414
1548
24496
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
6.7e-01
1.4e+00
—
—
3.5e+00
2.0e+00
9.7e-01
cases:1.00%
controls:0.51%
cases:0.62%
controls:0.15%
—
—
—
—
cases:0.56%
controls:0.02%
cases:0.84%
controls:0.12%
cases:1.22%
controls:0.47%
29
148
2871
28765
18
44
2885
28894
—
—
16
5
2840
28885
20
34
2357
28297
20
117
1613
24793
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
7.7e-02
1.2e+00
—
—
2.2e+00
3.2e+00
1.2e+00
cases:0.45%
controls:0.42%
cases:0.48%
controls:0.15%
—
—
—
—
cases:0.49%
controls:0.05%
cases:2.65%
controls:0.12%
cases:1.78%
controls:0.52%
13
120
2887
28793
14
44
2889
28894
—
—
14
15
2842
28875
63
33
2314
28298
29
129
1604
24781
Neck ultrasound examination
EP1AE [2001302284]
EP1AE [2001302284]
1.1e+00
2.1e+00
—
—
—
2.5e+00
2.1e+00
cases:1.03%
controls:0.36%
cases:0.48%
controls:0.06%
—
—
—
—
—
—
cases:0.72%
controls:0.06%
cases:2.27%
controls:0.28%
30
104
2870
28809
14
17
2889
28921
—
—
—
17
17
2360
28314
37
69
1596
24841
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
1.1e-01
3.7e-01
2.0e+00
—
3.3e+00
1.5e+00
6.2e-01
cases:6.76%
controls:6.09%
cases:3.96%
controls:2.76%
cases:2.17%
controls:0.31%
—
—
cases:7.67%
controls:0.30%
cases:10.94%
controls:2.65%
cases:14.70%
controls:8.47%
196
1760
2704
27153
115
798
2788
28140
63
90
2840
28848
—
219
88
2637
28802
260
751
2117
27580
240
2110
1393
22800
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
1.6e-01
6.7e-01
2.7e+00
1.0e+50
2.4e+00
2.0e+00
4.0e-01
cases:1.17%
controls:1.00%
cases:1.24%
controls:0.64%
cases:1.03%
controls:0.07%
cases:0.38%
controls:0.00%
cases:1.16%
controls:0.11%
cases:5.51%
controls:0.82%
cases:4.41%
controls:3.00%
34
290
2866
28623
36
185
2867
28753
30
20
2873
28918
11
0
2892
28938
33
31
2823
28859
131
231
2246
28100
72
748
1561
24162
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
2.9e-01
4.8e-01
2.0e+00
—
2.7e+00
2.0e+00
1.0e+00
cases:0.93%
controls:0.70%
cases:1.00%
controls:0.62%
cases:0.90%
controls:0.13%
—
—
cases:1.86%
controls:0.12%
cases:4.88%
controls:0.68%
cases:5.08%
controls:1.93%
27
202
2873
28711
29
180
2874
28758
26
37
2877
28901
—
53
35
2803
28855
116
193
2261
28138
83
481
1550
24429
Ultrasound examination of mammary glands
HA1AE [2001303886]
HA1AE [2001303886]
1.9e+00
1.8e+00
—
—
—
1.9e+00
2.0e+00
cases:0.79%
controls:0.12%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.34%
controls:0.05%
cases:0.92%
controls:0.12%
23
34
2877
28879
10
16
2893
28922
—
—
—
8
14
2369
28317
15
31
1618
24879
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7817-0 [3016888]
1.2e-01
1.8e+00
3.2e+00
—
2.7e+00
5.1e-01
-4.3e-01
cases:1.14%
controls:1.01%
cases:2.00%
controls:0.34%
cases:1.21%
controls:0.05%
—
—
cases:0.63%
controls:0.04%
cases:0.50%
controls:0.30%
cases:0.73%
controls:1.12%
33
292
2867
28621
58
99
2845
28839
35
15
2868
28923
—
18
12
2838
28878
12
86
2365
28245
12
279
1621
24631
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
-1.6e-01
2.4e+00
—
1.0e+50
—
3.4e+00
1.8e+00
cases:0.34%
controls:0.40%
cases:0.69%
controls:0.06%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.51%
controls:0.05%
cases:1.22%
controls:0.20%
10
117
2890
28796
20
18
2883
28920
—
11
0
2892
28938
—
36
15
2341
28316
20
49
1613
24861
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
-8.8e-03
1.3e-01
1.3e+00
4.2e+00
2.0e+00
3.9e-01
-2.4e-01
cases:16.93%
controls:17.05%
cases:9.58%
controls:8.49%
cases:4.72%
controls:1.30%
cases:4.82%
controls:0.08%
cases:8.37%
controls:1.26%
cases:13.13%
controls:9.27%
cases:19.47%
controls:23.43%
491
4931
2409
23982
278
2458
2625
26480
137
375
2766
28563
140
23
2763
28915
239
364
2617
28526
312
2627
2065
25704
318
5836
1315
19074
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
9728-7 [3025271]
1.2e+00
2.0e+00
—
—
—
3.4e+00
2.2e+00
cases:0.24%
controls:0.07%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:1.30%
controls:0.05%
cases:0.73%
controls:0.08%
7
21
2893
28892
6
8
2897
28930
—
—
—
31
13
2346
28318
12
21
1621
24889
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
4.8e-01
7.9e-01
1.7e+00
1.0e+50
2.6e+00
2.5e+00
8.5e-01
cases:1.38%
controls:0.86%
cases:0.59%
controls:0.27%
cases:0.31%
controls:0.06%
cases:0.17%
controls:0.00%
cases:0.49%
controls:0.04%
cases:3.83%
controls:0.34%
cases:2.94%
controls:1.28%
40
249
2860
28664
17
77
2886
28861
9
17
2894
28921
5
0
2898
28938
14
11
2842
28879
91
95
2286
28236
48
319
1585
24591
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7818-8 [3008230]
2.2e-01
1.7e+00
3.2e+00
—
2.7e+00
7.0e-01
-4.2e-01
cases:1.38%
controls:1.11%
cases:2.07%
controls:0.40%
cases:1.24%
controls:0.05%
—
—
cases:0.67%
controls:0.04%
cases:0.67%
controls:0.34%
cases:0.80%
controls:1.21%
40
322
2860
28591
60
116
2843
28822
36
15
2867
28923
—
19
13
2837
28877
16
95
2361
28236
13
301
1620
24609
scopolamine
S01FA02 [21605061]
S01FA02 [21605061]
6.7e-01
1.6e+00
—
—
1.0e+50
4.5e+00
3.0e+00
cases:0.38%
controls:0.19%
cases:0.17%
controls:0.03%
—
—
—
—
cases:0.77%
controls:0.00%
cases:2.48%
controls:0.03%
cases:1.16%
controls:0.06%
11
56
2889
28857
5
10
2898
28928
—
—
22
0
2834
28890
59
8
2318
28323
19
14
1614
24896
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
6.8e-03
4.8e-01
—
—
4.4e+00
2.4e+00
7.5e-01
cases:1.07%
controls:1.06%
cases:0.72%
controls:0.45%
—
—
—
—
cases:2.94%
controls:0.04%
cases:3.53%
controls:0.33%
cases:2.33%
controls:1.11%
31
307
2869
28606
21
130
2882
28808
—
—
84
11
2772
28879
84
93
2293
28238
38
277
1595
24633
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
9.1e-02
5.1e-01
1.7e+00
—
3.5e+00
2.9e+00
1.0e+00
cases:0.66%
controls:0.60%
cases:0.31%
controls:0.19%
cases:0.17%
controls:0.03%
—
—
cases:0.70%
controls:0.02%
cases:2.10%
controls:0.11%
cases:1.65%
controls:0.59%
19
173
2881
28740
9
54
2894
28884
5
9
2898
28929
—
20
6
2836
28884
50
32
2327
28299
27
146
1606
24764
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]
10334-1 [3037551]
5.8e-01
1.6e+00
2.9e+00
—
2.9e+00
1.1e+00
5.1e-01
cases:0.90%
controls:0.50%
cases:0.76%
controls:0.15%
cases:0.52%
controls:0.03%
—
—
cases:0.39%
controls:0.02%
cases:0.38%
controls:0.13%
cases:0.86%
controls:0.52%
26
145
2874
28768
22
44
2881
28894
15
8
2888
28930
—
11
6
2845
28884
9
37
2368
28294
14
129
1619
24781
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
25587-7 [3014702]
1.2e+00
3.0e+00
—
—
—
2.4e+00
2.1e+00
cases:0.28%
controls:0.08%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:0.38%
controls:0.04%
cases:0.61%
controls:0.08%
8
24
2892
28889
10
5
2893
28933
—
—
—
9
10
2368
28321
10
19
1623
24891
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
5.4e-01
9.5e-01
1.8e+00
—
2.8e+00
2.3e+00
7.9e-01
cases:2.10%
controls:1.23%
cases:1.10%
controls:0.43%
cases:0.21%
controls:0.03%
—
—
cases:0.67%
controls:0.04%
cases:4.08%
controls:0.41%
cases:3.37%
controls:1.55%
61
356
2839
28557
32
124
2871
28814
6
10
2897
28928
—
19
12
2837
28878
97
115
2280
28216
55
387
1578
24523
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
2.1e-02
1.4e-01
1.4e+00
2.4e+00
1.8e+00
1.1e+00
6.2e-01
cases:7.52%
controls:7.37%
cases:5.30%
controls:4.65%
cases:4.44%
controls:1.09%
cases:0.31%
controls:0.03%
cases:7.21%
controls:1.27%
cases:12.75%
controls:4.51%
cases:12.80%
controls:7.31%
218
2132
2682
26781
154
1347
2749
27591
129
316
2774
28622
9
8
2894
28930
206
368
2650
28522
303
1279
2074
27052
209
1820
1424
23090
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
4.1e-01
9.3e-01
2.9e+00
1.0e+50
3.0e+00
1.6e+00
5.8e-01
cases:1.03%
controls:0.69%
cases:0.55%
controls:0.22%
cases:0.55%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.67%
controls:0.03%
cases:1.68%
controls:0.36%
cases:2.08%
controls:1.18%
30
199
2870
28714
16
63
2887
28875
16
9
2887
28929
11
0
2892
28938
19
10
2837
28880
40
102
2337
28229
34
294
1599
24616
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
AA1CM [2001300117]
8.0e-01
2.7e+00
1.0e+50
1.0e+50
1.0e+50
—
4.7e+00
cases:0.28%
controls:0.12%
cases:0.34%
controls:0.02%
cases:0.31%
controls:0.00%
cases:0.65%
controls:0.00%
cases:0.53%
controls:0.00%
—
—
cases:5.57%
controls:0.05%
8
36
2892
28877
10
7
2893
28931
9
0
2894
28938
19
0
2884
28938
15
0
2841
28890
—
91
13
1542
24897
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
1.8e-01
5.5e-01
1.8e+00
1.0e+50
3.2e+00
2.4e+00
5.7e-01
cases:1.31%
controls:1.09%
cases:0.55%
controls:0.32%
cases:0.24%
controls:0.04%
cases:0.31%
controls:0.00%
cases:0.98%
controls:0.04%
cases:3.24%
controls:0.32%
cases:2.02%
controls:1.15%
38
316
2862
28597
16
92
2887
28846
7
11
2896
28927
9
0
2894
28938
28
12
2828
28878
77
90
2300
28241
33
286
1600
24624
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
7.0e-01
6.2e-01
1.9e+00
—
3.1e+00
3.1e+00
1.2e+00
cases:0.93%
controls:0.46%
cases:0.45%
controls:0.24%
cases:0.21%
controls:0.03%
—
—
cases:1.19%
controls:0.06%
cases:4.42%
controls:0.22%
cases:3.18%
controls:0.97%
27
134
2873
28779
13
70
2890
28868
6
9
2897
28929
—
34
16
2822
28874
105
61
2272
28270
52
242
1581
24668
chloramphenicol
S01AA01 [21603554]
S01AA01 [21603554]
8.8e-02
1.9e-01
1.3e+00
3.5e+00
1.5e+00
6.7e-01
3.0e-01
cases:8.00%
controls:7.38%
cases:3.07%
controls:2.54%
cases:1.03%
controls:0.29%
cases:0.59%
controls:0.02%
cases:1.19%
controls:0.26%
cases:5.22%
controls:2.74%
cases:12.43%
controls:9.50%
232
2133
2668
26780
89
735
2814
28203
30
83
2873
28855
17
5
2886
28933
34
74
2822
28816
124
775
2253
27556
203
2366
1430
22544
chloramphenicol
S03AA08 [21605197]
S03AA08 [21605197]
8.8e-02
1.9e-01
1.3e+00
3.5e+00
1.5e+00
6.7e-01
3.0e-01
cases:8.00%
controls:7.38%
cases:3.07%
controls:2.54%
cases:1.03%
controls:0.29%
cases:0.59%
controls:0.02%
cases:1.19%
controls:0.26%
cases:5.22%
controls:2.74%
cases:12.43%
controls:9.50%
232
2133
2668
26780
89
735
2814
28203
30
83
2873
28855
17
5
2886
28933
34
74
2822
28816
124
775
2253
27556
203
2366
1430
22544
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
4.7e-01
6.6e-01
2.3e+00
1.0e+50
—
3.0e+00
2.1e+00
cases:0.93%
controls:0.58%
cases:0.21%
controls:0.11%
cases:0.21%
controls:0.02%
cases:0.28%
controls:0.00%
—
—
cases:3.11%
controls:0.17%
cases:2.76%
controls:0.36%
27
168
2873
28745
6
31
2897
28907
6
6
2897
28932
8
0
2895
28938
—
74
47
2303
28284
45
90
1588
24820
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
-1.2e-01
5.7e-01
2.0e+00
—
3.2e+00
1.5e+00
2.3e-01
cases:2.55%
controls:2.87%
cases:2.14%
controls:1.22%
cases:0.96%
controls:0.13%
—
—
cases:3.61%
controls:0.15%
cases:4.63%
controls:1.10%
cases:4.59%
controls:3.70%
74
830
2826
28083
62
352
2841
28586
28
38
2875
28900
—
103
42
2753
28848
110
311
2267
28020
75
921
1558
23989
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
-9.6e-02
3.7e-01
1.6e+00
3.2e+00
1.9e+00
2.3e-01
-7.5e-03
cases:15.97%
controls:17.30%
cases:12.50%
controls:8.96%
cases:6.65%
controls:1.39%
cases:1.07%
controls:0.04%
cases:7.14%
controls:1.18%
cases:10.98%
controls:8.91%
cases:22.47%
controls:22.61%
463
5002
2437
23911
363
2593
2540
26345
193
402
2710
28536
31
13
2872
28925
204
340
2652
28550
261
2524
2116
25807
367
5631
1266
19279
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
3.9e-01
5.1e-01
2.7e+00
—
2.6e+00
1.9e+00
6.0e-01
cases:0.48%
controls:0.33%
cases:0.31%
controls:0.19%
cases:0.41%
controls:0.03%
—
—
cases:0.39%
controls:0.03%
cases:1.22%
controls:0.18%
cases:1.35%
controls:0.75%
14
95
2886
28818
9
54
2894
28884
12
8
2891
28930
—
11
8
2845
28882
29
52
2348
28279
22
186
1611
24724
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
2.3e-01
4.7e-01
1.9e+00
—
2.5e+00
1.9e+00
9.1e-01
cases:0.79%
controls:0.63%
cases:1.00%
controls:0.63%
cases:0.86%
controls:0.13%
—
—
cases:1.61%
controls:0.13%
cases:4.29%
controls:0.68%
cases:4.78%
controls:1.98%
23
183
2877
28730
29
181
2874
28757
25
37
2878
28901
—
46
38
2810
28852
102
194
2275
28137
78
494
1555
24416
Intraoperative use of ultrasonographic imaging
ZXM00 [2001311445]
ZXM00 [2001311445]
—
—
—
1.0e+50
—
4.0e+00
3.2e+00
—
—
—
—
—
—
cases:0.55%
controls:0.00%
—
—
cases:0.93%
controls:0.02%
cases:0.61%
controls:0.02%
—
—
—
16
0
2887
28938
—
22
5
2355
28326
10
6
1623
24904
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
-3.5e-01
9.8e-01
3.3e+00
—
2.2e+00
7.0e-01
3.4e-01
cases:0.93%
controls:1.32%
cases:1.41%
controls:0.54%
cases:2.10%
controls:0.08%
—
—
cases:0.81%
controls:0.09%
cases:1.18%
controls:0.59%
cases:2.51%
controls:1.80%
27
382
2873
28531
41
155
2862
28783
61
23
2842
28915
—
23
25
2833
28865
28
167
2349
28164
41
449
1592
24461
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
G40.19 [2000502138]
—
2.3e+00
—
1.0e+50
1.0e+50
4.1e+00
3.1e+00
—
—
cases:0.17%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
cases:0.53%
controls:0.00%
cases:1.22%
controls:0.02%
cases:1.59%
controls:0.07%
—
5
5
2898
28933
—
5
0
2898
28938
15
0
2841
28890
29
6
2348
28325
26
18
1607
24892
Eye and orbita ultrasound examination
CA1AE [2001300862]
CA1AE [2001300862]
—
—
—
1.0e+50
1.0e+50
3.9e+00
3.3e+00
—
—
—
—
—
—
cases:0.17%
controls:0.00%
cases:0.32%
controls:0.00%
cases:0.84%
controls:0.02%
cases:1.16%
controls:0.04%
—
—
—
5
0
2898
28938
9
0
2847
28890
20
5
2357
28326
19
11
1614
24899
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
1.7e-01
6.5e-01
2.0e+00
—
2.5e+00
1.4e+00
5.0e-01
cases:4.59%
controls:3.89%
cases:2.79%
controls:1.48%
cases:2.07%
controls:0.28%
—
—
cases:2.84%
controls:0.23%
cases:6.23%
controls:1.56%
cases:6.55%
controls:4.10%
133
1126
2767
27787
81
428
2822
28510
60
80
2843
28858
—
81
66
2775
28824
148
441
2229
27890
107
1021
1526
23889
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
-1.4e-01
6.5e-01
2.5e+00
—
2.1e+00
1.4e+00
5.1e-01
cases:1.48%
controls:1.69%
cases:1.72%
controls:0.91%
cases:1.58%
controls:0.13%
—
—
cases:1.12%
controls:0.14%
cases:2.99%
controls:0.77%
cases:3.37%
controls:2.04%
43
490
2857
28423
50
262
2853
28676
46
37
2857
28901
—
32
41
2824
28849
71
219
2306
28112
55
509
1578
24401
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
-5.4e-01
8.7e-01
2.7e+00
1.0e+50
2.1e+00
1.4e+00
3.0e-02
cases:0.31%
controls:0.53%
cases:0.72%
controls:0.30%
cases:0.52%
controls:0.03%
cases:0.31%
controls:0.00%
cases:0.53%
controls:0.06%
cases:1.51%
controls:0.38%
cases:1.59%
controls:1.55%
9
153
2891
28760
21
88
2882
28850
15
10
2888
28928
9
0
2894
28938
15
18
2841
28872
36
109
2341
28222
26
385
1607
24525
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
-1.8e-01
8.0e-01
2.6e+00
1.0e+50
2.3e+00
1.4e+00
8.5e-02
cases:0.86%
controls:1.03%
cases:1.24%
controls:0.56%
cases:1.00%
controls:0.08%
cases:0.62%
controls:0.00%
cases:0.88%
controls:0.09%
cases:2.65%
controls:0.68%
cases:2.76%
controls:2.54%
25
299
2875
28614
36
163
2867
28775
29
22
2874
28916
18
0
2885
28938
25
25
2831
28865
63
193
2314
28138
45
632
1588
24278
leuprorelin; implant, parenteral
L02AE02 [21603825]
L02AE02 [21603825]
3.4e+00
3.7e+00
—
—
1.0e+50
—
—
cases:1.00%
controls:0.03%
cases:0.69%
controls:0.02%
—
—
—
—
cases:0.21%
controls:0.00%
—
—
—
—
29
10
2871
28903
20
5
2883
28933
—
—
6
0
2850
28890
—
—
Oral Surgery
19 [38004464]
19 [38004464]
3.7e-01
9.6e-01
—
—
2.8e+00
1.8e+00
1.4e+00
cases:0.83%
controls:0.57%
cases:0.55%
controls:0.21%
—
—
—
—
cases:0.39%
controls:0.02%
cases:1.22%
controls:0.19%
cases:2.33%
controls:0.59%
24
165
2876
28748
16
61
2887
28877
—
—
11
7
2845
28883
29
55
2348
28276
38
146
1595
24764
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
3.1e-01
8.7e-01
—
—
2.8e+00
2.2e+00
2.0e+00
cases:0.66%
controls:0.48%
cases:0.38%
controls:0.16%
—
—
—
—
cases:0.39%
controls:0.02%
cases:0.88%
controls:0.10%
cases:1.35%
controls:0.19%
19
139
2881
28774
11
46
2892
28892
—
—
11
7
2845
28883
21
27
2356
28304
22
48
1611
24862
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
G40.20 [2000502139]
—
—
—
1.0e+50
—
3.8e+00
3.1e+00
—
—
—
—
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.56%
controls:0.04%
cases:2.76%
controls:0.12%
—
—
—
11
0
2892
28938
—
37
10
2340
28321
45
31
1588
24879
Body temperature
8310-5 [3020891]
8310-5 [3020891]
-5.7e-01
-1.4e-02
1.7e+00
—
3.5e+00
1.7e+00
5.0e-01
cases:0.31%
controls:0.55%
cases:0.31%
controls:0.31%
cases:0.28%
controls:0.05%
—
—
cases:1.75%
controls:0.06%
cases:1.51%
controls:0.28%
cases:1.96%
controls:1.20%
9
159
2891
28754
9
91
2894
28847
8
14
2895
28924
—
50
16
2806
28874
36
80
2341
28251
32
298
1601
24612
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
-2.3e-01
8.0e-01
2.3e+00
1.0e+50
2.5e+00
1.3e+00
-1.8e-02
cases:0.55%
controls:0.70%
cases:0.93%
controls:0.42%
cases:0.65%
controls:0.07%
cases:0.55%
controls:0.00%
cases:0.77%
controls:0.07%
cases:2.06%
controls:0.55%
cases:1.96%
controls:2.00%
16
201
2884
28712
27
122
2876
28816
19
19
2884
28919
16
0
2887
28938
22
19
2834
28871
49
156
2328
28175
32
497
1601
24413
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
2.6e-01
4.8e-01
1.1e+00
2.7e+00
1.1e+00
8.4e-01
3.8e-01
cases:9.66%
controls:7.60%
cases:4.20%
controls:2.64%
cases:1.31%
controls:0.43%
cases:0.31%
controls:0.02%
cases:1.16%
controls:0.38%
cases:5.64%
controls:2.50%
cases:11.02%
controls:7.84%
280
2198
2620
26715
122
765
2781
28173
38
125
2865
28813
9
6
2894
28932
33
111
2823
28779
134
709
2243
27622
180
1953
1453
22957
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
32713-0 [3043409]
-3.4e-01
2.2e-01
—
1.0e+50
4.1e+00
2.0e+00
8.2e-01
cases:0.31%
controls:0.44%
cases:0.24%
controls:0.19%
—
—
cases:0.59%
controls:0.00%
cases:1.58%
controls:0.03%
cases:1.05%
controls:0.14%
cases:1.47%
controls:0.65%
9
126
2891
28787
7
56
2896
28882
—
17
0
2886
28938
45
8
2811
28882
25
40
2352
28291
24
163
1609
24747
Parabulbar anesthesia
WX140 [2001310772]
WX140 [2001310772]
6.3e-01
1.2e+00
—
—
—
4.1e+00
1.5e+00
cases:0.72%
controls:0.39%
cases:0.48%
controls:0.15%
—
—
—
—
—
—
cases:5.47%
controls:0.10%
cases:2.14%
controls:0.49%
21
112
2879
28801
14
43
2889
28895
—
—
—
130
28
2247
28303
35
123
1598
24787
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
6.3e-02
6.1e-01
2.1e+00
—
2.3e+00
1.3e+00
4.5e-01
cases:3.93%
controls:3.70%
cases:2.62%
controls:1.44%
cases:1.93%
controls:0.25%
—
—
cases:2.31%
controls:0.24%
cases:5.51%
controls:1.56%
cases:7.04%
controls:4.62%
114
1070
2786
27843
76
416
2827
28522
56
71
2847
28867
—
66
69
2790
28821
131
441
2246
27890
115
1151
1518
23759
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
-1.8e-01
3.0e-01
1.2e+00
—
3.9e+00
2.1e+00
7.6e-01
cases:1.48%
controls:1.77%
cases:1.07%
controls:0.79%
cases:0.28%
controls:0.08%
—
—
cases:3.05%
controls:0.07%
cases:4.38%
controls:0.56%
cases:3.67%
controls:1.75%
43
513
2857
28400
31
230
2872
28708
8
24
2895
28914
—
87
19
2769
28871
104
159
2273
28172
60
435
1573
24475
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
R1230 [2001310176]
—
—
—
—
—
4.2e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.02%
cases:0.92%
controls:0.08%
—
—
—
—
—
28
5
2349
28326
15
19
1618
24891
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
-9.9e-02
7.1e-01
2.7e+00
—
2.9e+00
1.1e+00
5.4e-01
cases:0.28%
controls:0.30%
cases:0.31%
controls:0.15%
cases:0.31%
controls:0.02%
—
—
cases:0.53%
controls:0.03%
cases:0.67%
controls:0.24%
cases:1.10%
controls:0.64%
8
88
2892
28825
9
44
2894
28894
9
6
2894
28932
—
15
8
2841
28882
16
67
2361
28264
18
160
1615
24750
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
4.6e-01
8.1e-01
—
—
2.8e+00
2.2e+00
1.8e+00
cases:0.24%
controls:0.15%
cases:0.24%
controls:0.11%
—
—
—
—
cases:0.39%
controls:0.02%
cases:1.14%
controls:0.13%
cases:1.41%
controls:0.24%
7
44
2893
28869
7
31
2896
28907
—
—
11
7
2845
28883
27
37
2350
28294
23
61
1610
24849
Thyroglobulin Ab [Units/volume] in Serum or Plasma
8098-6 [3025547]
8098-6 [3025547]
1.1e+00
2.8e+00
—
—
—
2.3e+00
1.6e+00
cases:0.28%
controls:0.09%
cases:0.28%
controls:0.02%
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.49%
controls:0.10%
8
27
2892
28886
8
5
2895
28933
—
—
—
5
6
2372
28325
8
24
1625
24886
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 [3020073]
20607-8 [3020073]
—
—
—
—
—
4.2e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.02%
cases:0.55%
controls:0.04%
—
—
—
—
—
32
6
2345
28325
9
11
1624
24899
Mononuclear cells/Leukocytes in Cerebral spinal fluid
26492-9 [3033306]
26492-9 [3033306]
—
1.9e+00
—
1.0e+50
—
2.9e+00
1.8e+00
—
—
cases:0.24%
controls:0.03%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.38%
controls:0.02%
cases:0.49%
controls:0.08%
—
7
10
2896
28928
—
7
0
2896
28938
—
9
6
2368
28325
8
20
1625
24890
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
-3.2e-01
1.3e-01
—
1.0e+50
3.9e+00
1.9e+00
7.8e-01
cases:0.34%
controls:0.47%
cases:0.24%
controls:0.21%
—
—
cases:0.62%
controls:0.00%
cases:1.58%
controls:0.03%
cases:1.09%
controls:0.16%
cases:1.59%
controls:0.74%
10
137
2890
28776
7
61
2896
28877
—
18
0
2885
28938
45
9
2811
28881
26
46
2351
28285
26
184
1607
24726
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
F43.22 [2000502003]
3.9e-01
9.1e-01
—
—
2.2e+00
2.7e+00
1.7e+00
cases:0.38%
controls:0.26%
cases:0.24%
controls:0.10%
—
—
—
—
cases:0.25%
controls:0.03%
cases:1.68%
controls:0.11%
cases:1.96%
controls:0.37%
11
74
2889
28839
7
28
2896
28910
—
—
7
8
2849
28882
40
31
2337
28300
32
92
1601
24818
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
-1.5e-01
7.2e-01
2.4e+00
1.0e+50
2.1e+00
1.4e+00
5.8e-02
cases:1.07%
controls:1.24%
cases:1.45%
controls:0.71%
cases:1.21%
controls:0.11%
cases:0.69%
controls:0.00%
cases:1.09%
controls:0.13%
cases:3.41%
controls:0.87%
cases:3.06%
controls:2.89%
31
359
2869
28554
42
206
2861
28732
35
32
2868
28906
20
0
2883
28938
31
39
2825
28851
81
246
2296
28085
50
721
1583
24189
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
-1.1e-01
7.2e-01
—
—
2.2e+00
2.4e+00
1.9e+00
cases:0.24%
controls:0.27%
cases:0.24%
controls:0.12%
—
—
—
—
cases:0.28%
controls:0.03%
cases:1.05%
controls:0.09%
cases:1.16%
controls:0.17%
7
78
2893
28835
7
34
2896
28904
—
—
8
9
2848
28881
25
26
2352
28305
19
42
1614
24868
brivaracetam; oral, parenteral
N03AX23 [1588665]
N03AX23 [1588665]
—
—
—
—
—
3.5e+00
3.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.02%
cases:1.29%
controls:0.06%
—
—
—
—
—
14
5
2363
28326
21
15
1612
24895
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
-1.1e-01
6.8e-01
2.4e+00
1.0e+50
2.1e+00
1.4e+00
9.0e-02
cases:1.10%
controls:1.23%
cases:1.38%
controls:0.70%
cases:1.14%
controls:0.10%
cases:0.65%
controls:0.00%
cases:1.09%
controls:0.14%
cases:3.45%
controls:0.85%
cases:3.06%
controls:2.81%
32
357
2868
28556
40
203
2863
28735
33
30
2870
28908
19
0
2884
28938
31
40
2825
28850
82
241
2295
28090
50
699
1583
24211
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
-1.2e-01
6.5e-01
2.4e+00
1.0e+50
2.1e+00
1.4e+00
3.7e-02
cases:1.14%
controls:1.28%
cases:1.38%
controls:0.73%
cases:1.17%
controls:0.11%
cases:0.62%
controls:0.00%
cases:1.16%
controls:0.14%
cases:3.45%
controls:0.89%
cases:3.00%
controls:2.89%
33
371
2867
28542
40
210
2863
28728
34
31
2869
28907
18
0
2885
28938
33
40
2823
28850
82
251
2295
28080
49
721
1584
24189
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
419
133
36.26
307.65
1.8
2.0
—
—
—
0
0
179
27
70.28
307.65
1.1
1.2
—
—
—
0
0
271
0
+∞
287.01
1.0
0.0
—
—
—
0
0
910
2878
4.06
250.75
7.8
8.3
1.11
1.11
mmol/l
0.01
727
2360
910
2897
4.03
248.15
7.9
8.4
5.01
5.09
kpa
2.17
875
2784
910
2897
4.03
248.15
7.9
8.3
16.60
11.72
kpa
78.26
876
2785
131
25
54.66
230.49
1.5
1.2
—
—
—
0
0
1039
3844
3.56
223.54
2.2
2.2
27.73
29.73
s
21.69
1013
3741
703
2302
3.66
178.22
5.8
2.6
239.98
232.33
u/l
0.94
686
2152
214
248
9.19
171.07
2.0
1.4
—
—
—
0
0
159
0
+∞
167.20
1.1
0.0
—
—
—
0
0
1999
12101
2.84
164.64
13.2
4.1
10.48
12.12
umol/l
9.31
1963
11391
317
601
5.76
161.23
2.0
1.4
2200.73
1274.55
e6/l
0.58
251
481
313
592
5.77
159.56
1.9
1.3
48.92
26.38
e6/l
0.57
239
448
1222
5921
2.76
153.76
4.6
3.9
93.04
87.96
%
11.76
1191
5785
329
676
5.32
152.95
1.8
1.3
990.11
513.96
mg/l
2.18
323
640
1836
11044
2.62
146.22
9.1
6.3
1.20
1.21
mmol/l
11.66
1774
10069
1129
5449
2.69
140.71
2.7
2.2
—
—
—
0
0
137
113
12.64
138.51
2.5
2.4
55.90
53.98
umol/l
0.19
122
98
1950
12419
2.54
132.16
9.8
6.5
1.20
1.21
mmol/l
9.71
1730
10680
288
601
5.18
131.08
1.7
1.2
3.58
3.83
mmol/l
2.66
278
569
2036
13520
2.47
121.29
18.7
6.9
4.10
4.26
e9/l
2.20
1788
11541
620
2385
3.00
116.41
9.3
9.3
125.93
122.78
g/l
3.62
603
2335
1686
10569
2.30
110.65
3.3
2.5
—
—
estimate
—
0
0
828
3792
2.61
110.63
4.3
3.0
0.83
0.82
mmol/l
0.66
796
3522
643
2594
2.87
110.15
9.2
8.7
97.32
95.12
%
19.95
623
2504
2142
14890
2.42
109.80
8.5
4.9
6.73
6.75
mmol/l
0.19
2093
14079
119
123
10.02
103.24
1.8
1.7
—
—
—
0
0
452
1601
3.13
96.91
8.2
11.0
95.44
93.46
%
10.45
452
1594
137
192
7.42
93.01
1.8
1.2
2.47
2.23
mmol/l
0.68
129
181
125
160
8.10
91.75
2.2
2.2
1049.79
1300.89
e6/l
2.00
113
139
1724
11477
2.13
90.30
10.4
6.1
2.20
2.95
%
36.96
1672
10685
1315
7989
2.12
86.64
8.0
2.1
2.35
2.35
mmol/l
0.01
1247
7077
1624
10681
2.09
86.48
6.3
4.2
34.86
35.90
g/l
10.42
1552
9884
1738
11752
2.09
85.52
10.7
6.1
24.43
27.84
%
30.75
1696
11089
103
117
9.07
83.18
2.2
2.0
—
—
—
0
0
1358
8461
2.08
82.53
2.8
2.2
175.85
224.15
u/l
1.52
1326
7983
1820
12634
2.07
81.94
10.3
5.9
0.58
0.59
e9/l
1.95
1564
10793
540
2296
2.64
81.52
3.0
1.9
342.43
372.20
nmol/l
1.25
517
2102
1707
11593
2.05
81.45
10.3
6.0
60.24
57.27
%
18.59
1674
11020
1820
12678
2.05
80.60
10.3
5.9
0.03
0.04
e9/l
19.26
1564
10835
1833
12925
2.02
76.93
10.5
6.0
1.66
1.89
e9/l
5.16
1592
11301
1845
13106
2.01
75.01
11.0
6.1
0.14
0.20
e9/l
42.74
1596
11361
61
35
17.75
74.91
6.6
4.8
45.94
40.68
umol/l
0.58
52
29
360
1348
2.89
68.86
11.3
11.7
16.77
16.09
%
4.22
341
1302
329
1177
3.01
68.31
3.3
1.5
22.89
2.71
ug/l
0.77
254
873
1655
11571
1.92
67.62
10.9
16.9
1.16
1.31
inr
28.02
1426
9689
77
90
8.75
60.75
3.3
2.7
28.28
30.23
umol/l
0.64
61
65
2149
25158
0.52
55.11
4.9
6.0
2.74
2.68
mmol/l
2.54
1985
23493
664
10931
0.50
53.47
1.9
1.9
1.35
1.37
mmol/l
0.15
575
9255
2110
24787
0.53
53.34
4.4
5.2
4.64
4.58
mmol/l
2.06
1950
23220
2318
18784
1.93
53.26
15.5
5.9
77.87
77.18
u/l
0.29
2258
17580
81
119
6.96
52.59
2.1
1.2
61.66
53.75
%
0.42
29
16
81
120
6.90
52.19
2.3
2.2
165.39
228.15
e6/l
1.88
69
103
81
121
6.85
51.79
2.2
2.2
514.36
490.59
e6/l
0.13
66
98
2097
24631
0.54
51.74
4.3
5.2
1.43
1.44
mmol/l
0.36
1940
22917
84
134
6.41
50.45
1.2
1.1
—
—
—
0
0
471
2302
2.23
50.45
7.6
8.3
1.37
1.39
mmol/l
0.18
462
2253
464
2284
2.21
48.72
5.6
7.7
7.55
10.28
mmol/l
15.60
440
2184
2019
23845
0.56
47.77
5.7
6.6
39.02
39.64
mmol/mol
2.62
1888
22372
62
75
8.41
47.57
1.9
1.1
22.36
31.44
%
—
25
9
67
92
7.42
46.22
3.1
2.7
39.81
46.53
%
1.88
43
44
709
4178
1.90
45.03
2.1
1.8
—
—
—
0
0
79
134
6.02
44.65
1.1
1.1
2.01
1.09
u/l
1.54
42
63
145
409
3.67
43.95
4.0
6.1
468.96
547.20
iu/ml
0.09
24
56
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
74
121
6.24
43.39
1.2
1.1
—
—
—
0
0
763
4677
1.84
42.47
4.4
2.1
2.45
2.44
mmol/l
0.97
705
4093
1488
11047
1.67
41.31
18.7
10.1
0.00
0.00
e9/l
1.41
1191
8986
560
3164
1.94
39.87
2.0
1.8
—
—
—
0
0
1019
6897
1.71
39.80
3.4
3.1
0.46
0.40
e6/l
0.25
772
5013
139
409
3.51
39.53
3.4
5.6
348.58
358.01
umol/l
0.32
130
362
146
445
3.39
39.31
3.0
2.1
32.08
25.24
u/ml
0.19
128
353
534
2986
1.95
39.13
2.0
1.8
—
—
—
0
0
103
251
4.21
38.29
1.1
1.1
—
—
—
0
0
107
269
4.08
38.16
3.4
2.3
1.95
1.18
%
1.05
98
226
2024
23530
0.60
37.96
3.8
4.4
1.30
1.30
mmol/l
0.05
1871
21669
147
479
3.17
35.50
14.2
7.4
10.77
11.59
mmol/l
2.41
128
430
147
480
3.16
35.38
14.2
7.4
105.70
105.02
mmol/l
0.65
128
431
1152
8252
1.63
35.09
5.1
2.8
31.98
36.95
u/l
1.05
1109
7751
1132
8078
1.63
34.99
3.4
3.3
30.90
74.57
e6/l
3.27
875
6123
329
1605
2.17
34.75
12.4
6.7
25.23
24.47
mmol/l
3.30
307
1540
43
52
8.37
32.98
4.9
2.2
1.91
1.07
%
1.23
43
52
80
182
4.48
32.50
1.1
1.1
551.94
265.33
mg/l
1.50
72
158
346
1771
2.07
32.15
3.2
2.4
8.87
10.66
g/l
13.73
322
1635
82
193
4.34
31.91
1.2
1.2
79.30
37.83
mg/l
1.25
68
159
59
105
5.71
31.76
1.1
1.1
655.68
150.62
ng/l
0.62
22
26
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
185
732
2.62
31.27
3.1
4.2
0.40
0.34
iu/ml
0.87
100
419
221
970
2.38
29.94
2.0
2.3
533.96
718.62
ug/l
0.30
209
919
110
336
3.36
29.53
5.9
6.8
9.78
11.94
mg/l
5.56
104
311
168
660
2.63
28.80
1.9
1.7
—
—
—
0
0
66
142
4.73
28.73
1.4
1.2
0.49
0.53
ratio
0.80
30
86
82
216
3.87
27.46
3.6
2.6
17.56
19.07
nmol/l
0.58
82
198
2142
24107
0.64
27.12
4.7
5.2
5.91
5.99
mmol/l
2.18
1965
22129
49
86
5.77
26.77
1.3
1.1
—
—
—
0
0
72
177
4.14
26.51
1.1
1.1
—
—
—
0
0
263
1303
2.11
26.50
1.5
1.5
—
—
—
0
0
523
3259
1.73
26.06
5.5
6.0
1.02
1.05
mmol/l
0.98
491
3003
221
1035
2.22
25.66
12.1
5.2
0.98
0.86
%
4.67
203
974
594
3870
1.66
24.95
3.0
3.0
2.26
2.47
e6/l
0.21
291
1836
233
1136
2.14
24.45
11.8
4.9
1.55
1.62
%
0.66
215
1075
56
121
4.69
24.28
1.1
1.1
—
—
—
0
0
78
220
3.61
23.70
1.7
1.3
—
—
—
0
0
73
197
3.77
23.66
2.8
2.7
—
—
—
0
0
429
2613
1.74
22.98
2.9
2.4
7.16
7.67
umol/l
0.25
365
2257
1197
9268
1.47
22.84
4.1
3.8
54.99
100.22
e6/l
3.25
885
6414
30
10
30.27
22.76
7.0
1.0
91.35
17.45
u/ml
—
30
10
1899
16090
1.46
22.46
5.1
4.5
2199.50
1947.09
e6/l
0.05
26
242
124
475
2.68
22.37
3.8
4.4
2.34
2.58
mmol/l
0.43
89
303
630
4283
1.59
21.96
2.9
2.9
1.08
1.18
e6/l
0.21
330
2261
138
564
2.51
21.83
1.9
1.4
—
—
—
0
0
281
1529
1.92
21.69
1.7
1.7
—
—
—
0
0
103
367
2.87
21.33
2.0
1.4
—
—
—
0
0
129
518
2.55
21.18
1.9
2.9
32.35
36.36
umol/l
0.86
115
472
125
500
2.56
20.69
1.5
1.7
—
—
—
0
0
93
321
2.96
20.41
1.2
1.2
—
—
—
0
0
131
543
2.47
20.12
1.9
1.4
—
—
—
0
0
712
9635
0.66
20.08
3.2
3.5
7.72
7.64
mmol/l
0.18
597
8177
34
58
5.91
19.15
1.3
1.4
—
—
—
0
0
109
425
2.62
19.02
1.4
1.5
—
—
—
0
0
681
9215
0.67
18.89
3.9
4.2
11.35
8.38
mg/mmol
0.96
434
5797
81
281
2.93
17.65
1.6
1.5
283.22
279.45
mosm/kgh2o
0.70
68
211
384
2435
1.66
17.47
4.5
3.2
—
—
—
0
0
80
284
2.86
16.74
2.0
1.5
—
—
—
0
0
282
1663
1.76
16.72
1.9
1.6
—
—
—
0
0
157
761
2.12
16.72
2.2
2.9
—
—
—
0
0
751
5591
1.45
16.41
3.0
2.6
5.25
5.37
e6/l
0.08
699
5070
27
19
14.32
16.29
1.5
2.3
—
—
—
0
0
180
932
1.99
16.03
2.0
1.7
1.02
1.62
ug/l
0.83
155
815
61
194
3.19
15.47
1.9
1.4
—
—
—
0
0
136
644
2.16
15.39
2.3
1.5
7.47
8.07
u/l
0.25
107
506
411
2731
1.58
15.36
5.2
3.8
5.72
5.84
kpa
1.97
401
2648
314
1959
1.67
15.14
2.1
2.2
0.22
0.21
g/l
3.04
289
1794
146
718
2.08
14.99
1.4
1.3
—
—
—
0
0
45
121
3.76
14.76
1.2
1.1
—
—
—
0
0
400
2675
1.57
14.50
5.3
3.8
2.01
1.83
mmol/l
0.62
352
2327
52
158
3.33
14.21
1.4
1.6
—
—
—
0
0
72
265
2.76
14.14
1.3
1.1
—
—
—
0
0
75
283
2.69
14.04
1.9
1.5
—
—
—
0
0
288
4439
0.61
13.88
1.3
1.3
17.08
12.80
u/ml
0.40
106
1739
2131
23256
0.73
13.68
5.4
5.2
1.82
1.94
mu/l
3.79
1983
21498
13
0
+∞
13.55
1.1
0.0
—
—
—
0
0
112
518
2.21
13.47
1.5
1.3
—
—
—
0
0
112
518
2.21
13.47
1.5
1.3
—
—
—
0
0
21
13
16.26
13.44
1.1
1.1
—
—
—
0
0
291
1853
1.63
12.91
5.9
3.0
1.22
1.23
mmol/l
1.24
269
1564
1212
10088
1.33
12.75
4.1
3.9
79.21
88.55
ng/l
0.07
949
7164
138
715
1.97
12.31
2.7
2.8
102.19
91.98
%
5.31
133
700
23
22
10.52
12.23
1.3
1.4
—
—
—
0
0
131
669
2.00
12.18
2.9
2.5
202.47
182.87
%
1.53
125
636
143
756
1.93
12.04
3.0
1.5
48.01
23.94
u/ml
1.90
137
723
54
187
2.92
11.91
2.5
2.3
66.23
58.57
%
2.24
48
150
328
4753
0.65
11.78
1.4
1.3
31.99
32.30
iu/ml
0.02
109
1412
2581
27181
0.70
11.78
41.2
21.6
132.65
136.80
g/l
37.54
2563
26827
2581
27180
0.70
11.76
40.7
21.5
6.97
6.73
e9/l
4.72
2528
26409
345
2336
1.54
11.74
5.2
3.3
4.70
4.59
kpa
0.41
336
2256
2581
27175
0.70
11.67
40.7
21.4
4.40
4.53
e12/l
32.82
2526
26414
2581
27175
0.70
11.67
41.5
21.9
39.59
41.02
%
7.59
2558
26803
2581
27172
0.70
11.62
40.6
21.4
91.41
91.04
fl
3.90
2558
26812
2580
27163
0.70
11.61
40.7
21.5
239.67
247.18
e9/l
6.20
2530
26515
35
94
3.75
11.55
5.4
1.1
44.14
102.60
u/ml
—
5
29
103
491
2.14
11.53
1.6
1.4
—
—
—
0
0
226
1391
1.67
11.45
2.6
1.5
1.46
1.19
g/l
0.79
211
1286
25
52
4.84
11.42
2.1
2.4
1.79
2.81
ratio
1.01
25
47
160
900
1.82
11.13
2.2
1.4
23.18
25.24
iu/l
0.37
132
760
30
74
4.08
11.12
2.3
2.4
510.00
3405.58
u/ml
—
5
12
29
71
4.11
10.86
1.0
1.1
—
—
—
0
0
22
28
7.90
10.09
1.9
1.1
55.92
46.25
%
0.30
13
12
99
494
2.04
9.88
1.9
1.5
—
—
—
0
0
123
662
1.89
9.87
4.1
3.5
2.79
2.02
index
0.74
80
340
20
39
5.15
9.83
1.3
1.1
—
—
—
0
0
247
1616
1.57
9.78
5.9
4.1
24.80
24.19
mmol/l
3.03
241
1595
29
78
3.74
9.59
1.2
1.1
—
—
—
0
0
37
118
3.16
9.45
4.4
1.9
4.38
3.76
nmol/l
0.21
37
112
73
329
2.25
9.45
1.5
1.3
—
—
—
0
0
106
1933
0.53
9.44
1.7
1.7
3.45
3.50
mmol/l
0.19
79
1364
657
5190
1.34
9.36
3.8
4.0
133.14
481.01
ng/l
6.04
522
4138
84
410
2.08
8.93
1.3
1.5
121.46
139.93
au/ml
0.50
21
146
127
719
1.80
8.71
10.9
4.2
1.38
1.56
mg/l
1.67
116
649
259
1770
1.51
8.42
2.2
2.4
10.08
20.64
au/ml
4.22
18
170
8
0
+∞
8.33
1.0
0.0
—
—
—
0
0
169
2616
0.63
8.07
1.9
2.0
3.43
3.53
ratio
0.60
144
2056
303
2163
1.44
7.90
3.0
2.2
71.31
68.77
e9/l
0.56
230
1569
237
1615
1.51
7.82
1.2
1.3
54.35
55.55
au/ml
—
8
113
24
66
3.66
7.73
1.3
1.3
—
—
—
0
0
26
76
3.44
7.66
1.2
1.1
—
—
—
0
0
37
913
0.40
7.66
1.2
1.2
1.50
1.51
g/l
0.08
37
913
167
1058
1.61
7.61
1.9
2.0
34.96
39.65
u/l
2.44
150
927
22
58
3.81
7.52
2.0
1.2
—
—
—
0
0
17
24
7.11
7.47
1.1
1.3
—
—
—
0
0
33
844
0.38
7.43
1.2
1.1
0.56
0.65
ratio
—
8
97
62
290
2.16
7.41
2.0
1.5
0.22
0.35
nmol/l
2.17
47
239
25
73
3.44
7.38
1.2
1.1
—
—
—
0
0
1357
15172
0.81
7.38
2.9
2.9
—
—
—
0
0
26
78
3.35
7.37
1.2
1.1
—
—
—
0
0
19
32
5.97
7.36
1.1
1.3
—
—
—
0
0
72
360
2.02
7.24
1.1
1.1
—
—
—
0
0
42
169
2.51
7.08
2.0
1.4
—
—
—
0
0
21
56
3.77
7.07
1.6
3.4
34.71
45.21
%
1.18
21
56
209
1418
1.51
7.06
3.2
3.1
4.26
4.53
pmol/l
3.26
192
1254
1030
11810
0.81
7.00
2.1
2.1
94.89
95.48
pmol/l
0.16
578
6207
137
846
1.65
6.95
1.9
1.7
—
—
—
0
0
78
409
1.93
6.87
1.6
1.4
—
—
—
0
0
21
58
3.64
6.74
2.0
1.2
—
—
—
0
0
21
58
3.64
6.74
2.0
1.2
—
—
—
0
0
78
417
1.89
6.51
1.6
1.3
—
—
—
0
0
27
90
3.02
6.49
1.1
1.0
—
—
—
0
0
1028
11725
0.82
6.48
3.0
3.1
176.95
120.66
ug/l
4.05
957
10937
20
56
3.59
6.31
3.3
6.7
7.70
7.68
%
0.01
20
56
614
7386
0.79
6.29
4.0
3.7
22.84
24.12
%
1.18
301
3349
22
66
3.35
6.27
1.2
1.1
—
—
—
0
0
45
199
2.28
6.21
2.0
1.2
2.97
2.98
ug/l
0.01
36
178
220
1556
1.45
6.06
3.9
4.3
2.10
1.78
mmol/l
0.67
179
1108
27
94
2.89
6.04
3.7
3.0
1.24
1.57
ug/l
0.27
27
84
33
128
2.59
6.04
1.8
1.4
—
—
—
0
0
479
5905
0.78
5.97
1.3
1.3
1.99
1.65
u/ml
0.18
117
1596
1812
19490
0.83
5.89
4.8
4.2
14.80
14.82
pmol/l
0.08
1684
17884
16
40
4.01
5.89
1.6
1.6
—
0.68
—
0
5
47
217
2.18
5.87
1.1
1.1
—
—
—
0
0
30
114
2.65
5.72
1.8
1.4
—
—
—
0
0
15
27
5.58
5.67
1.7
1.4
—
—
—
0
0
202
1425
1.45
5.65
3.4
2.9
1.19
1.24
%
0.30
202
1417
47
223
2.12
5.51
4.7
3.7
14.89
14.01
index
0.15
38
123
233
1700
1.40
5.42
4.1
3.1
129.35
131.27
g/l
0.64
228
1644
138
911
1.54
5.36
2.2
1.8
—
—
—
0
0
294
2233
1.35
5.34
2.1
2.3
33.26
61.29
u/l
0.68
246
1846
30
119
2.54
5.28
1.9
1.4
—
—
—
0
0
14
26
5.40
5.22
1.1
1.1
—
—
—
0
0
189
1340
1.44
5.17
5.0
3.7
48.79
48.36
%
0.08
189
1314
121
783
1.57
5.15
2.4
1.7
416.83
290.54
mu/l
1.75
114
714
58
306
1.91
5.11
1.4
1.9
—
1493.33
—
0
12
14
27
5.20
5.07
1.1
1.0
—
—
—
0
0
35
740
0.47
5.00
1.3
1.3
—
—
—
0
0
51
263
1.95
4.82
1.7
2.0
14263.95
29.30
u/ml
0.49
46
235
109
700
1.58
4.82
3.4
1.5
2.20
1.69
ratio
0.45
54
402
802
9156
0.83
4.70
4.8
4.0
2.91
1.93
ug/l
1.79
714
8300
242
1824
1.35
4.64
4.0
4.3
5.19
5.17
kpa
0.14
235
1732
37
172
2.16
4.62
2.1
1.2
—
—
—
0
0
37
172
2.16
4.62
2.1
1.2
—
—
—
0
0
37
172
2.16
4.62
2.1
1.2
—
—
—
0
0
248
3229
0.75
4.60
2.6
2.6
184.58
145.10
ug/g
0.57
207
2587
23
86
2.69
4.57
2.0
1.2
—
—
—
0
0
23
86
2.69
4.57
2.0
1.2
—
—
—
0
0
23
86
2.69
4.57
2.0
1.2
—
—
—
0
0
23
86
2.69
4.57
2.0
1.2
—
—
—
0
0
14
31
4.53
4.55
1.1
1.2
—
—
—
0
0
29
123
2.37
4.48
1.1
1.4
—
—
—
0
0
14
32
4.39
4.43
1.1
1.0
—
—
—
0
0
1045
11607
0.85
4.37
2.5
2.5
75.82
77.40
nmol/l
1.02
958
10414
44
225
1.97
4.30
1.5
1.4
1.29
1.28
promille
0.01
33
173
2571
26537
0.82
4.22
34.3
18.4
75.32
79.09
umol/l
5.59
2545
26159
13
30
4.35
4.12
1.1
2.2
—
—
—
0
0
261
2027
1.31
4.11
3.8
1.6
65.12
66.71
g/l
2.39
234
1827
20
479
0.41
4.02
1.3
1.1
3.91
4.49
u/ml
0.06
12
266
142
1974
0.71
4.01
1.4
1.5
—
—
—
0
0
9
14
6.44
3.98
1.0
1.1
—
—
—
0
0
121
1728
0.69
3.98
1.4
1.3
269.53
233.26
u/ml
0.20
111
1607
13
32
4.07
3.89
1.0
1.2
—
—
—
0
0
17
59
2.89
3.89
1.4
2.3
21.14
19.22
umol/l
0.26
17
59
53
904
0.58
3.88
1.8
1.9
4.26
4.68
mg/l
0.15
44
655
58
337
1.73
3.84
1.4
1.4
314.31
324.93
pmol/l
0.10
52
288
9
15
6.01
3.81
1.7
4.0
—
—
—
0
0
242
3075
0.77
3.76
1.6
1.8
1.78
1.49
%
2.80
203
2721
6
5
12.02
3.76
7.2
1.0
—
—
—
0
0
41
740
0.55
3.69
1.4
1.6
1068.64
1010.95
mu/l
0.15
32
617
2543
26214
0.83
3.67
20.1
10.4
30.45
26.47
u/l
12.73
2503
25318
1773
18768
0.87
3.55
4.4
4.4
12.59
11.54
mm/h
2.04
1666
17559
113
786
1.45
3.52
3.7
1.5
30.74
34.24
mg/l
0.30
94
654
113
788
1.45
3.48
3.7
1.5
34.86
47.04
mg/l
2.53
93
659
31
152
2.05
3.45
3.9
3.5
17.10
26.91
mu/l
0.83
31
145
456
5345
0.83
3.43
3.0
2.8
0.74
0.71
ug/l
0.33
316
3348
12
32
3.76
3.38
1.1
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
18
70
2.58
3.38
1.2
1.1
80.56
106.17
%
1.84
18
64
27
127
2.14
3.35
1.1
1.1
1222.67
1615.98
miu/ml
1.05
27
127
28
546
0.51
3.28
1.2
1.1
5.70
2.23
u/ml
0.47
17
307
246
1962
1.28
3.21
3.4
2.3
65.13
66.81
ml/min/173m2
0.22
84
786
8
15
5.34
3.19
1.1
1.4
—
—
—
0
0
80
1178
0.67
3.15
1.5
1.7
0.39
0.32
mg/l
0.44
36
571
15
362
0.41
3.14
1.2
1.1
14.01
4.63
u/ml
—
7
172
71
461
1.55
3.11
1.4
1.4
256.49
255.17
u/ml
0.01
44
275
11
30
3.68
3.08
1.0
1.2
—
—
—
0
0
10
25
4.01
3.08
2.2
2.3
3.90
4.80
ug/l
—
10
25
6
8
7.51
3.05
7.5
6.0
—
—
—
0
0
8
16
5.01
3.05
1.0
1.1
—
—
—
0
0
17
68
2.51
3.04
1.2
1.1
83.56
91.62
%
—
9
34
17
69
2.47
2.95
1.2
1.0
87.89
89.35
%
—
9
34
2023
21115
0.88
2.93
35.1
18.3
333.63
332.80
g/l
3.54
2005
20991
42
694
0.60
2.81
1.5
1.5
8932.53
12171.78
e6/l
0.57
30
491
21
97
2.17
2.76
2.0
1.6
—
—
—
0
0
21
97
2.17
2.76
2.0
1.6
—
—
—
0
0
677
7546
0.87
2.70
1.7
1.7
19.41
20.16
nmol/l
0.70
601
6350
23
441
0.52
2.62
1.2
1.1
3.40
1.57
u/ml
0.32
14
229
2296
23709
0.88
2.59
26.8
13.6
85.31
80.13
ml/min/173m2
27.28
2142
21714
549
6195
0.86
2.59
4.2
4.0
1.02
1.27
kg/l
0.50
383
4053
5
7
7.15
2.55
1.2
1.1
1.90
1.33
mg/l
—
5
7
131
994
1.33
2.53
5.0
4.8
25.43
24.63
mmol/l
1.97
125
908
197
2437
0.80
2.52
1.8
2.1
—
—
—
0
0
55
357
1.55
2.48
1.4
1.4
0.61
5.58
nmol/l
0.50
55
344
8
21
3.82
2.46
1.1
1.0
—
—
—
0
0
6
12
5.01
2.40
1.0
1.0
—
—
—
0
0
7
17
4.12
2.36
1.1
1.1
—
—
—
0
0
9
216
0.41
2.30
1.3
1.4
112.34
209.83
pmol/l
—
9
216
50
324
1.55
2.29
14.0
6.4
6.93
7.36
mmol/l
0.46
42
273
117
888
1.33
2.29
2.3
1.4
9.68
10.22
g/l
0.63
102
774
412
3595
1.17
2.24
2.6
2.8
23.53
22.92
%
0.34
385
3328
0
61
0.00
2.23
0.0
1.1
—
64.54
—
0
61
180
2216
0.80
2.23
1.7
2.1
—
—
—
0
0
33
194
1.71
2.22
1.3
1.2
110.33
107.13
pmol/l
0.12
33
194
262
3098
0.83
2.18
4.1
5.1
32.00
32.43
%
0.28
197
2040
8
24
3.34
2.18
1.1
1.0
—
—
—
0
0
94
1253
0.74
2.17
1.1
1.1
—
1.44
—
0
14
26
144
1.81
2.14
2.2
1.8
—
—
—
0
0
12
264
0.45
2.09
1.4
1.5
48.75
59.11
ug/l
0.65
12
264
19
356
0.53
2.08
1.3
1.6
—
—
—
0
0
54
365
1.49
2.07
1.3
1.2
—
—
—
0
0
24
132
1.82
2.03
2.4
3.0
101.79
98.27
%
0.15
24
126
128
1003
1.29
2.02
2.4
1.4
4.21
4.24
g/l
0.14
115
895
128
1003
1.29
2.02
2.4
1.4
7.46
7.48
g/l
0.05
115
893
46
303
1.53
2.00
1.4
1.3
0.20
0.19
nmol/l
0.20
39
251
10
38
2.64
2.00
1.2
1.0
—
—
—
0
0
16
310
0.51
1.96
2.5
1.7
—
—
—
0
0
21
112
1.88
1.96
1.3
1.5
—
1199236.27
iu/ml
—
0
11
93
701
1.34
1.95
2.5
1.4
0.00
0.00
g/l
-0.00
78
623
89
667
1.34
1.94
1.3
1.2
—
—
—
0
0
127
1002
1.28
1.92
2.4
1.4
3.47
3.76
g/l
2.03
114
893
140
1119
1.26
1.91
1.8
1.7
1.67
1.53
g/l
0.80
123
964
96
731
1.32
1.89
2.5
1.4
0.05
0.00
g/l
0.58
81
667
119
938
1.28
1.83
2.3
1.4
2.89
2.91
g/l
0.08
105
829
5
12
4.17
1.82
1.8
1.2
—
—
—
0
0
27
440
0.61
1.82
1.3
1.5
79.29
60.19
ug/l
0.68
22
368
749
8099
0.90
1.74
3.3
3.3
1012.30
1466.59
ng/l
5.59
667
6957
109
856
1.28
1.74
2.8
1.4
1.13
0.39
g/l
1.49
85
736
87
663
1.32
1.73
2.5
1.4
0.00
0.00
g/l
-0.00
78
622
1739
16716
1.09
1.65
3.9
3.2
64.51
45.97
u/l
5.96
1658
15642
74
972
0.76
1.61
1.7
1.6
17.47
17.57
u/ml
0.00
15
208
5
14
3.57
1.61
1.0
1.1
—
—
—
0
0
6
20
3.00
1.58
1.3
1.1
—
—
—
0
0
31
199
1.56
1.56
2.1
2.7
34.30
30.69
mg/l
0.21
20
141
437
3937
1.13
1.54
2.5
2.7
2.28
2.31
g/l
0.56
412
3622
20
115
1.74
1.52
1.3
1.3
—
—
—
0
0
2521
24704
1.11
1.46
28.0
14.3
21.98
23.67
mg/l
2.22
2330
19991
14
73
1.92
1.43
1.4
1.3
—
—
—
0
0
14
73
1.92
1.43
1.4
1.3
—
—
—
0
0
12
227
0.53
1.43
1.1
1.3
3.18
2.24
u/ml
—
7
136
13
66
1.97
1.43
3.1
2.8
0.63
0.61
mmol/l
0.51
13
66
275
3118
0.87
1.42
1.4
1.5
—
—
—
0
0
600
5529
1.11
1.42
1.9
1.8
1.75
1.22
mg/l
1.99
493
4231
37
254
1.46
1.40
1.4
1.2
—
—
—
0
0
82
642
1.28
1.39
2.1
2.2
131.12
131.68
g/l
0.07
69
519
511
5571
0.90
1.39
1.6
1.7
47887810.68
32708486.87
pmol/l
0.18
426
4638
37
255
1.46
1.38
1.4
1.2
—
—
—
0
0
37
256
1.45
1.35
1.4
1.2
—
—
—
0
0
106
1298
0.81
1.35
1.0
1.1
—
—
—
0
0
27
406
0.66
1.34
1.4
1.4
1.51
1.12
ratio
0.54
15
254
27
406
0.66
1.34
1.4
1.5
0.93
0.97
ratio
0.19
15
254
27
406
0.66
1.34
1.4
1.5
1.31
1.22
ratio
0.24
16
254
31
208
1.49
1.32
1.5
1.4
26380.63
65327.96
e6/l
0.56
16
118
7
149
0.47
1.31
3.1
1.8
173.71
117.76
ng/l
—
7
149
39
275
1.42
1.30
1.4
1.2
—
—
—
0
0
27
402
0.67
1.29
1.4
1.4
—
—
—
0
0
13
69
1.89
1.28
1.2
1.1
—
—
—
0
0
249
2197
1.14
1.25
2.6
2.4
11.96
14.70
nmol/l
6.23
223
2002
386
4245
0.90
1.24
1.4
1.5
—
—
—
0
0
88
1085
0.81
1.22
1.6
2.1
—
—
—
0
0
57
434
1.32
1.22
1.7
2.1
4.75
4.96
mmol/24h
0.16
47
376
463
4253
1.10
1.18
2.5
2.7
13.31
13.20
umol/l
0.11
434
3937
30
206
1.46
1.17
2.7
2.3
1.33
1.68
u/field
0.38
15
126
10
50
2.00
1.16
1.7
1.1
—
—
—
0
0
12
210
0.57
1.14
1.0
1.3
10.25
8.82
mmol/l
0.50
12
200
11
197
0.56
1.14
1.2
1.2
—
—
—
0
0
151
1294
1.18
1.13
4.1
3.2
1.02
1.02
ratio
2.23
140
1185
7
137
0.51
1.09
1.0
1.3
—
—
—
0
0
109
1297
0.83
1.08
1.6
2.2
—
—
—
0
0
22
327
0.67
1.08
1.7
2.2
0.11
0.53
mmol/l
0.30
22
315
94
776
1.22
1.07
1.1
1.4
—
—
—
0
0
37
270
1.37
1.06
1.4
1.2
—
—
—
0
0
18
113
1.60
1.05
1.3
1.3
—
—
—
0
0
29
205
1.42
1.00
2.1
2.3
639.16
623.93
ml
0.09
19
133
25
172
1.46
0.99
1.0
1.1
3.28
12.82
nmol/l
—
7
37
91
1090
0.83
0.99
1.6
1.8
5.66
6.31
iu/ml
0.09
16
252
36
481
0.75
0.98
1.2
1.4
—
—
—
0
0
0
29
0.00
0.97
0.0
1.2
—
6.09
—
0
29
21
306
0.68
0.95
1.5
1.5
55.45
62.75
%
0.37
15
195
15
93
1.62
0.93
1.1
1.2
—
—
—
0
0
33
243
1.36
0.92
1.5
1.4
1245.30
1800.04
e6/l
0.73
23
170
52
653
0.79
0.90
2.6
2.2
274.65
111.01
ug/min
0.51
27
394
62
760
0.81
0.88
1.9
2.0
202.71
211.20
pmol/l
0.29
56
720
18
119
1.52
0.88
2.1
2.3
—
—
—
0
0
18
119
1.52
0.88
1.9
1.8
1.31
3.49
u/field
0.83
13
93
50
395
1.27
0.87
1.1
1.3
5.25
5.71
u/ml
0.09
20
190
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
824
7857
1.07
0.85
2.9
2.5
57.58
60.06
u/l
0.48
773
7252
36
273
1.32
0.85
1.4
1.2
—
—
—
0
0
75
623
1.21
0.85
2.3
2.1
1489.36
4517.83
u/l
1.10
25
265
638
6736
0.93
0.84
2.2
2.4
2.92
2.74
mg/l
1.10
563
5809
55
676
0.81
0.81
1.4
1.5
—
—
—
0
0
48
382
1.26
0.81
1.1
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
262
2397
1.10
0.78
2.2
2.4
5.28
8.07
ug/l
3.04
226
2121
12
74
1.62
0.78
1.1
1.2
—
—
—
0
0
6
34
1.77
0.76
9.0
11.0
5.05
5.80
mmol/l
—
6
34
28
209
1.34
0.75
1.1
1.1
—
—
—
0
0
52
635
0.82
0.74
1.5
1.5
—
—
—
0
0
50
405
1.24
0.74
1.2
1.1
—
0.93
—
0
17
16
230
0.69
0.72
1.1
1.3
—
—
—
0
0
6
110
0.54
0.72
1.0
1.1
153.30
194.73
iu/ml
—
6
110
52
426
1.22
0.70
1.5
1.6
—
—
—
0
0
5
26
1.92
0.70
1.2
1.1
—
—
—
0
0
12
180
0.67
0.67
28.3
19.2
1232.00
1378.78
nmol/l
0.30
12
174
48
581
0.82
0.65
1.2
1.2
7.51
50.20
u/ml
—
7
54
17
236
0.72
0.64
1.5
1.5
—
—
—
0
0
8
131
0.61
0.63
3.0
1.7
—
—
—
0
0
991
10235
0.95
0.62
4.3
3.7
0.04
0.08
estimate
0.41
283
2186
22
165
1.34
0.60
1.2
1.5
—
—
—
0
0
67
779
0.86
0.60
1.2
1.2
15.52
41.03
u/ml
—
6
39
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
16
220
0.73
0.59
2.4
1.7
12.33
25.08
u/ml
—
6
50
15
106
1.42
0.57
1.6
1.4
4.15
4.80
umol/l
0.26
15
91
11
161
0.68
0.57
1.4
1.6
7.43
8.47
mmol/l
0.94
11
161
89
1008
0.88
0.56
1.1
1.2
0.64
1.12
u/ml
—
5
78
12
172
0.70
0.56
13.8
15.0
624.58
795.69
nmol/l
0.72
12
166
17
124
1.37
0.55
1.9
2.7
280.18
168.47
umol/l
0.30
11
74
6
37
1.62
0.55
2.0
2.3
—
—
—
0
0
6
37
1.62
0.55
2.0
2.3
—
—
—
0
0
12
82
1.46
0.54
3.1
1.2
22.57
1424.13
pmol/l
—
6
11
773
7467
1.05
0.51
4.2
4.0
0.00
0.00
estimate
1.08
309
2473
17
225
0.75
0.51
1.1
1.1
—
—
—
0
0
64
734
0.87
0.50
1.2
1.3
27.46
5.69
u/ml
—
10
105
86
965
0.89
0.49
1.8
2.0
40.19
40.24
nmol/l
0.01
86
933
64
732
0.87
0.49
1.2
1.2
2.39
2.69
u/ml
—
7
58
76
671
1.14
0.48
1.2
1.1
—
3.83
—
0
88
2088
20604
1.04
0.48
35.0
17.2
13.97
13.54
%
32.67
2076
20274
10
143
0.70
0.47
1.1
1.1
—
—
—
0
0
148
1606
0.92
0.46
1.2
1.2
173.47
139.47
u/ml
0.32
45
623
8
118
0.68
0.45
1.4
2.5
162.88
158.75
nmol/l
—
8
106
8
118
0.68
0.45
4.4
4.6
—
—
—
0
0
50
578
0.86
0.45
1.5
2.0
0.89
0.83
nmol/l
0.20
43
488
697
7194
0.96
0.43
3.5
2.9
0.19
0.05
0.43
21
188
1391
13646
1.03
0.42
4.2
3.8
0.01
0.01
estimate
0.15
336
2543
21
261
0.80
0.41
1.1
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
37
315
1.18
0.40
1.7
1.3
—
—
—
0
0
46
399
1.15
0.39
1.2
1.2
4.88
3.68
u/ml
0.17
16
145
227
2140
1.07
0.39
2.4
3.4
174.39
219.55
ng/l
1.16
205
1956
7
103
0.68
0.39
2.4
2.9
25.34
94.35
ug/l
—
7
93
17
215
0.79
0.39
1.1
1.1
—
—
—
0
0
17
215
0.79
0.39
1.1
1.1
—
—
—
0
0
1384
13597
1.03
0.38
4.1
3.8
11.24
4.96
estimate
0.46
354
2752
16
203
0.79
0.38
1.1
1.2
—
—
—
0
0
29
344
0.84
0.37
1.0
1.1
—
2.77
—
0
61
24
289
0.83
0.36
1.0
1.1
—
—
—
0
0
112
1213
0.92
0.36
1.9
2.0
0.03
0.65
estimate
0.48
35
389
105
1138
0.92
0.35
1.3
1.3
—
—
—
0
0
10
74
1.35
0.32
7.2
7.5
6.91
5.15
kpa
—
10
74
59
653
0.90
0.31
1.1
1.1
2.95
7.53
eliau/ml
—
6
70
17
208
0.82
0.31
1.1
1.2
—
—
—
0
0
16
129
1.24
0.30
1.1
1.2
—
—
—
0
0
7
55
1.27
0.30
6.3
8.1
10.81
10.22
%
—
7
55
65
713
0.91
0.29
1.4
1.4
276.59
296.02
ug/g
0.38
41
425
21
249
0.84
0.29
1.1
1.2
—
—
—
0
0
79
852
0.93
0.26
1.9
1.7
—
—
—
0
0
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
203
2117
0.96
0.24
2.6
2.4
0.46
0.42
e6/l
0.09
195
2017
487
4993
0.97
0.24
2.0
1.4
2.20
2.49
g/l
1.77
319
2976
15
125
1.20
0.22
1.4
1.6
7.25
8.83
ug/l
0.27
15
107
10
79
1.27
0.22
1.2
1.5
235.70
70.67
nmol/24h
—
10
79
661
6737
0.98
0.22
3.2
2.4
318.92
351.07
umol/l
12.80
592
5869
44
401
1.10
0.21
1.2
1.2
23.14
20.11
u/l
0.24
39
344
0
10
0.00
0.21
0.0
4.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
7.93
—
0
11
64
687
0.93
0.20
1.5
2.0
3.13
12.35
iu/l
0.55
24
274
0
14
0.00
0.20
0.0
1.1
—
38.15
—
0
6
21
183
1.15
0.20
1.2
1.6
80.10
85.81
umol/l
0.32
21
183
1357
13426
1.02
0.19
4.1
3.8
0.01
0.00
estimate
0.73
338
2679
65
694
0.94
0.18
1.2
1.3
147.00
218.20
miu/ml
0.64
18
313
29
261
1.11
0.18
2.6
4.1
—
—
—
0
0
7
58
1.21
0.18
1.9
1.6
0.44
0.47
e9/l
—
7
58
58
541
1.07
0.18
3.3
3.7
32.49
28.00
mg/l
0.24
35
387
7
59
1.19
0.18
1.1
1.2
264.86
259.90
pmol/l
—
7
40
19
167
1.14
0.16
1.3
1.2
—
—
—
0
0
5
70
0.71
0.16
1.0
1.0
0.13
1.81
u/ml
—
5
70
722
7121
1.02
0.15
4.2
3.2
0.04
0.16
estimate
0.46
273
2103
46
429
1.07
0.15
1.1
1.1
1.00
1560.29
iu/ml
—
9
85
9
81
1.11
0.15
2.7
2.8
9.48
9.98
kpa
—
9
81
9
81
1.11
0.15
2.7
2.8
4.81
5.00
kpa
—
9
81
7
90
0.78
0.14
1.1
1.5
—
—
—
0
0
21
230
0.91
0.11
1.3
1.1
—
85.10
—
0
10
66
690
0.96
0.11
1.3
1.1
—
—
—
0
0
199
1946
1.02
0.10
3.9
4.1
108.84
90.11
ng/l
1.30
173
1662
2551
25439
1.01
0.10
31.5
17.4
139.14
139.78
mmol/l
25.07
2523
24890
66
687
0.96
0.10
1.3
1.1
—
—
—
0
0
5
45
1.11
0.09
1.2
2.2
—
—
—
0
0
314
3092
1.02
0.09
10.3
6.6
—
—
—
0
0
13
116
1.12
0.09
1.4
1.8
1.17
5.97
nmol/l
1.68
13
94
13
116
1.12
0.09
1.1
1.3
200.38
174.85
mmol/24h
0.53
13
116
20
216
0.93
0.08
1.1
1.3
—
330.00
—
0
6
7
67
1.04
0.08
1.3
1.2
—
13.00
—
0
25
18
166
1.08
0.07
1.3
1.2
—
—
—
0
0
86
841
1.02
0.05
1.6
1.5
0.00
4.24
iu/ml
0.52
13
150
459
4557
1.01
0.05
1.8
1.8
1122.52
1159.11
nmol/l
0.42
369
3467
73
719
1.02
0.02
1.4
1.3
—
—
—
0
0
14
146
0.96
0.00
1.3
1.1
—
—
—
0
0
2551
25498
1.00
0.00
31.2
17.5
3.96
3.99
mmol/l
5.94
2518
24891
11
113
0.97
0.00
1.2
1.2
9.27
8.70
mm/h
0.06
11
113
32
324
0.99
0.00
1.0
1.1
2.32
2.50
eliau/ml
—
10
139
30
299
1.00
0.00
2.0
2.2
18.56
19.31
mg/l
—
9
97
13
127
1.02
0.00
1.0
1.1
—
—
—
0
0
15
145
1.03
0.00
1.0
1.2
131.93
139.63
nmol/l
0.25
15
145
21
211
1.00
0.00
1.1
1.0
303.14
289.85
mg/l
0.31
21
190
0
7
0.00
-0.00
0.0
1.4
—
2.86
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.4
—
410.60
—
0
5
7
70
1.00
-0.00
1.0
1.2
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.6
—
—
—
0
0
6
64
0.94
-0.00
1.0
1.4
1.16
1.17
mmol/l
—
6
64
0
9
0.00
-0.00
0.0
1.7
—
1.36
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
8
84
0.95
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
-0.00
1.8
1.2
39.64
39.89
g/l
—
8
87
5
57
0.88
-0.00
1.0
1.2
—
—
—
0
0
8
88
0.91
-0.00
2.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
1.67
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_EYE_BRAIN_NEURO_WIDE – Malignant neoplasm of eye, brain and central nervous system, including Hilmo
GWS hits: 5
This endpoint is excluded (different definition than used in FinnGen).